Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1434
Encontrada(s) 15 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation

  • Juárez Fernández, María
  • Porras Sanabria, David
  • Petrov, Petar
  • Román Sagüillo, Sara
  • García Mediavilla, María Victoria
  • Soluyanova, Polina
  • Martínez Flórez, Susana
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Jover Atienza, Ramiro
  • Sánchez Campos, Sonia
[EN] Gut microbiota plays a key role in obesity and non-alcoholic fatty liver disease (NAFLD), so synbiotics could be a therapeutic alternative. We aim to evaluate a nutritional intervention together with the administration of the bacteria Akkermansia muciniphila and the antioxidant quercetin in an in vivo model of early obesity and NAFLD. 21-day-old rats were fed with control or high-fat diet for six weeks. Then, all animals received control diet supplemented with/without quercetin and/or A. muciniphila for three weeks. Gut microbiota, NAFLD-related parameters, circulating bile acids (BAs) and liver gene expression were analyzed. The colonization with A. muciniphila was associated with less body fat, while synbiotic treatment caused a steatosis remission, linked to hepatic lipogenesis modulation. The synbiotic promoted higher abundance of Cyanobacteria and Oscillospira, and lower levels of Actinobacteria, Lactococcus, Lactobacillus and Roseburia. Moreover, it favored elevated unconjugated hydrophilic BAs plasma levels and enhanced hepatic expression of BA synthesis and transport genes. A. muciniphila correlated with circulating BAs and liver lipid and BA metabolism genes, suggesting a role of this bacterium in BA signaling. Beneficial effects of A. muciniphila and quercetin combination are driven by gut microbiota modulation, the shift in BAs and the gut-liver bile flow enhancement., SI, This work was supported by grants from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R; PID2020-120363RB-I0), Junta de Castilla y León (FEDER) (GRS2126/A/2020; LE063U16; LE017P20), and Instituto de Salud Carlos III (PI17/01089, PI20/00690, cofunded by European Regional Development Fund “A way to achieve Europe”). MJF was supported by a fellowship from Ministerio de Ciencia, Innovación y Universidades (FPU18/06257); DP and SRS by a fellow-ship from Junta de Castilla y León cofunded by the European Social Fund; PP by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, cofunded by the European Social Fundation. CIBERehd is funded by the Instituto de Salud Carlos III, Spain.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat Mesquida, Margalida
  • Álvarez Álvarez, Laura
  • Rubín García, María
  • Martínez González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Goday, Albert
  • Martínez, J. Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • Lopez Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Riquelme Gallego, Blanca
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayón Orea, Carmen
  • Guillem Saiz, Patricia
  • Valle Hita, Cristina
  • Cabanes, Robert
  • Abete, Itziar
  • Goicolea Güemez, Leire
  • Gómez Gracia, Enrique
  • Tercero Maciá, Cristina
  • Colom, Antoni
  • García Ríos, Antonio
  • Castro Barquero, Sara
  • Fernández García, José C.
  • Santos Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío
  • Khoury, Nadine
  • Castañer, Olga
  • Zulet, María Ángeles
  • Vaquero Luna, Jessica
  • Bes-Rastrollo, Maira
  • Heras Delgado, Sara de las
  • Ciurana, Ramón
  • Martín Sánchez, Vicente
  • Tur, Josep A.
  • Bouzas, Cristina
[EN] Background Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims To assess the association between MetS severity and amount of carbon dioxide ( CO2) emitted in an adult population. Design Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. Trial registration ISRCTN, ISRCT N8989 8870. Registered 05 September 2013., SI, We thank all PREDIMED-Plus participants and investigators. CIBEROBN, CIBERESP, and CIBERDEM are initiatives of the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) food companies donated extra-virgin olive oil. The Almond Board of California (Modesto, CA), American Pistachio Growers (Fresno, CA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA) donated nuts for the PREDIMED-Plus pilot study., Funding This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. J.S-S is partially supported by ICREA under the ICREA Academia programme. C.B. was granted by Juan de la Cierva grant. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication., info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01120/ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS, info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01522//ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Prospective association of changes in (poly)phenol intake, body weight and physical activity with inflammatory profile

  • Rubín García, María
  • Vitelli Storelli, Facundo Ezequiel
  • Álvarez Álvarez, Laura
  • Fitó, Montserrat
  • Vázquez Ruiz, Zenaida
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Serra-Majem, Lluis
  • Wärnberg, Julia
  • Romaguera, Dora
  • Estruch, Ramón
  • Pintó, Xavier
  • Martínez, José Alfredo
  • Vázquez, Clotilde
  • Vidal, Josep
  • Tur, Josep A.
  • Alonso Gómez, Ángel M.
  • Ros, Emilio
  • Vioque, Jesús
  • López Miranda, José
  • Bueno Cavanillas, Aurora
  • Tinahones, Francisco J.
  • Lapetra, José
  • Daimiel, Lidia
  • Delgado Rodríguez, Miguel
  • Matía Martín, Pilar
  • Babio, Nancy
  • Schröder, Helmut
  • Lamuela Raventós, Rosa M.
  • Martín Sánchez, Vicente
  • Zamora Ros, Raúl
[EN] Backgrounds and aim: To prospectively evaluate the associations between changes in (poly)phenol intake, body weight(BW), and physical activity(PA) with changes in an inflammatory score after 1-year. Methods and results: This is a prospective observational analysis involving 484 participants from the PREDIMED-Plus with available inflammatory measurements. (Poly)phenol intake was estimated using a validated semi-quantitative food frequency questionnaire and the Phenol-Explorer database. An inflammatory score was calculated based on 8 blood biomarkers (IL-6, IL-8, IL-18, MCP-1, C-peptide, hs-CRP, leptin, and RANTES). The association between BW, PA, (poly)phenol intake and inflammatory score was evaluated using structural equations. Mediation analyses were performed to assess the relationship between change in (poly)phenol intake and inflammatory score was mediated by the change in BW. A higher increase in total (poly)phenol intake was related to a decrease in the inflammatory score (β = −0.005mg/1000 Kcal; CI95 % = -0.100,0.000) along with a decrease in BW (β = −0.006mg/1000 Kcal; CI95 % = -0.010,-0.003). Increased PA was associated with a lower inflammatory score (β = −0.129MET-min/d; CI95 % = −0.238,-0.021) and BW (β = −0.248MET-min/d; CI95 % = -0.343,-0.152). Finally, a decrease in BW was associated with a decrease in the inflammatory score (β = 0.240 kg; CI95 % = 0.155,0.325). Mediation analyses revealed that changes in BW explained 22 % of the overall association between changes in (poly)phenol intake and inflammatory score. Conclusions: An inverse association between changes in (poly)phenol intake and inflammatory status was observed, with BW playing a significant mediating role, emphasising the impact of BW reduction on inflammation reduction, SI, This work was supported by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigaci´on para la Salud (FIS), which is cofounded by the European Regional Development Fund (2 coordinated FIS projects [led by J.S.-S. and J.V.] funded by the following grant codes: PI13/00673, PI13/00492, PI13/00272, PI13/ 01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/ 01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/ 00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/ 00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/ 00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/ 01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/ 01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/ 01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/ 01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/ 00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Eu- ropean Research Council (Advanced Research Grant 2013–2018, grant number 340918); Recercaixa (2013ACUP00194); Consejería de Salud de la Junta de Andalucía (PI0458/2013); and a SEMERGEN grant. CIBERobn (Centros de Investigaci´on Biom´edica en Red: Obesidad y Nutrici´on), CIBEResp (Centros de Investigaci´on Biom´edica en Red: Epidemiologia y Salud Publica), and CIBERdem (Centros de Inves- tigaci´on Biom´edica en Red: Diabetes y Enfermedades Metab´olicas aso- ciadas) are initiatives of Carlos III Health Institute, Madrid, Spain. We thank CERCA Program/Generalitat de Catalunya for the institutional support to IDIBELL and IISPV, and PROMETEO 21/2021 from the Generalitat Valenciana. RZ-R was supported by the “Miguel Servet II” (CPII20/00009) program from the Instituto de Salud Carlos III (Co- funded by European Social Fund (ESF) investing in your future). J.S.-S. is partially supported by the ICREA Academia program. None of the funding sources took part in the design, collection, analysis or inter- pretation of the data, or in the decision to submit the manuscript for publication. The remaining authors have no disclosures to report
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways

  • Petrov, Petar Dianov
  • Soluyanova, Polina
  • Sánchez Campos, Sonia
  • Castell, José Vicente
  • Jover Atienza, Ramiro
[EN] Treatment of β-lactamase positive bacterial infections with a combination of amoxicillin (AMOX) and clavulanic acid (CLAV) causes idiosyncratic drug-induced liver injury (iDILI) in a relevant number of patients, often with features of intrahepatic cholestasis. This study aims to determine serum bile acid (BA) levels in amoxicillin/clavulanate (A+C)-iDILI patients and to investigate the mechanism of cholestasis by A+C in human in vitro hepatic models. In six A+C-iDILI patients, significant elevations of serum primary conjugated BA definitely demonstrated A+C-induced cholestasis. In cultured human Upcyte hepatocytes and HepG2 cells, CLAV was more cytotoxic than AMOX, and, at subcytotoxic concentrations, it altered the expression of more than 1,300 genes. CLAV, but not AMOX, downregulated the expression of key genes for BA transport (BSEP, NTCP, OSTα and MDR2) and synthesis (CYP7A1 and CYP8B1). CLAV also caused early oxidative stress, with reduced GSH/GSSG ratio, along with induction of antioxidant nuclear factor erythroid 2-related factor 2 (NRF2) target genes. Activation of NRF2 by sulforaphane also resulted in downregulation of NTCP, OSTα, ABCG5, CYP7A1 and CYP8B1. CLAV also inhibited the BA-sensor farnesoid X receptor (FXR), in agreement with the downregulation of FXR targets BSEP, OSTα and ABCG5. We conclude that CLAV, the culprit molecule in A+C, downregulates several key biliary transporters by modulating NRF2 and FXR signaling, thus likely promoting intrahepatic cholestasis. On top of that, increased ROS production and GSH depletion may aggravate the cholestatic injury by A+C, SI, Patients in this study were part of a large DILI cohort recruited during the Project HECATOS (EU Grant Agreement No: 602156) and were diagnosed by Dr. Isabel Conde (Unit of Clinical Hepatotoxicity, Hospital La Fe), during her engagement to that project. This research was supported by Instituto de Salud Carlos III through the projects PI17/ 01089 and PI20/00690 (co-founded by European Regional Development Fund “A way to achieve Europe”). PDP is currently supported by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, co-founded by the European Social Fund
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Effect of dietary phenolic compounds intake on mortality in the “Seguimiento Universidad De Navarra” (SUN) Mediterranean cohort

  • Vázquez Ruiz, Zenaida
  • Toledo, Estefanía
  • Vitelli Storelli, Facundo Ezequiel
  • Bes Rastrollo, Maira
  • Martínez González, Miguel Ángel
[EN] Plant-based dietary patterns have been demonstrated to reduce the risk of non-communicable disease (NCD), including cardiovascular disease (CVD), type 2 diabetes, cancer, and all-cause mortality. Phenolic compounds (PC), abundant in plant-based foods, have been considered as instrumental in this attenuation of NCD risk. We evaluated the association between dietary intake of PC and the risk of all-cause mortality in a relatively young Mediterranean cohort of 18,173 Spanish participants in the “Seguimiento Universidad de Navarra” (SUN) project, after a median follow-up of 12.7 years. Intake of PC was estimated at baseline and repeatedly after 10-year follow-up using a 136-item validated food frequency questionnaire and the Phenol-Explorer database. During 236,329 person-years, 544 deaths were confirmed. Cox regression models compared low intake (lowest quintile) vs. high intake (the four upper quintiles merged, as a reference category) of total energy-adjusted PC intake. Adjusted hazard ratios (HR) for low PC intake among those participants aged over 45 years during follow-up were 1.32; 95% CI 1.02–1.71 for all-cause mortality, HR:1.44; 95% CI 1.02–2.02 for cancer mortality; HR: 0.88; 95% CI 0.47–1.66 for CVD mortality and HR: 1.69 95% CI 1.04–2.74 for causes of death other than cancer or CVD. In conclusion, a low intake of total PC was associated with a significantly higher risk of all-cause mortality, and, specifically, a higher risk for cancer in a relatively young cohort. Among PC classes a low intake of flavonoids and phenolic acids showed significant effects for non-cancer/non-CVD mortality. Cherries, chocolate, apples and pears, olives, and coffee, were the major sources of between-person variability for total PC intake in our Mediterranean cohort, SI, Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The project SUN has received funding from the Spanish Government - Instituto de Salud Carlos III, and the European Regional Develop- ment Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI20/00564 and G03/140), the Government of Navarra (27/2011, 45/2011, 122/2014), the National Plan on Drugs (2020 / 021) as well as the University of Navarra
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Sarcopenic Obesity and Longitudinal Trajectories on Cognitive Performance and Subtle Cognitive Impairment Over 6 Years in Older Adults

  • Vázquez Lorente, Héctor
  • Paz Graniel, Indira
  • Margara Escudero, Hernando J.
  • Martínez González, Miguel Ángel
  • Romaguera, Dora
  • Martínez Urbistondo, Diego
  • Estruch, Ramón
  • Martín Sánchez, Vicente
  • Vidal, Josep
  • Fitó, Montserrat
  • Goñi, Nuria
  • Chaplin, Alice
  • Zulet, María Ángeles
  • Sacanella, Emilio
  • Paz Fernández, José Antonio de
  • Altés, Andreu
  • García Gavilán, Jesús Francisco
  • Konieczna, Jadwiga
  • Martínez, J. Alfredo
  • Salas Salvadó, Jordi
[EN] Background: Sarcopenic obesity has been suggested as a potential risk factor for cognitive decline; however, few prospective studies have been conducted to test this hypothesis. We aimed to assess the relationship between baseline sarcopenic obesity and 6-year trajectories of cognitive performance and subtle cognitive impairment in older adults. Methods: This longitudinal study comprised 1097 older adults aged 55–75 years (mean [SD] age, 65.3 [4.9] years; 506 females [46.1%] and 591 males [53.9%]) exhibiting baseline overweight/obesity and metabolic syndrome. Baseline lower-limb muscle strength was determined by the validated 30-s Chair Stand Test. Baseline total body weight, fat mass percentage and appendicular lean mass were obtained through dual-energy x-ray absorptiometry scans. Baseline sarcopenic obesity (n = 364 [33.2%]) was subsequently defined based on the new European Society for Clinical Nutrition and Metabolism and the European Association for the Study of Obesity consensus criteria. Cognitive performance was assessed at baseline, 2, 4 and 6 years of follow-up through five composite scores derived from a comprehensive battery of eight validated neuropsychological tests, encompassing global cognitive function, general cognitive function, executive function, attention and language. Subtle cognitive impairment was defined for those z-scores 0.5 standard deviations below the mean for each cognitive performance composite score at baseline. Linear and logistic two-level mixed models including lost to follow-up participants were fitted as main analyses. Complete case analyses were additionally performed. Results: After adjusting for multiple covariates, main analyses showed that, compared to older adults without sarcopenic obesity, those with sarcopenic obesity showed a higher decline in global cognitive function (between-group difference, −1.0 [95% CI, −2.2 to 0.2] after 6 years; overall p = 0.048) and general cognitive function (between-group difference, −2.5 [95% CI, −4.4 to 0.5] after 6 years; overall p = 0.028) and had a higher risk of subtle global cognitive function impairment (between-group difference, 2.3 [95% CI, 0.9 to 5.6] after 6 years; overall p = 0.038) over 6 years of follow-up. Associations remained consistent in the complete case analysis and attenuated when comparing those participants with baseline sarcopenic obesity with those only presenting sarcopenia, obesity or overweight. Of note, participants with baseline sarcopenia or obesity, compared to the absence of these conditions, showed no relationship with cognitive performance and subtle cognitive impairment over 6 years of follow-up. Conclusions: Sarcopenic obesity may be considered a potential independent risk factor for cognitive decline over the long term that warrants further evaluation in clinical settings, SI, This study was supported by the official Spanish Institutions for FundingScientific Biomedical Research, CIBER Fisiopatología de la Obesidad yNutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), throughthe Fondo de Investigación para la Salud (FIS), which is co-funded bythe European Regional Development Fund (six coordinated FIS proj-ects led by J.S.-S. and J.V., including the following projects: PI13/00673,PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184,PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618,PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972,PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094,PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120,PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827,PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926,PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017,PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138,PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158and PI23/00220); the Especial Action Project entitled: Implementación yevaluación de una intervención intensiva sobre la actividad física CohortePREDIMED-Plus grant to J.S.-S.; the European Research Council(Advanced Research Grant 2014–2019; agreement #340918) grantedto M.A.M.-G.; the Agencia Catalana de Recerca i Universitats, AGAUR(2021SGR00336 to J.S.-S; the Recercaixa (number 2013ACUP00194) grantto J.S.-S.; grants from the Consejería de Salud de la Junta de Andalucía(PI0458/2013, PS0358/2016 and PI0137/2018); the PROMETEO/21/2021and the AICO/2021/347 grants from the Generalitat Valenciana; theMINECO (CNS2022–135862) grant to D.R. and the Horizon 2020 PRIMEstudy (Prevention and Remediation of Insulin Multimorbidity in Europe;grant agreement #847879). J.K. received funding from ISCIII, throughthe Miguel Servet Project (CP24/00089), co-funded by the EuropeanUnion. H.V.-L. was funded by a research grant from the Agència de Gestiód‘Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV- 01).H.J.M.-E holds a ContratoPre-doctoral de Formacion en Investigacion en Salud (PFIS FI24/00038)funded by the ISCIII. None of the funding sources took part in the design,collection, analysis, interpretation of the data or writing of the report orin the decision to submit the manuscript for publication. J.S.-S., senior au-thor, gratefully acknowledges the financial support by ICREA under theICREA Academia program.Ethics StatementThe study protocol was approved by the Research Ethics Committees ofall recruiting centres. In addition, all participants signed an informedconsent form upon entry into the study.Conflicts of InterestThe authors declare no conflicts of interest.Data Availability StatementData described in the manuscript, codebook and analytic code will bemade available upon request pending application and approval of thePREDIMED-Plus Steering Committee. There are restrictions on theavailability of data for the PREDIMED-Plus trial, due to the signed con-sent agreements around data sharing, which only allow access to exter-nal researchers for studies following the project purposes. Requestorswishing to access the PREDIMED-Plus trial data used in this study canmake a request to the PREDIMED-Plus trial Steering Committee chair:jordi.salas@urv.cat. The request will then be passed to members of thePREDIMED-Plus Steering Committee for deliberation
Docta Complutense
Publication Artículo científico (JournalArticle)

Antipsychotic medication influences the discriminative value of acylethanolamides as biomarkers of substance use disorder

  • Herrera-Imbroda, Jesús
  • Flores-López, María
  • Requena-Ocaña, Nerea
  • Araos, Pedro
  • Ropero, Jessica
  • García Marchena, Nuria
  • Bordallo, Antonio
  • Suarez, Juan
  • Pavón-Morón, Francisco Javier
  • Serrano, Antonia
  • Mayoral, Fermín
  • Rodríguez De Fonseca, Fernando Antonio
Plasma acylethanolamides (NAEs), including the endocannabinoid anandamide (AEA), have been proposed as circulating biomarkers of substance use disorders. However, the concentration of these lipid transmitters might be influenced by the use of drugs prescribed for either the treatment of addiction or the associated psychiatric co-morbidities such as psychosis. As an example, neuroleptics, used for attenuation of psychotic symptoms and sedation, might theoretically interfere with the monoamine-mediated production of NAEs, obstructing the interpretation of plasma NAEsasclinical biomarkers. To solve the lack of information on the impact of neuroleptics on the concentration of NAEs, we evaluated the concentrations of NAEs in a control group and compared them to those present in (a) substance use disorders (SUD) patients that are not prescribed with neuroleptics, and (b) SUD patients (both alcohol use disorder and cocaine use disorder patients) using neuroleptics. The results demonstrate that SUD patients exhibited greater concentrations of NAEsthan the control population, affecting all species with the exception of stearoylethanolamide (SEA) and palmitoleoylethanolamide (POEA). Neuroleptic treatment enhanced the concentrations of NAEs, especially those of AEA, linoleoylethanolamide (LEA), and oleoylethanolamide (OEA). This effect of neuroleptic treatment was observed independently of the drug addiction that motivated the demand for treatment (either alcohol or cocaine). This study remarks the need to control the current use of psychotropic medication as a potential confounding variable when considering the use of NAEsasbiomarkers in SUD.
Docta Complutense
Publication Artículo científico (JournalArticle)

Is Time to Positivity in Staphylococcus aureus Bacteremia a Harbinger of Endocarditis?

  • Tonizzo, Anna
  • Muñoz García, Patricia Carmen
  • Burillo Albizua, Almudena
  • Adán, Iván
  • Alcalá Hernández, Luis
  • Bouza Santiago, Emilio
Esta carta al editor analiza críticamente el valor del tiempo hasta la positividad (time to positivity, TTP) de los hemocultivos en pacientes con bacteriemia por Staphylococcus aureus (SAB) como marcador para descartar endocarditis infecciosa (EI). A partir de una cohorte retrospectiva de 973 episodios de SAB registrados entre 2005 y 2024 en un hospital terciario, en la que todos los pacientes fueron evaluados sistemáticamente mediante ecocardiografía, los autores observan que, aunque el TTP fue significativamente más corto en pacientes con EI, no puede establecerse un punto de corte fiable para excluir la enfermedad. Un TTP >13 horas mostró un valor predictivo negativo del 86,6%, inferior al descrito en estudios previos, posiblemente debido a diferencias metodológicas y a una evaluación incompleta de EI en otras series. Los autores concluyen que el TTP puede aportar información útil, pero debe integrarse en modelos predictivos multifactoriales y no utilizarse de forma aislada para descartar endocarditis.
Docta Complutense
Publication Artículo científico (JournalArticle)

Influence of Boiling Processing and Hydration Steps on the Allergenic Content of Peanut and the Release of Major and Minor Allergens

  • Valdelvira, Rafael
  • Stodulski, Damian
  • Galleani, Celine
  • Crespo, Jesús F.
  • Cabanillas, Beatriz
The effects of food processing on the release of major and minor allergens from their biological sources have been only partially investigated in peanut. This study aimed to examine, in vitro, the impact of atmospheric boiling across a wide range of durations on the allergenic content of peanuts and the release of major and minor allergens from this legume. The influence of kernel pre-hydration was also assessed. Our findings indicate that pre-hydration increased the susceptibility of Ara h 1 to subsequent boiling, resulting in a significant reduction in its detectability within the kernel. In contrast, Ara h 2 and Ara h 3 were more boiling-resistant. The minor allergens Ara h 8 and Ara h 9 were released into the hydration water in smaller quantities than major allergens. Moreover, boiling did not facilitate the transfer of Ara h 8 and Ara h 9 into the boiling water. Our study demonstrated that major allergens were more readily released from peanuts through hydration than minor allergens. Additionally, our results revealed that peanuts subjected to hydration followed by boiling exhibited a reduced Ara h 1 content, which might have potential utility in the initial stages of immunotherapy in the future.
Docta Complutense
Publication Artículo científico (JournalArticle)

Sex-related disparities in the incidence and outcomes of infective endocarditis according to type 2 diabetes mellitus status in Spain, 2016–2020

  • López De Andrés, Ana Isabel
  • Jiménez García, Rodrigo
  • Hernández Barrera, Valentín
  • Miguel Díez, Javier De
  • Miguel Yanes, José María De
  • Martínez Hernández, David
  • Carabantes Alarcón, David
  • Zamorano León, José Javier
  • Noriega, Concepción
Background: We performed a study to assess sex-differences in incidence (2016-2020), clinical characteristics, use of therapeutic procedures, and in-hospital outcomes in patients with infective endocarditis (IE) according to T2DM status. Methods: Ours was a retrospective cohort study using data from the Spanish National Hospital Discharge Database. We estimated the incidence of hospitalizations for IE in men and women aged ≥ 40 years with and without T2DM. Propensity score matching (PSM) and multivariable logistic regression were used to compare subgroups according to sex and the presence of T2DM. Results: From 2016 to 2020, IE was coded in 9,958 patients (66.79% men). T2DM was diagnosed in 2,668 (26.79%). The incidence of IE increased significantly from 15.29 cases per 100,000 persons with T2DM in 2016 to 17.69 in 2020 (p < 0.001). However, this increment was significant only among men with T2DM (19.47 cases per 100,000 in 2016 vs. 22.84 in 2020; p = 0.003). The age-adjusted incidence of IE was significantly higher in people with T2DM (both sexes) than in those without T2DM (IRR, 2.86; 95% CI, 2.74-2.99). The incidence of IE was higher in men with T2DM than in women with T2DM (adjusted IRR, 1.85; 95% CI, 1.54-3.31). After PSM, in-hospital mortality (IHM) was higher among T2DM women than matched T2DM men (22.65% vs. 18.0%; p = 0.018). The presence of T2DM was not associated with IHM in men or women. Conclusions: T2DM is associated with a higher incidence of hospitalization for IE. Findings for T2DM patients who had experienced IE differed by sex, with higher incidence rates and lower IHM in men than in women. T2DM was not associated to IHM in IE in men or in women.
Docta Complutense
Publication Artículo científico (JournalArticle)

BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury

  • Saiz, M. L.
  • Lozano-Chamizo, L.
  • Florez, A. B.
  • Marciello, Marzia
  • Diaz-Bulnes, P.
  • Corte-Iglesias, V.
  • Bernet, C. R.
  • Rodrigues-Diez, R. R.
  • Martin-Martin, C.
  • Rodriguez-Santamaria, M.
  • Fernandez-Vega, I.
  • Rodriguez, R. M.
  • Diaz-Corte, C.
  • Suarez-Alvarez, B.
  • Filice, Marco
  • Lopez-Larrea, C.
Targeting epigenetic mechanisms has emerged as a potential therapeutic approach for the treatment of kidney diseases. Specifically, inhibiting the bromodomain and extra-terminal (BET) domain proteins using the small molecule inhibitor JQ1 has shown promise in preclinical models of acute kidney injury (AKI) and chronic kidney disease (CKD). However, its clinical translation faces challenges due to issues with poor pharmacokinetics and side effects. Here, we developed engineered liposomes loaded with JQ1 with the aim of enhancing kidney drug delivery and reducing the required minimum effective dose by leveraging cargo protection. These liposomes efficiently encapsulated JQ1 in both the membrane and core, demonstrating superior therapeutic efficacy compared to freely delivered JQ1 in a mouse model of kidney ischemia-reperfusion injury. JQ1-loaded liposomes (JQ1-NPs) effectively targeted the kidneys and only one administration, one-hour after injury, was enough to decrease the immune cell (neutrophils and monocytes) infiltration to the kidney—an early and pivotal step to prevent damage progression. By inhibiting BRD4, JQ1-NPs suppress the transcription of pro-inflammatory genes, such as cytokines (il-6) and chemokines (ccl2, ccl5). This success not only improved early the kidney function, as evidenced by decreased serum levels of BUN and creatinine in JQ1-NPs-treated mice, along with reduced tissue expression of the damage marker, NGAL, but also halted the production of extracellular matrix proteins (Fsp-1, Fn-1, α-SMA and Col1a1) and the fibrosis development. In summary, this work presents a promising nanotherapeutic strategy for AKI treatment and its progression and provides new insights into renal drug delivery.
Docta Complutense
Publication Artículo científico (JournalArticle)

Chronic Glaucoma Using Biodegradable Microspheres to Induce Intraocular Pressure Elevation. Six-Month Follow-Up

  • Rodrigo, María Jesús
  • García Herranz, David
  • Subías, Manuel
  • Martínez-Rincón, Teresa
  • Mendez-Martínez, Silvia
  • Bravo Osuna, Irene
  • Carretero, Ana
  • Ruberte, Jesús
  • García Feijoo, Julián
  • Pablo, Luis Emilio
  • Herrero Vanrell, María Del Rocío
  • García-Nartín, Elena
To compare two prolonged animal models of glaucoma over 24 weeks of follow-up. A novel pre-trabecular model of chronic glaucoma was achieved by injection of biodegradable poly lactic-co-glycolic acid (PLGA) microspheres (10–20 μm) (Ms20/10) into the ocular anterior chamber to progressively increase ocular hypertension (OHT). Methods: Rat right eyes were injected to induce OHT: 50% received a suspension of Ms20/10 in the anterior chamber at 0, 2, 4, 8, 12, 16 and 20 weeks, and the other 50% received a sclerosing episcleral vein injection biweekly (EPIm). Ophthalmological clinical signs, intraocular pressure (IOP), neuroretinal functionality measured by electroretinography (ERG), and structural analysis of the retina, retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) protocols using optical coherence tomography (OCT) and histological exams were performed. Results: Both models showed progressive neuroretinal degeneration (p < 0.05), and contralateral eye affectation. The Ms20/10 model showed a more progressive increase in IOP and better preservation of ocular surface. Although no statistical differences were found between models, the EPIm showed a tendency to produce thicker retinal and thinner GCL thicknesses, slower latency and smaller amplitude as measured using ERG, and more aggressive disturbances in retinal histology. In both models, while the GCL showed the greatest percentage loss of thickness, the RNFL showed the greatest and earliest rate of thickness loss. Conclusions: The intracameral model with biodegradable microspheres resulted more like the conditions observed in humans. It was obtained by a less-aggressive mechanism, which allows for adequate study of the pathology over longer periods.
Docta Complutense
Publication Artículo científico (JournalArticle)

Relationship between the feeling of emptiness and suicide reattempt: Conclusions from cross-sectional and longitudinal analyses

  • Pemau Gurumeta, Andrés
  • Marín Martín, Carolina
  • De La-Torre Luque, Alejandro Francisco
  • Ayad Ahmed, Wala
  • López Villatoro, José Manuel
  • Fernández Rodrigues, Verónica
  • Mola Cárdenes, Pablo
  • Carrasco Perera, José Luis
  • Díaz Marsa, Marina Francisca
Introduction: The feeling of emptiness is a complex subjective experience considered relevant in the suicidal process, acting as a risk factor for suicide ideation, attempts and even reattempts. However, empirical studies are still scarce. Objectives: This study has three objectives: to compare emptiness levels in healthy people and those with suicide attempts; to compare the emptiness level between people with a single suicide attempt and multiple suicide attempts at baseline; and to study emptiness as a risk factor for the appearance of new suicidal attempts after an index one. Methodology: In the study, 382 healthy controls and 58 participants with a recent suicide attempt (in the past 15 days) participated. All completed the feeling of emptiness scale (FES). Information was also collected on sociodemographic characteristics and history of suicide attempts. First, the control sample scores were compared with those of the clinical sample. Later, the single attempt and reattempt groups (any amount greater than one attempt at baseline) were compared. Finally, the clinical sample was followed for 1 year and 3 months (through clinical records). Survival analysis was performed. Results: The clinical group obtained higher scores across the FES subscales, even when controlling for other relevant variables (p < 0.01). When comparing people with one versus several attempts, differences were also observed in all subscales except one, the reattempt group getting higher scores (p < 0.05). Regarding the survival analysis, the feeling of emptiness was significantly associated with the risk of reattempt (HR = 1.04; p < 0.05). All people who reattempted during follow-up belonged to the reattempt group at baseline. Conclusions: People who have attempted suicide present higher emptiness scores. Furthermore, emptiness appears to significantly predict the occurrence of new attempts at follow-up. The feeling of emptiness may be associated with the lack of vital meaning and disconnection from others, fundamental aspects of the ideation-to-action suicide models. Including emptiness in suicide assessments could increase clinicians' predictive ability.
Docta Complutense
Publication Artículo científico (JournalArticle)

The mediating role of reflective functioning in the association between childhood trauma and suicide attempt

  • Andreo Jover, J.
  • De La-Torre Luque, Alejandro Francisco
  • Díaz Marsa, Marina Francisca
  • Fernández Rodrigues, Verónica
  • Pemau Gurumeta, Andrés
  • Diaz Carracedo, Patricia Cristina
  • Saiz González, María Dolores
  • Ayad Ahmed, Wala
  • Carrasco Perera, José Luis
Background: Childhood trauma is intimately related with suicidal behaviour. Patients who have suffered childhood trauma develop impaired Reflective Functioning (RF), which refers to the capacity to understand ourselves and others in terms of intentional mental states. An improvement in RF has been associated with a reduction in suicidal attempts, but the mediating role of RF between childhood trauma and suicidal behaviour has not been addressed so far. Objective: We aim to examine the potential mediating effect of RF among childhood trauma and suicide attempts. Method: We included 748 patients who had attempted suicide at least once. They were asked to complete the Reflective Functioning Questionnaire (RFQ-8), the Columbia-Suicide Severity Rating scale (CSSRS), and the Childhood Trauma Questionnaire-Short Form (CTQ-SF). We conducted linear regressions by simple mediating model to examine the role of RF in the indirect association between childhood trauma and the number of suicide attempts. Results: Our results show significant indirect effects through hypo and hypermentalizing between Emotional Abuse (EA) and Sexual Abuse (SA) in childhood and the number of suicide attempts in lifetime. These results indicate that ineffective RF significantly mediates the association between childhood trauma and suicidality. Conclusion: This is the first study supporting the mediational role of RF in the relationship between EA and SA, and the number of suicide attempt in lifetime. These findings have important implications for reducing suicide rates and preventing future re-attempts. Further studies analysing this mediating role and focusing efforts on increasing RF-based interventions are required.
Docta Complutense
Publication Artículo científico (JournalArticle)

Enhanced susceptibility of galectin-1 deficient mice to experimental colitis

  • Fernández Pérez, Raquel
  • López Santalla, Mercedes
  • Sánchez Domínguez, Rebeca
  • Alberquilla, Omaira
  • Gutiérrez Cañas, Irene
  • Juarranz Moratilla, Yasmina
  • Bueren, Juan A.
  • Garin, Marina I.
Galectin-1 is a<jats:italic>β</jats:italic>-galactoside-binding lectin, ubiquitously expressed in stromal, epithelial, and different subsets of immune cells. Galectin-1 is the prototype member of the galectin family which shares specificity with<jats:italic>β</jats:italic>-galactoside containing proteins and lipids. Immunomodulatory functions have been ascribed to endogenous galectin-1 due to its induction of T cell apoptosis, inhibitory effects of neutrophils and T cell trafficking. Several studies have demonstrated that administration of recombinant galectin-1 suppressed experimental colitis by modulating adaptive immune responses altering the fate and phenotype of T cells. However, the role of endogenous galectin-1 in intestinal inflammation is poorly defined. In the present study, the well-characterized acute dextran sulfate sodium (DSS)-induced model of ulcerative colitis was used to study the function of endogenous galectin-1 during the development of intestinal inflammation. We found that galectin-1 deficient mice (<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice) displayed a more severe intestinal inflammation, characterized by significantly elevated clinical scores, than their wild type counterparts. The mechanisms underlying the enhanced inflammatory response in colitic<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice involved an altered Th17/Th1 profile of effector CD4<jats:sup>+</jats:sup>T cells. Furthermore, increased frequencies of Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells in colon lamina propria in<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice were found. Strikingly, the exacerbated intestinal inflammatory response observed in<jats:italic>Lgals1<jats:sup>−</jats:sup></jats:italic><jats:sup>/</jats:sup><jats:italic><jats:sup>−</jats:sup></jats:italic>mice was alleviated by adoptive transfer of wild type Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells at induction of colitis. Altogether, these data highlight the importance of endogenous galectin-1 as a novel determinant in regulating T cell reactivity during the development of intestinal inflammation.
Docta Complutense
Publication Artículo científico (JournalArticle)

Osteogenic-Inducing Apatite/Agarose/Gelatin Hybrid Scaffolds Embedding Gold Nanoparticles

  • Cabañas Criado, María Victoria
  • Padilla, Paola S.
  • Cicuéndez Maroto, Mónica
  • Sánchez Salcedo, Sandra
  • Román Zaragoza, Jesús
  • Peña López, Juan
To prepare porous scaffolds combining hydrogel and hydroxycarbonateapatite, enriched with a promising therapeutic agent, gold nanoparticles, to improve bone regeneration. The fabrication procedure is conducted under mild conditions, without toxic or aggressive chemicals, at physiological pH, and low temperatures; Methods: Gold nanoparticles (15–20 nm), were obtained by the Turkevith method. The scaffolds were fabricated by the GELPOR3D method, which has demonstrated its ability to integrate thermal labile molecules, during the scaffold fabrication process. The role of these nanoparticles in promoting cell adhesion, proliferation, and mineralization processes in vitro has been studied using osteoprogenitor MC3T3-E1 cells; Results: The scaffold fabrication conditions, combined with the surface functionalization of the gold nanoparticles with poly(ethylene glycol), ensure their uniform distribution throughout the scaffold and facilitate their gradual release over 48 h in a physiological medium. A significant increase in the mean cell area and a significant decrease in the circularity index during the early stages of osteoblast differentiation are observed. These pieces of evidence suggest that adequate cell spreading could lead to enhanced proliferation and matrix deposition activity; Conclusions: Scaffolds containing these gold nanoparticles exhibited a marked improvement in adhesion, proliferation, and mineralization of preosteoblasts (MC3T3 cells) at the concentrations studied. The functionalization of the nanoparticles, along with the shaping procedure employed, is critical for their homogeneous dispersion throughout the scaffold and their progressive release. The findings confirm the crucial role of gold nanoparticles in the early stages of osteoblast differentiation, which is essential for the transition from premature osteoblasts to mature osteoblasts.
Docta Complutense
Publication Artículo científico (JournalArticle)

An immuno-fragile profile is associated with mortality risk in patients with chronic kidney disease

  • Ceprián, Noemí
  • Martínez De Toda Cabeza, Irene
  • Jara Caro, Paula
  • Yuste, Claudia
  • Valera Arévalo, Gemma
  • González de Pablos, Ignacio
  • Figuer, Andrea
  • Alique, Matilde
  • Ramírez, Rafael
  • Morales Ruiz, Enrique
  • Carracedo, Julia
Background/Objectives: Patients with chronic kidney disease (CKD) face higher risks of infections, poor vaccine responses, and cardiovascular diseases, leading to increased morbidity and mortality due to immune dysfunction and frailty. This study aims to evaluate immune status and frailty in CKD patients across different treatments, examine the influence of frailty on immune status, and link these factors to mortality. Methods: A total of 174 participants were included (end-stage renal disease, ESRD n = 40; hemodialysis, HD n = 40; peritoneal dialysis, n = 36; kidney transplant patients, n = 40; healthy subjects n = 18). Immunophenotyping of lymphocyte and monocyte subpopulations was performed, and frailty was assessed using the Edmonton Frail Scale. Principal component analysis (PCA) integrated immune and frailty variables to define an “immuno-fragile profile,” and survival was monitored for up to six years. Results: CKD patients, especially those on HD, showed decreased lymphocyte counts and proinflammatory monocyte subpopulations with increased expression of costimulatory molecules B7.2/CD86 and ICAM-1/CD54). Frailty was most prevalent in HD patients (53%), with notable sex differences. PCA identified three components—lymphocyte counts, monocyte co-stimulatory expression, and frailty—that together explained 70% of the variance. Survival analysis revealed that patients with lower lymphocyte counts and higher frailty scores had increased mortality risk, especially in the HD and ESRD groups. Cox regression confirmed that the immuno-fragile profile independently predictedmortality. Conclusions: The integration of immune alterations and frailty defines an immuno-fragile profile strongly associated with mortality in CKD patients, which may serve as a robust prognostic tool to improve risk stratification and guide personalized interventions in clinical practice.
Docta Complutense
Publication Artículo científico (JournalArticle)

New mechanisms involved in the development of cardiovascular disease in chronic kidney disease

  • Figuer, Andrea
  • Alique, Matilde
  • Valera Arévalo, Gemma
  • Serroukh, Nadia
  • Ceprían, Noemí
  • De Sequera Ortiz, Patricia
  • Morales Ruiz, Enrique
  • Carracedo Añón, Julia María
  • Ramírez, Rafael
  • Bodega, Guillermo
Chronic kidney disease (CKD) is a pathology with a high worldwide incidence and an upward trend affecting the elderly. When CKD is very advanced, the use of renal replacement therapies is required to prolong its life (dialysis or kidney transplantation). Although dialysis improves many complications of CKD, the disease does not reverse completely. These patients present an increase in oxidative stress, chronic inflammation and the release of extracellular vesicles (EVs), which cause endothelial damage and the development of different cardiovascular diseases (CVD). CKD patients develop premature diseases associated with advanced age, such as CVD. EVs play an essential role in developing CVD in patients with CKD since their number increases in plasma and their content is modified. The EVs of patients with CKD cause endothelial dysfunction, senescence and vascular calcification. In addition, miRNAs free or transported in EVs together with other components carried in these EVs promote endothelial dysfunction, thrombotic and vascular calcification in CKD, among other effects. This review describes the classic factors and focuses on the role of new mechanisms involved in the development of CVD associated with CKD, emphasizing the role of EVs in the development of cardiovascular pathologies in the context of CKD. Moreover, the review summarized the EVs’ role as diagnostic and therapeutic tools, acting on EV release or content to avoid the development of CVD in CKD patients
Docta Complutense
Publication Artículo científico (JournalArticle)

Fetal programming and lactation: modulating gene expression in response to undernutrition during intrauterine life

  • Monedero Cobeta, Ignacio
  • Gomez Bris, Raquel
  • Rodríguez Rodríguez, Pilar
  • Saez, Angela
  • Quintana Villamandos, María Begoña
  • González Granado, José María
  • Arribas, Silvia Magdalena
Background: Adverse environmental conditions during intrauterine life, known as fetal programming, significantly contribute to the development of diseases in adulthood. Fetal programming induced by factors like maternal undernutrition leads to low birth weight and increases the risk of cardiometabolic diseases. Methods: We studied a rat model of maternal undernutrition during gestation (MUN) to investigate gene expression changes in cardiac tissue using RNA-sequencing of day 0-1 litters. Moreover, we analyzed the impact of lactation at day 21, in MUN model and cross-fostering experiments, on cardiac structure and function assessed by transthoracic echocardiography, and gene expression changes though qPCR. Results: Our analysis identified specific genes with altered expression in MUN rats at birth. Two of them, Agt and Pparg, stand out for being associated with cardiac hypertrophy and fibrosis. At the end of the lactation period, MUN males showed increased expression of Agt and decreased expression of Pparg, correlating with cardiac hypertrophy. Cross-fostering experiments revealed that lactation with control breastmilk mitigated these expression changes reducing cardiac hypertrophy in MUN males. Conclusions: Our findings highlight the interplay between fetal programming, gene expression, and cardiac hypertrophy suggesting that lactation period is a potential intervention window to mitigate the effects of fetal programming. Impact: Heart remodeling involves the alteration of several groups of genes and lactation period plays a key role in establishing gene expression modification caused by fetal programming. We could identify expression changes of relevant genes in cardiac tissue induced by undernutrition during fetal life. We expose the contribution of the lactation period in modulating the expression of Agt and Pparg, relevant genes associated with cardiac hypertrophy. This evidence reveal lactation as a crucial intervention window for preventing or countering fetal programming
Docta Complutense
Publication Artículo científico (JournalArticle)

Body composition and CO2 dietary emissions

  • García, Silvia
  • Monserrat-Mesquida, Margalida
  • Mas-Fontao, Sebastián
  • Cuadrado Soto, Esther
  • Ortiz-Ramos, María
  • Matía Martín, María Del Pilar
  • Daimiel, Lidia
  • Vázquez, Clotilde
  • Tur, Josep A.
  • Bouzas, Cristina
Background: The amount and quality of foods consumed not only impact on individual health, as reflected in body composition, but they could influence on greenhouse gas emissions and then, on environment. Aim: This study aims to assess the relationship between the body composition and the CO2 emissions resulting from the dietary choices of an adult population. Design: A cross-sectional study on baseline data from 778 participants aged 55–75 years old, with metabolic syndrome (MetS) as part of the PREDIMED-Plus study. Methods: Food intake was registered using a validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted was calculated using data from the Agribalyse® 3.0.1 database. Anthropometry (body weight, height, and waist, and hip circumference, and body mass index) was determined by usual measurements, and body composition (fat mass, visceral fat, muscular mass, fat free mass, and total body water) were assessed by bioimpedance. Results: CO2 emissions were linearly and positively associated with weight, waist circumference, visceral fat, fat free mass, total body water and energy intake. Conclusion: Body composition is associated with dietary CO2 emissions. The higher total body water, fat free mass, and body weight, the higher the dietary CO2 emissions were, following a linear relationship.
Docta Complutense
Publication Artículo científico (JournalArticle)

Risk factors for suicide reattempt: a systematic review and meta-analysis

  • Pemau Gurumeta, Andrés
  • Marín Martín, Carolina
  • Díaz Marsa, Marina Francisca
  • De La-Torre Luque, Alejandro Francisco
  • Ayad Ahmed, Wala
  • González Pinto, Ana
  • Garrido Torres, Nathalia
  • Garrido Sanchez, Lucia
  • Roberto, Natalia
  • Lopez Peña, Purificacion
  • Mar Barrutia, Lorea
  • Grande, Iria
  • Guinovart, Marti
  • Hernandez Calle, Daniel
  • Jimenez Treviño, Luis
  • Lopez Sola, Clara
  • Mediavilla, Roberto
  • Perez Aranda, Adrian
  • Ruiz Veguilla, Miguel
  • Seijo Zazo, Elisa
  • Toll, Alba
  • Elices, Matilde
  • Perez Sola, Victor
  • Ayuso Mateos, Jose Luis
  • SURVIVE Consortium
Background Suicide is one of the main external causes of death worldwide. People who have already attempted suicide are at high risk of new suicidal behavior. However, there is a lack of information on the risk factors that facilitate the appearance of reattempts. The aim of this study was to calculate the risk of suicide reattempt in the presence of suicidal history and psychosocial risk factors and to estimate the effect of each individual risk factor. Methods This systematic review and meta-analysis were conducted following the PRISMA-2020 guidelines. Studies on suicide reattempt that measured risk factors were searched from inception to 2022. The risk factors studied were those directly related to suicide history: history of suicide prior to the index attempt, and those that mediate the transition from suicidal ideation to attempt (alcohol or drug misuse, impulsivity, trauma, and non-suicidal self-injury). Results The initial search resulted in 11 905 articles. Of these, 34 articles were selected for this meta-analysis, jointly presenting 52 different effect sizes. The pooled effect size across the risk factors was significant (OR 2.16). Reattempt risk may be increased in presence of any of the following risk factors: previous history, active suicidal ideation, trauma, alcohol misuse, and drug misuse. However, impulsivity, and non-suicidal self-injury did not show a significant effect on reattempt. Conclusion Most of the risk factors traditionally associated with suicide are also relevant when talking about suicide reattempts. Knowing the traits that define reattempters can help develop better preventive and intervention plans.
Docta Complutense
Publication Artículo científico (JournalArticle)

Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice

  • Olivera-Salazar, Rocío
  • García-Arranz, Mariano
  • Sánchez Muñoz, Aranzazu
  • Olmedillas-López, Susana
  • Vega-Clemente, Luz
  • Serrano, Luis Javier
  • Herrera González, Blanca María
  • García-Olmo, Damián
Colorectal cancer cells can transfer the oncogene KRAS to distant cells, predisposing them to malignant transformation (Genometastasis Theory). This process could contribute to liver metastasis;besides, hepatic progenitor cells (HPCs) have been found to be involved in liver malignant neoplasms. The objective of this study is to determine if mouse HPCs—Oval cells (OCs)—are susceptible to incorporate Kras GAT (G12D) mutation from mouse colorectal cancer cell line CT26.WT and if OCs with the incorporated mutation behave like malignant cells. To achieve this, three lines of OCs in diferent conditions were exposed to CT26.WT cells through transwell co-culture for a week. The presence of KrasG12D and capacity to form tumors were analyzed in treated samples by droplet digital PCR and colony-forming assays, respectively. The results showed that the KrasG12D mutation was detected in hepatic culture conditions of undiferentiated OCs and these cells were capable of forming tumors in vitro. Therefore, OCs are susceptible to malignant transformation by horizontal transfer of DNA with KrasG12D mutation in an undiferentiated condition associated with the liver microenvironment. This study contributes to a new step in the understanding of the colorectal metastatic process.
Docta Complutense
Publication Artículo científico (JournalArticle)

Nanodevices based on mesoporous glass nanoparticles enhanced with zinc and curcumin to fight infection and regenerate bone

  • Sánchez Salcedo, Sandra
  • Heras, Clara
  • Lozano Borregón, Daniel
  • Vallet Regí, María Dulce Nombre
  • Salinas Sánchez, Antonio Jesús
Nanotechnology-based approaches are emerging as promising strategies to treat different bone pathologies such as infection, osteoporosis or cancer. To this end, several types of nanoparticles are being investigated, including those based on mesoporous bioactive glasses (MGN) which exhibit exceptional structural and textural properties and whose biological behaviour can be improved by including therapeutic ions in their composition and loading them with biologically active substances. In this study, the bone regeneration capacity and antibacterial properties of MGNs in the SiO2–CaO–P2O5 system were evaluated before and after being supplemented with 2.5% or 4% ZnO and loaded with curcumin. in vitro studies with preosteoblastic cells and mesenchymal stem cells allowed determining the biocompatible MGNs concentrations range. Moreover, the bactericidal effect of MGNs with zinc and curcumin against S. aureus was demonstrated, as a significant reduction of bacterial growth was detected in both planktonic and sessile states and the degradation of a pre-formed bacterial biofilm in the presence of the nanoparticles also occurred. Finally, MC3T3-E1 preosteoblastic cells and S. aureus were co-cultured to investigate competitive colonisation between bacteria and cells in the presence of the MGNs. Preferential colonisation and survival of osteoblasts and effective inhibition of both bacterial adhesion and biofilm formation of S. aureus in the co-culture system were detected. Our study demonstrated the synergistic antibacterial effect of zinc ions combined with curcumin and the enhancement of the bone regeneration characteristics of MGNs containing zinc and curcumin to obtain systems capable of simultaneously promoting bone regeneration and controlling infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids

  • Lo Faro, Alfredo
  • Sprega, Giorgia
  • Beradinelli, Diletta
  • Tini, Anstasio
  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Papaseit, Esther|||0000-0003-2620-4274
  • Berretta, Paolo|||0000-0002-1748-5628
  • Di Giorgi, Alessandro|||0000-0003-2997-221X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Takaishvili, Nino
  • Farkas, Tivadar
  • Busardo, Francesco Paolo|||0000-0002-3082-4532
  • Chankvetadze, Bezhan
In the present study enantioselective high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its major phase-1 metabolites 4-hydroxy-3-methoxyamphetamine (HMA), 4-hydroxy-3-methoxymethamphetamine (HMMA) and 3,4-methylenedioxyamphetamine (MDA) in human plasma, sweat, oral fluid (OF) and urine. The simultaneous separation of all these compounds and their respective enantioseparation was accomplished on two polysaccharide-based chiral columns. The Lux AMP column with a proprietary chiral selector enabled baseline separation of the enantiomers of MDMA, HMA and HMMA while MDA enantiomers could not be separated with this column under the experimental conditions used in this study. The Lux i-Amylose-3 column based on amylose tris(5-chloro-3-methylphenylcarbamate) as chiral selector baseline-separated the enantiomers of MDMA, HMMA and MDA while the enantiomers of HMA could not be separated. Thus, the various samples were analyzed by using both columns alternatively in combinations with acetonitrile containing 25% (v/v) 5 mM ammonium bicarbonate buffer at pH 11.0 as mobile phase. Analysis time was less than 4 min with the Lux AMP column and less than 6 min with the Lux i-Amylose-3 column. Both methods were validated and applied to the enantioselective determination of MDMA and its phase-I metabolites in human biological fluids, and enantioselective metabolism of MDMA was confirmed.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction

  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Merenciano, Héctor|||0000-0002-1734-0381
  • Llopis-Lorente, Jordi|||0000-0002-3958-8062
  • Molina-Garcia, Tamara
  • Perez-Solé, Nerea|||0000-0003-3527-0337
  • de Dios, Elena
  • Marcos-Garces, Víctor
  • Monmeneu, José V.
  • Lopez-Lereu, María P.
  • Canoves, Joaquim
  • Bonanad, Clara
  • Moratal, David|||0000-0002-2825-3646
  • Núñez, Julio|||0000-0003-1672-7119
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Sanchis, Juan|||0000-0003-0797-8709
  • Chorro, Francisco J.
  • Rios-Navarro, Cesar|||0000-0002-6405-6279
  • Bodi, Vicente|||0000-0001-6425-5828
We aimed to assess the correlation of cardiovascular magnetic resonance (CMR)-derived epicardial adipose tissue (EAT) with infarct size (IS) and residual systolic function in ST-segment elevation myocardial infarction (STEMI). We enrolled patients discharged for a first anterior reperfused STEMI submitted to undergo CMR. EAT, left ventricular (LV) ejection fraction (LVEF), and IS were quantified at the 1-week (n = 221) and at 6-month CMR (n = 167). At 1-week CMR, mean EAT was 31 ± 13 mL/m. Patients with high EAT volume (n = 72) showed larger 1-week IS. After adjustment, EAT extent was independently related to 1-week IS. In patients with large IS at 1 week (>30% of LV mass, n = 88), those with high EAT showed more preserved 6-month LVEF. This association persisted after adjustment and in a 1:1 propensity score-matched patient subset. Overall, EAT decreased at 6 months. In patients with large IS, a greater reduction of EAT was associated with more preserved 6-month LVEF. In STEMI, a higher presence of EAT was associated with a larger IS. Nevertheless, in patients with large infarctions, high EAT and greater subsequent EAT reduction were linked to more preserved LVEF in the chronic phase. This dual and paradoxical effect of EAT fuels the need for further research in this field.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder - an example of participatory research

  • Caballeria, Elsa
  • Balcells-Oliveró, Mercè
  • Bataller, Ramon|||0000-0002-1119-7799
  • Bruguera, Pol
  • Cabrera, Noel
  • Estruch, Alexandra
  • Freixa, Neus
  • Garcia-Pañella, Óscar
  • Graell, Mireia
  • Gratacós Ginès, Jordi|||0000-0003-1181-7238
  • Guzman, Pablo
  • Hernandez Rubio, Anna|||0000-0001-8612-7827
  • Lligoña, Anna
  • Pérez-Guasch, Martina
  • Pons-Cabrera, María Teresa
  • Pose, Elisa|||0000-0002-0224-7686
  • Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351
  • López-Pelayo, Hugo|||0000-0002-3850-8374
Background: With the aim of improving treatment retention in patients with the onset of alcohol-related liver disease (ArLD), we designed a blended intervention (brief motivational intervention + 'serious game' (SG)). We present the participatory design methodology and outcomes and the usability assessment of the intervention. Methods: (1) The design of the SG was based on the outcomes of two 3-h co-creation sessions with 37 participants (healthcare and technology professionals, patients, and patients' relatives). The brief face-to-face motivational intervention was based on the 5 As Model and adapted to the ArLD population. (2) Usability pilot study: 20 participants (10 ArLD patients + 10 healthcare professionals) received the intervention. System Usability Scale (SUS) and Post-Study System Usability Questionnaire (PSSUQ) were applied to assess the SG usability and patients' satisfaction with it. Weekly semi-structured interviews on the phone were conducted to identify the preferred elements in the SG and those aspects that should be improved. Results: (1) Design: an SG in the form of a gamified web app, consisting of a daily activity for six weeks and adapted brief motivational interviewing. (2) Usability pilot study: usability results were excellent for both patients and healthcare professionals (SUS median score = 85). The general usability, the quality of the information provided by the SG and the quality of the interface were very positively rated in the PSSUQ (overall median score = 2, IQR = 1-2). The best-rated aspects were the provision of feedback, the use of metaphors and the application of audiovisual material. Changes in the design, response mechanics and content were applied after the study. Conclusions: The usability and acceptability of an intervention for increasing retention to treatment in patients with recent onset of ArLD and AUD were excellent for patients and healthcare professionals. A randomized-controlled trial is required to test the efficacy of this approach.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS

  • Massano, Marta
  • Nuñez-Montero, Melani
  • Papaseit, Esther|||0000-0003-2620-4274
  • Hladun, Olga|||0000-0002-6230-5876
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Ventura, Mireia|||0000-0003-1133-6872
  • Marchei, Emilia|||0000-0002-7158-6032
  • Alladio, Eugenio
  • Gerace, Enrico
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Salomone, Alberto
Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption. In this context, we investigated their metabolic profile using of UHPLC-QTOF-HRMS to elucidate the distribution of the parent drug and its metabolites in urine samples over time. Initially, both male and female volunteers were divided into three groups and eight subjects of each group were administered intranasally or orally with one SC (20-40 mg of NEH or NEP intranasal, 100-150 mg of 4-CMC oral). Urine samples were collected at 0-2 and 2-4 or 2-5 h. Urine (50 μL) was diluted 1:2 with acetonitrile/methanol (95:5) and injected into the UHPLC-QTOF-HRMS. Phase-I and phase-II metabolites were identified on the basis of fragmentation patterns and exact masses. Several phase-I and glucuronide-phase-II metabolites were identified in urine samples. Keto group reduction, hydroxylation and dealkylation were the common metabolic pathways identified for all cathinones and the presence of NEH-glucuronide, NEP-glucuronide and 4-CMC-glucuronide was also relevant. Significant is the slower metabolite formation for 4-CMC, which was detected at high concentrations in its original form even 5 h after administration, due to its long half-life and low intrinsic clearance compared to the other SCs. UHPLC-QTOF-HRMS demonstrated a considerable capability to semi-quantify the three synthetic cathinones and identify the target metabolites with high reliability. The introduction of new target compounds improves the efficiency of toxicological screening analysis on real samples and extends the window of detection of the SCs in biological matrices.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure

  • Núñez-Marín, Gonzalo|||0000-0003-2867-5344
  • Romero-González, Gregorio|||0000-0001-7481-3678
  • Bover, Jordi|||0000-0003-3577-2273
  • Górriz, Jose Luis|||0000-0002-1134-9051
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Sanchis, Juan|||0000-0003-0797-8709
  • Núñez, Julio|||0000-0003-1672-7119
  • De la Espriella, Rafael|||0000-0002-8720-3999
Introduction: This study aimed to evaluate the association between the NephroCheck® test AKIRisk® score, diuretic efficiency (DE), and the odds of worsening kidney function (WKF) within the first 72 h of admission in patients hospitalized for acute heart failure (AHF). Methods: The study prospectively enrolled 125 patients admitted with AHF. NephroCheck® test was obtained within the first 24 h of admission. DE was defined as net fluid urine output per 40 mg of furosemide equivalents. Results: The median AKIRisk® score was 0.11 (IQR 0.06-0.34), and 38 (30.4%) patients had an AKIRisk® score >0.3. The median cumulative DE at 72 h was 1,963 mL (IQR 1317-3,239 mL). At 72 h, a total of 10 (8%) patients developed an absolute increase in sCr =0.5 mg/dL (WKF). In a multivariable setting, there was an inverse association between the AKIRisk® score and DE within the first 72 h. In fact, the highest the AKIRisk® score (centered at 0.3), the higher the likelihood of poor DE (below the median) and WKF at 72 h (odds ratio [OR] 2.04; 95%; CI: 1.02-4.07; p = 0.043, and OR 3.31, 95% CI: 1.30-8.43; p = 0.012, respectively). Conclusion: In patients with AHF, a higher NephroCheck® AKIRisk® score is associated with poorer DE and a higher risk of WKF at 72 h. Further research is needed to confirm the role of urinary cell cycle arrest biomarkers in the AHF scenario.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • Corrales, Patricia|||0000-0002-9817-8389
  • González, Lorena
  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Martínez, Ester
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Moreno Santabarbara, Pablo|||0000-0002-6652-120X
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Herrero, Laura|||0000-0003-4244-4673
Introduction: Obesity is a chronic condition associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). WAT is distributed into two main depots: subcutaneous WAT (sWAT) and visceral WAT (vWAT), each with different biochemical features and metabolic roles. Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 has been widely studied in the peripheral proinflammatory immune response; however, little is known about its role in adipocytes in the context of obesity. Aim & Methods: We aimed to study the levels of IL-16 in WAT derived from sWAT and vWAT depots of humans with obesity and the role of this cytokine in palmitate-exposed 3T3-L1 adipocytes. Results: The results demonstrated that IL-16 expression was higher in vWAT compared with sWAT in individuals with obesity. In addition, IL-16 serum levels were higher in patients with obesity compared with normal-weight individuals, increased at 6 months after bariatric surgery, and at 12 months after surgery decreased to levels similar to before the intervention. Our in vitro models showed that IL-16 could modulate markers of adipogenesis (Pref1), lipid metabolism (Plin1, Cd36, and Glut4), fibrosis (Hif1a, Col4a, Col6a, and Vegf), and inflammatory signaling (IL6) during adipogenesis and in mature adipocytes. In addition, lipid accumulation and glycerol release assays suggested lipolysis alteration. Discussion: Our results suggest a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction

  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Crisóstomo, Verónica|||0000-0003-1740-7029
  • Moscoso, Isabel|||0000-0002-6078-4666
  • Báez-Díaz, Claudia
  • Blanco-Blázquez, Virginia|||0000-0003-1971-919X
  • Gómez-Mauricio, Guadalupe
  • Albericio, Guillermo
  • Aguilar, Susana
  • Fernández Santos, María Eugenia|||0000-0001-9229-0022
  • Fernández Avilés, Francisco|||0000-0001-5501-5275
  • Sánchez Margallo, Francisco Miguel|||0000-0003-2138-988X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Bernad, Antonio
Human cardiac progenitor cells (hCPC) are considered a good candidate in cell therapy for ischemic heart disease, demonstrating capacity to improve functional recovery after myocardial infarction (MI), both in small and large preclinical animal models. However, improvements are required in terms of cell engraftment and efficacy. Based on previously published reports, insulin-growth factor 1 (IGF-1) and hepatocyte growth factor (HGF) have demonstrated substantial cardioprotective, repair and regeneration activities, so they are good candidates to be evaluated in large animal model of MI. We have validated porcine cardiac progenitor cells (pCPC) and lentiviral vectors to overexpress IGF-1 (co-expressing eGFP) and HGF (co-expressing mCherry). pCPC were transduced and IGF1-eGFP pos and HGF-mCherry pos populations were purified by cell sorting and further expanded. Overexpression of IGF-1 has a limited impact on pCPC expression profile, whereas results indicated that pCPC-HGF-mCherry cultures could be counter selecting high expresser cells. In addition, pCPC-IGF1-eGFP showed a higher cardiogenic response, evaluated in co-cultures with decellularized extracellular matrix, compared with native pCPC or pCPC-HGF-mCherry. In vivo intracoronary co-administration of pCPC-IGF1-eGFP and pCPC-HFG-mCherry (1:1; 40 × 10 6 /animal), one week after the induction of an MI model in swine, revealed no significant improvement in cardiac function.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CBT4CBT web-based add-on treatment for cocaine use disorder, Study protocol for a randomized controlled trial

  • Mallorquí-Bagué, Núria|||0000-0003-1434-3162
  • Palazón-Llecha, Alba|||0009-0002-9174-5317
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Batlle, Francesca|||0000-0002-8684-9579
  • Duran-Sindreu, Santiago|||0000-0002-8767-1821
  • Trujols, Joan|||0000-0003-0396-7105
Cocaine use disorder (CUD) is a chronic condition that presents high relapse rates and treatment dropouts. Web-based interventions have proven to be effective when optimizing face-to-face treatments in different mental health conditions and have the potential to optimize current CUD treatments. However, web-based interventions in addictive behaviors are still limited. The aim of this study is to evaluate whether adding a web-based cognitive behavioral therapy (i.e., CBT4CBT) to standard CUD treatment, improves treatment outcomes in a Spanish sample of patients with severe CUD (which requires inpatient treatment). Additionally, we aim to explore predictive factors of treatment response and treatment gender-related differences. All individuals coming for inpatient cocaine detoxification who meet the inclusion criteria will have the possibility to be part of the study. The participants of this open-label randomized controlled clinical trial (RCT) will be allocated to treatment as usual (TAU) or TAU+CBT4CBT after the hospitalization for cocaine detoxification. During the inpatient treatment they will all receive an individualized psychological intervention. There will be six time point assessments: at 48-72 h of starting inpatient treatment, at the end of inpatient treatment and before starting day care and outpatient treatment, at the end of the 8 weeks CTB4CBT / TAU arm treatment and at three follow-up time points (1-, 3-, and 6-months post-treatment). To the best of our knowledge, this is the first RCT that explores the efficacy of adding a web-based cognitive behavioral therapy to usual CUD treatment with patients of a clinical sample in Europe. Trial registration: IIBSP-CTB-2020-116, NCT05207228. Submitted 8 of April 2021, posted 26 of January 2022. https://clinicaltrials.gov/ct2/show/NCT05207228?cond=Cocaine+Use+Disorder&draw=2&rank=1.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study, Role as a Prognostic Factor and an Immune-Suppressive Biomarker

  • Martínez Bosch, Neus|||0000-0003-3596-0039
  • Vilariño, Noelia|||0000-0001-5115-6628
  • Alameda, Francesc|||0000-0002-7302-6901
  • Mojal, Sergi|||0000-0003-0523-3869
  • Arumí-Uria, Montserrat|||0000-0003-0341-9686
  • Carrato, Cristina|||0000-0002-1953-8287
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Ribalta Farres, Teresa|||0000-0003-2692-0051
  • Vidal, Noemí|||0000-0002-2852-6667
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Menéndez, Sílvia|||0000-0002-9116-8743
  • Del Barco Berrón, Sonia|||0000-0002-4951-6871
  • Gallego, Oscar S.
  • Pineda, Estela|||0000-0003-2128-747X
  • Lopez Martos, Raquel|||0009-0003-4328-9094
  • Hernández, Ainhoa|||0000-0003-4678-6662
  • Mesia, Carlos
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • de la Iglesia, Nuria|||0000-0002-1083-7715
  • Balañá, Carmen|||0000-0003-0771-0390
  • Martinez Garcia, Maria|||0000-0001-5891-3935
  • Navarro, Pilar|||0000-0003-4314-4584
Glioblastoma (GBM) is the most frequent primary malignant brain tumor and has a dismal prognosis. Unfortunately, despite the recent revolution of immune checkpoint inhibitors in many solid tumors, these have not shown a benefit in overall survival in GBM patients. Therefore, new potential treatment targets as well as diagnostic, prognostic, and/or predictive biomarkers are needed to improve outcomes in this population. The β-galactoside binding protein Galectin-1 (Gal-1) is a protein with a wide range of pro-tumor functions such as proliferation, invasion, angiogenesis, and immune suppression. Here, we evaluated Gal-1 expression by immunohistochemistry in a homogenously treated cohort of GBM (the GLIOCAT project) and correlated its expression with clinical and molecular data. We observed that Gal-1 is a negative prognostic factor in GBM. Interestingly, we observed higher levels of Gal-1 expression in the mesenchymal/classical subtypes compared to the less aggressive proneural subtype. We also observed a Gal-1 expression correlation with immune suppressive signatures of CD4 T-cells and macrophages, as well as with several GBM established biomarkers, including SHC1, PD-L1, PAX2, MEOX2, YKL-40, TCIRG1, YWHAG, OLIG2, SOX2, Ki-67, and SOX11. Moreover, Gal-1 levels were significantly lower in grade 4 IDH-1 mutant astrocytomas, which have a better prognosis. Our results confirm the role of Gal-1 as a prognostic factor and also suggest its value as an immune-suppressive biomarker in GBM.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Obstetric complications and clinical presentation in first episode of psychosis

  • Valli, Isabel|||0000-0003-3052-7383
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Cuesta, M.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bioque, Miquel|||0000-0001-6887-7149
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Garriga, Marina|||0000-0001-7312-4969
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Bitanihirwe, B.
  • Cannon, M.
  • Bernardo, Miquel|||0000-0001-8748-6717
Psychotic disorders exhibit a complex aetiology that combines genetic and environmental factors. Among the latter, obstetric complications (OCs) have been widely studied as risk factors, but it is not yet well understood how OCs relate to the heterogeneous presentations of psychotic disorders. We assessed the clinical phenotypes of individuals with a first episode of psychosis (FEP) in relation to the presence of OCs. Two-hundred seventy-seven patients with an FEP were assessed for OCs using the Lewis-Murray scale, with data stratified into three subscales depending on the timing and the characteristics of the obstetric event, namely: complications of pregnancy, abnormal foetal growth and development and difficulties in delivery. We also considered other two groups: any complications during the pregnancy period and all OCs taken altogether. Patients were clinically evaluated with the Positive and Negative Syndrome Scale for schizophrenia. Total OCs and difficulties in delivery were related to more severe psychopathology, and this remained significant after co-varying for age, sex, traumatic experiences, antipsychotic dosage and cannabis use. Our results highlight the relevance of OCs for the clinical presentation of psychosis. Describing the timing of the OCs is essential in understanding the heterogeneity of the clinical presentation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins

  • Reis, Ana|||0000-0002-4537-9902
  • Rocha, Sara
  • Dias, Irundika HK.|||0000-0002-6620-8221
  • Costa, Raquel|||0000-0002-9245-4565
  • Soares, Raquel|||0000-0002-9157-5541
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Pérez, Antonio|||0000-0001-5528-1143
  • de Freitas, Victor|||0000-0003-0586-2278
The incidence of diabetes on the worldwide population has tripled in the past 5 decades. While drug-based therapies are valuable strategies to treat and ease the socio-economic burden of diabetes, nutritional strategies offer valuable alternatives to prevent and manage diabetes onset and contribute to the sustainability of health budgets. Whilst, intervention studies have shown that (poly)phenol-rich diets improve fasting glucose levels and other blood parameters, very little is known about the distribution of ingested polyphenols in circulation and the impact of diabetes on its cargo. In this study we investigate the impact of type 2 diabetes on the cargo of plasma (poly)phenols. Our results show that phenolic compounds are heterogeneously distributed in circulation though mainly transported by lipoprotein populations. We also found that diabetes has a marked effect on the phenolic content transported by VLDL resulting in the decrease in the content of flavonoids and consequently a decrease in the antioxidant capacity. In addition to the reduced bioavailability of (poly)phenol metabolites and increase of oxidative status in LDL and HDL populations in diabetes, cell-based assays show that sub-micromolar amounts of microbial (poly)phenol metabolites are able to counteract the pro-inflammatory status in glucose-challenged endothelial cells. Our findings highlight the relevance of triglyceride-rich lipoproteins in the transport and delivery of bioactive plant-based compounds to the endothelium in T2DM supporting the adoption of nutritional guidelines as an alternative strategy to drug-based therapeutic approaches.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with transperineal prostate biopsies

  • Morote Robles, Juan|||0000-0002-2168-323X
  • Paesano, Nahuel|||0000-0001-9278-5543
  • Picola, Natàlia|||0000-0002-8944-4294
  • Muñoz Rodríguez, José Manuel|||0000-0002-4688-6420
  • Ruiz-Plazas, Xavier|||0000-0003-2135-3860
  • Muñoz Rivero, Marta Viridiana|||0000-0002-6899-3956
  • Celma, Ana|||0000-0002-3128-3811
  • García-de Manuel, Gemma
  • Miró, Berta|||0000-0001-6049-8697
  • Servian, Pol|||0000-0002-3727-8159
  • Abascal, Jose Maria|||0000-0001-8374-6593
To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1, followed by transrectal and transperineal prostate biopsies. Prospective analysis of 3,264 men with PSA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease

  • Fortea, Juan|||0000-0002-1340-638X
  • García-Arcelay, Elena
  • Terrancle, Ángeles
  • Gálvez, Blanca
  • Díez-Carreras, Verónica
  • Rebollo, Pablo|||0000-0002-7517-6540
  • Maurino, Jorge|||0000-0001-9858-3555
  • García-Ribas, Guillermo
Alzheimer's disease (AD) biomarkers reflect key elements of pathophysiology and improve the diagnostic process. However, their use in routine clinical practice is still limited. We aimed to assess neurologists' barriers and enablers to early AD diagnosis using core AD biomarkers. We conducted an online study in collaboration with the Spanish Society of Neurology. Neurologists answered a survey exploring their attitudes towards AD diagnosis using biomarkers in mild cognitive impairment (MCI) or mild AD dementia. Multivariate logistic regression analyses were conducted to determine the association between neurologists' characteristics and diagnostic attitudes. We included 188 neurologists with a mean age (SD) of 40.6 (11.3) years, 52.7% male. Most participants had access to AD biomarkers, mainly in cerebrospinal fluid (CSF) (89.9%,#x0025;, n = 169). The majority of participants (95.2%,#x0025;, n = 179) considered CSF biomarkers useful for an etiological diagnosis in MCI. However, 85.6% of respondents (n = 161) used them in less than 60% of their MCI patients in routine clinical practice. Facilitating patients and their families to plan for the future was the most frequent enabler for the use of biomarkers. Short consultation time and practicalities associated with the programming of a lumbar puncture were the most common barriers. A younger neurologist age (p = 0.010) and a higher number of patients managed weekly (p = 0.036) were positively associated with the use of biomarkers. Most neurologists had a favorable attitude to the use of biomarkers, especially in MCI patients. Improvements in resources and consultation time may increase their use in routine clinical practice.
Dipòsit Digital de Documents de la UAB
Publication

Changes in glucagon-like peptide 1 and 2 levels in people with obesity after a diet-induced weight-loss intervention are related to a specific microbiota signature, A prospective cohort study

  • Rodríguez-Peña, M-Mar
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Seco, Jesus|||0000-0002-4049-8873
  • Ceperuelo Mallafré, Victòria|||0000-0002-4460-9761
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Pérez-Brocal Vicente|||0000-0002-1927-9676
  • Attolini, Camille Stephan-Otto
  • Moya, Andrés|||0000-0002-2867-1119
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Megía, Ana|||0000-0002-5101-9452
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

  • Pose, Elisa|||0000-0002-0224-7686
  • Solà, Elsa|||0000-0001-6897-2760
  • Lozano, Juan José
  • Juanola, Adrià|||0000-0003-4832-5130
  • Sidorova, Julia
  • Zaccherini, Giacomo|||0000-0002-3219-6963
  • de Wit, Koos|||0000-0001-8472-8549
  • Uschner, Frank
  • Tonon, Marta
  • Kazankov, Konstantin
  • Jiménez, Cesar|||0000-0003-2455-2048
  • Campion, Daniela
  • Napoleone, Laura
  • Ma, Ann T.|||0000-0002-9059-111X
  • Carol, Marta
  • Morales Ruiz, Manuel|||0000-0002-9074-2272
  • Alessandria, Carlo|||0000-0001-5468-694X
  • Beuers, Ulrich
  • Caraceni, Paolo|||0000-0002-1439-056X
  • Francoz, Claire|||0000-0001-7391-8507
  • Durand, François
  • Mookerjee, Rajeshwar P.
  • Trebicka, Jonel|||0000-0002-7028-3881
  • Vargas Blasco, Víctor|||0000-0002-7190-6948
  • Piano, Salvatore|||0000-0002-9356-5830
  • Watson, Hugh|||0000-0002-6931-3158
  • Abraldes, Juan G.|||0000-0003-3421-937X
  • Kamath, P.S.|||0000-0002-7888-1165
  • Davis, Mark M.
  • Ginès, Pere|||0000-0003-4657-4504
Patients with decompensated cirrhosis, particularly those with acute-on-chronic liver failure (ACLF), show profound alterations in plasma metabolomics. The aim of this study was to investigate the effect of treatment with simvastatin and rifaximin on plasma metabolites of patients with decompensated cirrhosis, specifically on compounds characteristic of the ACLF plasma metabolomic profile. Two cohorts of patients were investigated. The first was a descriptive cohort of patients with decompensated cirrhosis (n = 42), with and without ACLF. The second was an intervention cohort from the LIVERHOPE-SAFETY randomized, double-blind, placebo-controlled trial treated with simvastatin 20 mg/day plus rifaximin 1,200 mg/day (n = 12) or matching placebo (n = 13) for 3 months. Plasma samples were analyzed using ultrahigh performance liquid chromatography-tandem mass spectroscopy for plasma metabolomics characterization. ACLF was characterized by intense proteolysis and lipid alterations, specifically in pathways associated with inflammation and mitochondrial dysfunction, such as the tryptophan-kynurenine and carnitine beta-oxidation pathways. An ACLF-specific signature was identified. Treatment with simvastatin and rifaximin was associated with changes in 161 of 985 metabolites in comparison to treatment with placebo. A remarkable reduction in levels of metabolites from the tryptophan-kynurenine and carnitine pathways was found. Notably, 18 of the 32 metabolites of the ACLF signature were affected by the treatment. Conclusion: Treatment with simvastatin and rifaximin modulates some of the pathways that appear to be key in ACLF development. This study unveils some of the mechanisms involved in the effects of treatment with simvastatin and rifaximin in decompensated cirrhosis and sets the stage for the use of metabolomics to investigate new targeted therapies in cirrhosis to prevent ACLF development.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations

  • Perez-Rando, Marta|||0000-0002-5286-1545
  • Penades-Gomiz, Carlota
  • Martinez-Marin, Pablo
  • García-Martí, Gracián|||0000-0002-9850-2580
  • Aguilar Cortes, Eduardo|||0000-0002-7875-5644
  • Escarti, Maria J.
  • Grasa, Eva|||0000-0003-1100-7489
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Sanjuan, Julio
  • Nacher, Juan|||0000-0001-7599-3957
Auditory hallucinations (AH) are one of the most prevalent symptoms of schizophrenia. They might cause several brain alterations, especially changes in the volumes of hippocampus and amygdala, regions related to the relay and processing of auditory cues and emotional memories. We have recruited 41 patients with schizophrenia and persistent AH, 35 patients without AH, and 55 healthy controls. Using their MRIs, we have performed semiautomatic segmentations of the hippocampus and amygdala using Freesurfer. We have also performed bilateral correlations between the total PSYRATS score and the volumes of affected subregions and nuclei. In the hippocampus, we found bilateral increases in the volume of its hippocampal fissure and decreases in the right fimbria in patients with and without AH. The volume of the right hippocampal tail and left head of the granule cell layer from the dentate gyrus were decreased in patients with AH. In the amygdala, we found its left total volume was shrunk, and there was a decrease of its left accessory basal nucleus in patients with AH. We have detected volume alterations of different limbic structures likely due to the presence of AH. The volumes of the right hippocampal tail and left head of the granule cell layer from the dentate gyrus, and total volume of the amygdala and its accessory basal nucleus, were only affected in patients with AH. Bilateral volume alterations in the hippocampal fissure and right fimbria seem inherent of schizophrenia and due to traits not contemplated in our research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Type 2 Diabetes in Obesity, A Systems Biology Study on Serum and Adipose Tissue Proteomic Profiles

  • Arderiu, Gemma|||0000-0001-8598-4106
  • Mendieta, Guiomar|||0000-0001-6652-9036
  • Gallinat, Alex|||0000-0002-1521-2175
  • Lambert, Carmen|||0000-0002-7929-4990
  • Díez-Caballero, Alberto
  • Ballesta, Carlos
  • Badimon, Lina|||0000-0002-9162-2459
Obesity is associated with metabolic disorders such as insulin resistance and type 2 diabetes mellitus (T2DM), further increasing an already heightened cardiovascular risk. Here, amongst obese class III bariatric surgery patients, we have investigated the effect of T2DM in serum and in two, same patient, adipose tissue (AT) depots through proteomic profile expression analyses. Serum and AT samples from subcutaneous (SAT) and visceral (VAT) fat were collected during bariatric surgery. Bead-based targeted multiplex assay systems were used to simultaneously detect and quantify multiple targets in serum samples (targeted proteomics) and analyze changes in adipokine serum composition. AT samples were assessed through an untargeted proteomics approach. Through a systems biology analysis of the proteomic data, information on the affected biological pathways was acquired. In obese class III individuals, the presence of T2DM induced a significantly higher systemic release of ghrelin, GLP-1, glucagon, MMP3, BAFF, chitinase 3-like 1, TNF-R1 and TNF-R2, and a lower systemic release of IL-8. SAT and VAT proteomes belonging to the same patient showed significant differences in local protein content. While the proteins upregulated in VAT were indicative of metabolic dysregulation, SAT protein upregulation suggested adequate endocrine regulation. The presence of T2DM significantly affected VAT protein composition through the upregulation of dysregulating metabolic pathways, but SAT protein composition was not significantly modified. Our results show that T2DM induces metabolic dysregulation in obese individuals with changes in systemic marker levels and impairment of proteostasis in VAT but not in SAT.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism, A Development and Validation Study Involving Two Independent Prospective Cohorts

  • Muñoz Martin, Andrés|||0000-0001-6977-8249
  • Ay, Cihan
  • Grilz, Ella
  • López, Sonia|||0000-0002-5023-5153
  • Font, C.|||0000-0002-3547-7373
  • Pachón, Vanesa
  • Castellón, Victoria
  • Martínez Marín, Virginia
  • Salgado, Mercedes
  • Martínez, Eva
  • Calzas, Julia|||0000-0002-9416-9514
  • Ortega Morán, Laura|||0000-0003-0456-7322
  • Rupérez, Ana|||0000-0003-2338-4257
  • Salas, Eduardo|||0000-0002-6837-2471
  • Pabinger, Ingrid
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with cancer receiving chemotherapy, but its accuracy in identifying patients at high risk has been questioned. The aim of this study was to develop and validate a clinical-genetic score that improves the assessment of VTE risk in oncology outpatients within 6 months of diagnosis. The new score was developed using the data of 364 outpatients belonging to the Spanish ONCOTHROMB 12-01 population. In this cohort, clinical data associated with the risk of VTE were collected at the time of diagnosis, including the Khorana score. These patients were also genotyped for the 51 genetic variants known to be associated with VTE. Multivariate logistic regression was performed to determine the weight of each genetic and clinical variable in relation to VTE risk, allowing a clinical-genetic risk score (the ONCOTHROMB score) to be developed. The Khorana and the ONCOTHROMB scores were then compared via the area under the receiver operating characteristic curve (AUC), calibration, and the number of patients needed to treat. The new score was then validated in a study of 263 patients in the Vienna Cancer and Thrombosis Study population.RESULTSNine genetic variants, tumor site, TNM stage, and a body mass index of.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Lipidome Profiling in Childhood Obesity Compared to Adults, A Pilot Study

  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • González, Lorena
  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Valls, Aina|||0000-0002-0751-5029
  • Real, Nativitat
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Jenkins, Benjamin|||0000-0003-0038-9709
  • Galán, María|||0000-0002-4758-8388
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Koulman, Albert|||0000-0001-9998-051X
  • Corrales, Patricia|||0000-0002-9817-8389
  • Vidal-Puig, Antonio
  • Cereijo, Rubén|||0000-0002-1108-230X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
The objective is to assess the circulating lipidome of children with obesity before and after lifestyle intervention and to compare the data to the circulating lipidome of adults with obesity before and after bariatric surgery. Ten pediatric (PE) and thirty adult (AD) patients with obesity were prospectively recruited at a referral single center. The PE cohort received lifestyle recommendations. The AD cohort underwent bariatric surgery. Clinical parameters and lipidome were analyzed in serum before and after six months of metabolic intervention. The abundance of phosphatidylinositols in the PE cohort and phosphatidylcholines in the AD significantly increased, while O-phosphatidylserines in the PE cohort and diacyl/triacylglycerols in the AD decreased. Fifteen lipid species were coincident in both groups after lifestyle intervention and bariatric surgery. Five species of phosphatidylinositols, sphingomyelins, and cholesteryl esters were upregulated. Eight species of diacylglycerols, glycerophosphoglycerols, glycerophosphoethanolamines, and phosphatidylcholines were downregulated. Most matching species were regulated in the same direction except for two phosphatidylinositols: PI(O-36:2) and PI(O-34:0). A specific set of lipid species regulated after bariatric surgery in adult individuals was also modulated in children undergoing lifestyle intervention, suggesting they may constitute a core circulating lipid profile signature indicative of early development of obesity and improvement after clinical interventions regardless of individual age.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients

  • López-Cotarelo, Pilar
  • González-Jiménez, Adela
  • Agudo-Jiménez, Teresa
  • Abarca-Zabalía, Judith
  • Aladro, Yolanda|||0000-0001-9459-5452
  • Pilo, Belén
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Espino-Paisan, Laura
  • Urcelay, Elena|||0000-0001-8470-8396
One of the 233 polymorphisms associated with multiple sclerosis (MS) susceptibility lies within the NDFIP1 gene, and it was previously identified as eQTL in healthy controls. NDFIP1 shows interesting immune functions and is involved in the development of the central nervous system. We aimed at studying the NDFIP1 variant on activation and metabolism of immune cells. NDFIP1 mRNA and protein expression were assessed in PBMCs by qPCR and western blot in 87 MS patients and 84 healthy controls genotyped for rs4912622. Immune activation after PHA stimulation was evaluated by CD69 upregulation, and metabolic function of both basal and PHA-activated lymphocytes was studied by Seahorse Xfp-Analyzer. In minor-allele homozygous controls but not in patients, we found higher NDFIP1 expression, significantly reduced protein levels, and CD69 upregulation in B- and T-cells. PBMCs from minor-allele homozygous controls showed significantly higher basal mitochondrial respiration and ATP production compared to major-allele carriers, while minor-allele homozygous patients showed significantly lower metabolic activity than carriers of the major allele. In conclusion, we describe associations in minor-allele homozygous controls with lower levels of NDFIP1 protein, CD69 upregulation, and raised mitochondrial activity, which are not replicated in MS patients, suggesting a NDFIP1 differential effect in health and disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Scheeren Brum, Wagner|||0000-0002-9777-0559
  • Molfetta, Guglielmo Di
  • Benedet, Andréa Lessa
  • Arslan, Burak
  • Jonaitis, Erin Mc Mullen
  • Langhough, Rebecca E.
  • Cody, Karly Alex
  • Wilson, Rachael E.
  • Carlsson, Cynthia M.
  • Vanmechelen, Eugeen|||0000-0002-9466-5366
  • Montoliu Gaya, Laia|||0000-0001-7684-6318
  • Lantero Rodríguez, Juan|||0000-0002-7426-678X
  • Rahmouni, Nesrine
  • Tissot, Cécile
  • Stevenson, Jenna
  • Servaes, Stijn|||0000-0002-4431-957X
  • Therriault, Joseph
  • Pascoal, Tharick|||0000-0001-9057-8014
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Johnson, Sterling C.
  • Jeromin, Andreas
  • Blennow, Kaj|||0000-0002-1890-4193
  • Zetterberg, Henrik|||0000-0003-3930-4354
IMPORTANCE Phosphorylated tau (p-tau) is a specific blood biomarker for Alzheimer disease (AD) pathology, with p-tau217 considered to have the most utility. However, availability of p-tau217 tests for research and clinical use has been limited. Expanding access to this highly accurate AD biomarker is crucial for wider evaluation and implementation of AD blood tests. OBJECTIVE To determine the utility of a novel and commercially available immunoassay for plasma p-tau217 to detect AD pathology and evaluate reference ranges for abnormal amyloid β (Aβ) and longitudinal change across 3 selected cohorts. DESIGN, SETTING, AND PARTICIPANTS This cohort study examined data from 3 single-center observational cohorts: cross-sectional and longitudinal data from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort (visits October 2017-August 2021) and Wisconsin Registry for Alzheimer's Prevention (WRAP) cohort (visits February 2007-November 2020) and cross-sectional data from the Sant Pau Initiative on Neurodegeneration (SPIN) cohort (baseline visits March 2009-November 2021). Participants included individuals with and without cognitive impairment grouped by amyloid and tau (AT) status using PET or CSF biomarkers. Data were analyzed from February to June 2023. EXPOSURES Magnetic resonance imaging, Aβ positron emission tomography (PET), tau PET, cerebrospinal fluid (CSF) biomarkers (Aβ42/40 and p-tau immunoassays), and plasma p-tau217 (ALZpath pTau217 assay). MAIN OUTCOMES AND MEASURES Accuracy of plasma p-tau217 in detecting abnormal amyloid and tau pathology, longitudinal p-tau217 change according to baseline pathology status. RESULTS The study included 786 participants (mean [SD] age, 66.3 [9.7] years; 504 females [64.1%] and 282 males [35.9%]). High accuracy was observed in identifying elevated Aβ (area under the curve [AUC], 0.92-0.96; 95% CI, 0.89-0.99) and tau pathology (AUC, 0.93-0.97; 95% CI, 0.84-0.99) across all cohorts. These accuracies were comparable with CSF biomarkers in determining abnormal PET signal. The detection of abnormal Aβ pathology using a 3-range reference yielded reproducible results and reduced confirmatory testing by approximately 80%. Longitudinally, plasma p-tau217 values showed an annual increase only in Aβ-positive individuals, with the highest increase observed in those with tau positivity. CONCLUSIONS AND RELEVANCE This study found that a commercially available plasma p-tau217 immunoassay accurately identified biological AD, comparable with results using CSF biomarkers, with reproducible cut-offs across cohorts. It detected longitudinal changes, including at the preclinical stage.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction

  • Planas-Cerezales, Lurdes|||0000-0001-7636-444X
  • Arias-Salgado, Elena G.
  • Berastegui García, Cristina|||0000-0001-9774-9349
  • Montes-Worboys, Ana|||0000-0002-3204-779X
  • González-Montelongo, Rafaela
  • Lorenzo-Salazar, José. M.
  • Vicens-Zygmunt, Vanesa|||0000-0002-0940-3215
  • Garcia-Moyano, Marta
  • Dorca, Jordi|||0000-0002-8137-878X
  • Flores, Carlos|||0000-0001-5352-069X
  • Perona, Rosario|||0000-0002-2973-5153
  • Roman Broto, Antonio|||0000-0002-9417-3484
  • Molina Molina, Maria|||0000-0002-1852-1723
Introduction: Fibrotic interstitial lung diseases (ILDs) are the first indication for lung transplantation (LT). Telomere dysfunction has been associated with poor post-transplant outcomes. The aim of the study was to evaluate the morbi-mortality and quality of life in fibrotic ILDs after lung transplant depending on telomere biology. Methods: Fibrotic ILD patients that underwent lung transplant were allocated to two arms; with or without telomere dysfunction at diagnosis based on the telomere length and telomerase related gene mutations revealed by whole-exome sequencing. Post-transplant evaluation included: (1) short and long-term mortality and complications and (2) quality of life. Results: Fifty-five percent of patients that underwent LT carried rare coding mutations in telomerase-related genes. Patients with telomere shortening more frequently needed extracorporeal circulation and presented a higher rate of early post-transplant hematological complications, longer stay in the intensive care unit (ICU), and a higher number of long-term hospital admissions. However, post-transplant 1-year survival was higher than 80% regardless of telomere dysfunction, with improvement in the quality of life and oxygen therapy withdrawal. Conclusions: Post-transplant morbidity is higher in patients with telomere dysfunction and differs according to elapsed time from transplantation. However, lung transplant improves survival and quality of life and the associated complications are manageable.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Role of Digital Rectal Examination for Early Detection of Significant Prostate Cancer in the Era of Magnetic Resonance Imaging

  • Morote Robles, Juan|||0000-0002-2168-323X
  • Paesano, Nahuel|||0000-0001-9278-5543
  • Picola, Natàlia|||0000-0002-8944-4294
  • Muñoz Rodríguez, José Manuel|||0000-0002-4688-6420
  • Ruiz-Plazas, Xavier|||0000-0003-2135-3860
  • Muñoz Rivero, Marta Viridiana|||0000-0002-6899-3956
  • Celma, Ana|||0000-0002-3128-3811
  • García-de Manuel, Gemma
  • Miró, Berta|||0000-0001-6049-8697
  • Abascal, Jose Maria|||0000-0001-8374-6593
  • Servian, Pol|||0000-0002-3727-8159
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Trilla Herrera, Enrique|||0000-0001-9401-0872
The role of digital rectal examination (DRE) in the early detection of significant prostate cancer (PCa) is being questioned in the era of magnetic resonance imaging (MRI). However, some men with suspected PCa may still be identified solely through DRE, even with low serum prostate-specific antigen (PSA) levels. Additionally, most predictive models designed to improve significant PCa diagnostic pathways incorporate DRE findings. We assessed the role of DRE among 5005 men with serum PSA levels.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer

  • Morote Robles, Juan|||0000-0002-2168-323X
  • Borque-Fernando, Ángel|||0000-0003-0178-4567
  • Esteban, Luis M.|||0000-0002-3007-302X
  • Celma, Ana|||0000-0002-3128-3811
  • Campistol i Torres, Miriam|||0000-0002-3212-3473
  • Miró, Berta|||0000-0001-6049-8697
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Trilla Herrera, Enrique|||0000-0001-9401-0872
Risk-stratified pathways (RSPs) are recommended by the European Association of Uro-logy (EAU) to improve the early detection of clinically significant prostate cancer (csPCa). RSPs can reduce magnetic resonance imaging (MRI) demand, prostate biopsies, and the over-detection of insignificant PCa (iPCa). Our goal is to analyze the efficacy and cost-effectiveness of several RSPs by using sequential stratifications from the serum prostate-specific antigen level and digital rectal examination, the Barcelona risk calculators (BCN-RCs), MRI, and Proclarix™. In a cohort of 567 men with a serum PSA level above 3.0 ng/mL who underwent multiparametric MRI (mpMRI) and targeted and/or systematic biopsies, the risk of csPCa was retrospectively assessed using Proclarix™ and BCN-RCs 1 and 2. Six RSPs were compared with those recommended by the EAU that, stratifying men from MRI, avoided 16.7% of prostate biopsies with a prostate imaging-reporting and data system score of <3, with 2.6% of csPCa cases remaining undetected. The most effective RSP avoided mpMRI exams in men with a serum PSA level of.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV

  • Burgos, Joaquín|||0000-0001-8445-3047
  • Benítez-Martínez, Aleix
  • Mancebo, Cristina
  • Massana, Núria|||0000-0002-5403-3161
  • Astorga-Gamaza, Antonio|||0000-0002-1276-5276
  • Castellvi, Josep|||0000-0001-5745-9996
  • Landolfi, Stefania|||0000-0002-1059-635X
  • Curran, Adrian|||0000-0002-1263-0814
  • García Pérez, Jorge Néstor|||0000-0003-4986-6094
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Buzón, Maria José|||0000-0003-4427-9413
  • Genescà Ferrer, Meritxell|||0000-0001-6413-3812
Men who have sex with men (MSM) with HIV are at high risk for squamous intraepithelial lesion (SIL) and anal cancer. Identifying local immunological mechanisms involved in the development of anal dysplasia could aid treatment and diagnostics. Here, we studied 111 anal biopsies obtained from 101 MSM with HIV, who participated in an anal screening program. We first assessed multiple immune subsets by flow cytometry, in addition to histological examination, in a discovery cohort. Selected molecules were further evaluated by immunohistochemistry in a validation cohort. Pathological samples were characterized by the presence of resident memory T cells with low expression of CD103 and by changes in natural killer cell subsets, affecting residency and activation. Furthermore, potentially immunosuppressive subsets, including CD15 + CD16 + mature neutrophils, gradually increased as the anal lesion progressed. Immunohistochemistry verified the association between the presence of CD15 in the epithelium and SIL diagnosis for the correlation with high-grade SIL. A complex immunological environment with imbalanced proportions of resident effectors and immune-suppressive subsets characterized pathological samples. Neutrophil infiltration, determined by CD15 staining, may represent a valuable pathological marker associated with the grade of dysplasia. Assessment of changes in relevant anal dysplasia-associated mucosal immune subsets provides potential targets for immunotherapy and a complementary biomarker for current diagnostics.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel risk loci for COVID-19 hospitalization among admixed American populations

  • Diz-de Almeida, Silvia|||0000-0003-2813-8928
  • Cruz, Raquel|||0000-0002-6964-8898
  • Luchessi, Andre D.
  • Lorenzo-Salazar, José M.
  • López de Heredia, Miguel|||0000-0003-2826-9565
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Montelongo, Rafaela
  • Nogueira Silbiger, Vivian|||0000-0002-9252-0278
  • Sevilla Porras, Marta
  • Tenorio Castaño, Jair Antonio|||0000-0002-5308-2316
  • Nevado, Julián|||0000-0001-5611-2659
  • Aguado, José María|||0000-0002-9520-8255
  • Aguilar, Carlos
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
  • Almadana, Virginia
  • Almoguera, Berta|||0000-0002-5599-2954
  • Alvarez, Nuria
  • Andreu-Bernabeu, Álvaro
  • Arana-Arri, Eunate|||0000-0001-9759-333X
  • Arango, Celso|||0000-0003-3382-4754
  • Arranz, María Jesús|||0000-0002-6757-9198
  • Artiga, Maria-Jesus
  • Baptista-Rosas, Raúl C.|||0000-0002-0273-4740
  • Barreda Sánchez, María
  • Belhassen-Garcia, Moncef
  • Bezerra, Joao F.
  • Bezerra, Marcos AC.
  • Boix-Palop, Lucía|||0000-0002-4080-0008
  • Brion, María|||0000-0001-7463-2148
  • Brugada, Ramon|||0000-0001-6607-3032
  • Bustos, Matilde
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • Carbonell, Cristina|||0000-0002-6271-5111
  • Castaño, Luis|||0000-0003-0437-9401
  • Castelao, Jose E.
  • Conde-Vicente, Rosa
  • Cordero-Lorenzana, M. Lourdes
  • Cortes-Sanchez, Jose L.
  • Corton, Marta|||0000-0003-0087-1626
  • Darnaude, M. Teresa
  • De Martino-Rodríguez, Alba|||0000-0002-2436-9852
  • Campo Pérez, Víctor del|||0000-0002-9424-9653
  • Diaz de Bustamante, Aranzazu
  • Domínguez-Garrido, Elena|||0000-0002-2066-0511
  • Eirós, Rocío
  • Fariñas, M. Carmen
  • Fernandez-Nestosa, María J.|||0000-0001-7764-7791
  • Fernández-Robelo, Uxía
  • Fernández-Rodríguez, Amanda|||0000-0002-5110-2213
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Gago-Dominguez, Manuela
  • Gil-Fournier, Belén
  • Gómez-Arrue, Javier
  • González Álvarez, Beatriz
  • González Bernaldo de Quirós, Fernan
  • González-Neira, Anna
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Gutiérrez-Bautista, Juan F.|||0000-0003-1374-0756
  • Herrero, María José
  • Herrero-Gonzalez, Antonio
  • Jimenez-Sousa, María A.
  • Lattig, María Claudia|||0000-0003-2113-9266
  • Liger Borja, Anabel
  • Lopez-Rodriguez, Rosario
  • Mancebo, Esther
  • Martín-López, Caridad
  • Martín, Vicente|||0000-0003-0552-2804
  • Martinez-Nieto, Oscar
  • Martinez-Lopez, Iciar
  • Martinez-Resendez, Michel F.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Mazzeu, Juliana F.
  • Merayo Macías, Eleuterio
  • Minguez, Pablo|||0000-0003-4099-9421
  • Moreno Cuerda, Victor
  • Oliveira, Silviene F.|||0000-0002-7741-0257
  • Ortega-Paino, Eva
  • Parellada, Mara|||0000-0001-7977-3601
  • Paz-Artal, Estela|||0000-0002-0646-2375
  • Santos, Ney PC.
  • Pérez-Matute, Patricia
  • Perez, Patricia
  • Pérez-Tomás, M. Elena|||0000-0002-5429-3414
  • Perucho, Teresa
  • Pinsach-Abuin, Mellina
  • Pita, Guillermo|||0000-0003-2393-0510
  • Pompa-Mera, Ericka N.
  • Porras-Hurtado, Gloria L.
  • Pujol, Aurora|||0000-0002-9606-0600
  • Ramiro-León, Soraya
  • Resino, Salvador|||0000-0001-8783-0450
  • Fernandes, Marianne R.
  • Rodríguez-Ruiz, Emilio
  • Rodriguez-Artalejo, Fernando
  • Rodriguez-Garcia, José A.
  • Ruiz-Cabello, Francisco
  • Ruiz-Hornillos, Javier
  • Ryan, Pablo|||0000-0002-4212-7419
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Tamayo, Eduardo
  • Tamayo-Velasco, Alvaro
  • Taracido-Fernandez, Juan Carlos
  • Teper, AlejandroHospital de Niños Ricardo Gutierrez (Buenos Aires, Argentina)
  • Torres-Tobar, Lilian
  • Urioste, Miguel|||0000-0001-7583-7305
  • Valencia-Ramos, Juan
  • Yáñez, Zuleima
  • Zarate, Ruth N.
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Sánchez, Pascual
  • Real, Luis M.|||0000-0003-4932-7429
  • Guillén-Navarro, Encarna|||0000-0002-2915-7381
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Parra, Esteban J.|||0000-0002-2057-8577
  • Riancho, José A.|||0000-0003-0691-8755
  • Rojas-Martinez, Augusto|||0000-0003-3765-6778
  • Flores, Carlos|||0000-0001-5352-069X
  • Lapunzina, Pablo|||0000-0002-6324-4825
  • Carracedo, Ángel|||0000-0003-1085-8986
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited the discovery of population-specific common risk loci. In this second study nested in the SCOURGE consortium, we conducted a genome-wide association study (GWAS) for COVID-19 hospitalization in admixed Americans, comprising a total of 4702 hospitalized cases recruited by SCOURGE and seven other participating studies in the COVID-19 Host Genetic Initiative. We identified four genome-wide significant associations, two of which constitute novel loci and were first discovered in Latin American populations (BAZ2B and DDIAS). A trans-ethnic meta-analysis revealed another novel cross-population risk locus in CREBBP. Finally, we assessed the performance of a cross-ancestry polygenic risk score in the SCOURGE admixed American cohort. This study constitutes the largest GWAS for COVID-19 hospitalization in admixed Latin Americans conducted to date. This allowed to reveal novel risk loci and emphasize the need of considering the diversity of populations in genomic research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug

  • Velasco, Roser|||0000-0003-3194-9406
  • Marco, Carla
  • Domingo-Domenech, Eva|||0000-0001-8907-090X
  • Stradella, Agostina|||0000-0002-2307-8869
  • Santos Vivas, Cristina|||0000-0002-9854-5097
  • Laquente, Berta|||0000-0002-2477-1673
  • Ferrer, German
  • Argyriou, Andreas A.|||0000-0003-2131-7114
  • Bruna, Jordi|||0000-0001-6895-5047
A real-time biomarker in chemotherapy-induced peripheral neurotoxicity (CIPN) would be useful for clinical decision-making during treatment. Neurofilament light chain (NfL) can be detected in blood in the case of neuroaxonal damage. The aim of the study was to compare the levels of plasma NfL (pNfL) according to the type of chemotherapeutic agent and the severity of CIPN. This single-center prospective observational longitudinal study included patients treated with paclitaxel (TX; n = 34), brentuximab vedotin (BV; n = 29), or oxaliplatin (PT; n = 19). All patients were assessed using the Total Neuropathy Score-clinical version and Common Terminology Criteria for Adverse Events before, during, and up to 6-12 months after the end of treatment. Nerve conduction studies (NCS) were performed before and after chemotherapy discontinuation. Consecutive plasma samples were analyzed for NfL levels using a Simoa ® analyzer. Changes in pNfL were compared between groups and were eventually correlated with clinical and NCS data. Clinically relevant (CR) CIPN was considered to be grade ≥ 2. Eighty-two patients, mostly women (59.8%), were included. One third of the patients who received TX (29.4%), BV (31%), or PT (36.8%) developed CR-CIPN, respectively, without differences among them (p = 0.854). Although pNfL significantly increased during treatment and decreased throughout the recovery period in all three groups, patients receiving TX showed significantly greater and earlier changes in pNfL levels compared to the other agents (p < 0.001). A variable change in pNfL is observed depending on the type of agent and mechanism of neurotoxicity with comparable CIPN severity, strongly implying the need to identify different cutoff values for each agent.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Design and baseline characteristics of SALT-HF trial, hypertonic saline therapy in ambulatory heart failure

  • Cobo Marcos, M.
  • Comín-Colet, Josep|||0000-0001-8780-720X
  • De la Espriella, Rafael|||0000-0002-8720-3999
  • Rubio Gracia, J.
  • Morales-Rull, J.L.
  • Zegrí-Reiriz, Isabel|||0000-0001-9742-8537
  • Llacer, P.
  • Diez-Villanueva, P.
  • Jiménez-Marrero, S.
  • de Juan Bagudá, J.
  • Ortiz Cortés, C.
  • Goirigolzarri-Artaza, J.
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Barrios, E.
  • del Prado Díaz, S.
  • Montero Hernández, E.
  • Sanchez-Marteles, M.
  • Nuñez, J.
Hypertonic saline solution (HSS) plus intravenous (IV) loop diuretic appears to enhance the diuretic response in patients hospitalized for heart failure (HF). The efficacy and safety of this therapy in the ambulatory setting have not been evaluated. We aimed to describe the design and baseline characteristics of the SALT-HF trial participants. 'Efficacy of Saline Hypertonic Therapy in Ambulatory Patients with HF' (SALT-HF) trial was a multicenter, double-blinded, and randomized study involving ambulatory patients who experienced worsening heart failure (WHF) without criteria for hospitalization. Enrolled patients had to present at least two signs of volume overload, use ≥ 80 mg of oral furosemide daily, and have elevated natriuretic peptides. Patients were randomized 1:1 to treatment with a 1-h infusion of IV furosemide plus HSS (2.6-3.4% NaCl depending on plasmatic sodium levels) versus a 1-h infusion of IV furosemide at the same dose (125-250 mg, depending on basal loop diuretic dose). Clinical, laboratory, and imaging parameters were collected at baseline and after 7 days, and a telephone visit was planned after 30 days. The primary endpoint was 3-h diuresis after treatment started. Secondary endpoints included (a) 7-day changes in congestion data, (b) 7-day changes in kidney function and electrolytes, (c) 30-day clinical events (need of IV diuretic, HF hospitalization, cardiovascular mortality, all-cause mortality or HF-hospitalization). A total of 167 participants [median age, 81 years; interquartile range (IQR), 73-87, 30.5% females] were randomized across 13 sites between December 2020 and March 2023. Half of the participants (n = 82) had an ejection fraction.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder

  • Pardo, Jèssica|||0000-0003-4665-4213
  • Montal, Victor|||0000-0002-5714-9282
  • Campabadal, Anna|||0000-0002-2833-4884
  • Oltra, Javier|||0000-0002-9268-4504
  • Uribe, Carme|||0000-0002-1415-687X
  • Roura, Ignacio|||0000-0001-8877-899X
  • Bargalló, Núria|||0000-0001-6284-5402
  • Martí Domenech, Maria Josep|||0000-0002-9872-7835
  • Compta, Yaroslau|||0000-0001-6443-0104
  • Iranzo, Alex|||0000-0002-5618-8271
  • Fortea, Juan|||0000-0002-1340-638X
  • Junqué, Carme|||0000-0002-6381-3063
  • Segura, Bàrbara|||0000-0002-9673-5479
Evidence regarding cortical atrophy patterns in Parkinson's disease (PD) with probable rapid eye movement sleep behavior disorder (RBD) (PD-pRBD) remains scarce. Cortical mean diffusivity (cMD), as a novel imaging biomarker highly sensitive to detecting cortical microstructural changes in different neurodegenerative diseases, has not been investigated in PD-pRBD yet. The aim was to investigate cMD as a sensitive measure to identify subtle cortical microstructural changes in PD-pRBD and its relationship with cortical thickness (CTh). Twenty-two PD-pRBD, 31 PD without probable RBD (PD-nonpRBD), and 28 healthy controls (HC) were assessed using 3D T1-weighted and diffusion-weighted magnetic resonance imaging on a 3-T scanner and neuropsychological testing. Measures of cortical brain changes were obtained through cMD and CTh. Two-class group comparisons of a general linear model were performed (P < 0.05). Cohen's d effect size for both approaches was computed. PD-pRBD patients showed higher cMD than PD-nonpRBD patients in the left superior temporal, superior frontal, and precentral gyri, precuneus cortex, as well as in the right middle frontal and postcentral gyri and paracentral lobule (d.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Features related to the presence of internet gaming disorder and their impact on the treatment outcomes

  • Ayala-Rojas, Rocío Elena|||0000-0002-0101-4215
  • Rosinska, Magda Julia|||0009-0009-9918-7592
  • Perales, Iván|||0000-0001-6799-6373
  • Soldevilla-Morera, Jorge
  • Granero, Roser|||0000-0001-6308-3198
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
Background and aims: Internet gaming disorder (IGD) is a highly engrossing activity with the individual spending up to 10 h per day gaming, this causes issues in accomplishing their tasks and personal goals. Also, to generate in them increased anxiety, impulsivity and lack of social skills, this impacts the good personal development and individual's quality of life. Therefore, it is vital to better understand, in terms of treatment, which factors are associated with therapeutic outcomes (largely to achieve control over the use of video games and the lack of relapses) following a standardized Cognitive Behavioral Therapy (CBT) protocol. This study aimed to explore sociodemographic and personality variables and their relation to treatment outcome in patients with IGD. Method: The sample included n 5 105 patients with IGD, considered between January 2005 and December 2022 and recruited from the Behavioral Addictions Unit at the University Hospital of Bellvitge. Data at baseline was registered (sociodemographic and clinical measures), as well as the therapy outcomes (compliance with the guidelines, presence of relapses and dropouts). Results: Patients were mainly males (n 5 95) with a mean age of 24.97 (SD 5 12.03). All patients included in this sample had individual CBT treatment in relation to their problematic gaming behavior. In terms of patients who relapsed, they had higher interpersonal sensitivity, hostility and persistence with lower selfdirectedness. Patients who dropped out were males with an older age of IGD onset. When looking at treatment noncompliance, it was related to higher psychoticism and reward dependence, and lower cooperation. Patients with IGD show higher levels of treatment noncompliance. Conclusion: These findings evidence a positive and promising effect of CBT on IGT. The factors identified as predictors of good and poor treatment outcomes should be considered for developing new evidencebased interventions focused on learning healthier key coping strategies to manage both cravings and triggers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Factors associated with the discrepancy between objective and subjective cognitive impairment in bipolar disorder

  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Sánchez-Moreno, Jose|||0000-0003-1520-093X
  • Lima, Flávia M.|||0000-0002-9066-768X
  • Roca, Xavier
  • Segú, Xavier|||0000-0003-4376-9680
  • Montejo, Laura|||0000-0003-4407-9454
  • Solé, Brisa|||0000-0003-1673-8248
  • Hidalgo-Mazzei, Diego|||0000-0002-2693-6849
  • Martin-Parra, Sara
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Torrent, Carla|||0000-0003-0335-582X
  • Rosa, Adriane|||0000-0001-8629-4625
The aim of this study is to evaluate the discrepancy between objective cognitive measures and cognitive subjective complaints in a sample of euthymic patients with bipolar disorder (BD). Methods: One hundred and sixteen participants (83 euthymic patients with BD and 33 healthy controls) were enrolled for this study. Patients were assessed with a comprehensive neuropsychological battery and they also reported their subjective cognitive complaints with the Cognitive Complaints in Bipolar Disorder Rating Scale (COBRA). The discrepancy between objective and subjective data was calculated using a novel methodology proposed in a previous study (Miskowiak, 2016). Statistical analyses included Pearson correlations and multiple linear regression. Results: Higher number of previous depressive episodes was identified as one variable associated with the global sensitivity composite score (Beta = 0.25; t = 2.1; p = 0.04) and with the verbal learning and memory sensitivity score (Beta = 0.26; t = 2.16; p = 0.03). That is, patients with more previous depressive episodes tend to over-report cognitive complaints. In contrast, higher number of previous hospitalizations was associated with stoicism in the global total score (Beta = -0.27; t = -2.24: p = 0.029) and in the domain of attention/processing speed (Beta = -0.34; t = -2.52; p = 0.016), indicating patients with more hospitalizations tend to report less cognitive complaints. Discussion: Our study identified some factors that might help to explain the discrepancy between objective and subjective cognitive measures in BD, including number of previous depressive episodes and number of previous hospitalizations. This highlights the need of the combined use of both types of cognitive measures to make an accurate assessment of cognitive dysfunctions and their effective treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype, Clinical Implications for Infective Endocarditis

  • García-González, Javier
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Hernández Meneses, Marta|||0000-0001-9991-1127
  • Verdejo, Miguel Ángel|||0000-0001-7870-0515
  • Bodro, Marta|||0000-0002-0520-8279
  • Díez de los Ríos, Javier
  • Gasch, Oriol|||0000-0001-8518-458X
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Falces, Carles|||0000-0002-3483-3786
  • Perissinotti, Andrés|||0000-0003-4190-2425
  • Vidal, Bárbara
  • Quintana, Eduard|||0000-0002-5386-7463
  • Moreno Camacho, Asunción|||0000-0001-6382-0039
  • Piquet, Maria
  • Roca, Ignasi|||0000-0002-1800-1576
  • Fernandez-Pittol, Mariana|||0000-0002-1685-7127
  • San José-Villar, Sol M.
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Miró, José M.|||0000-0001-8057-7755
(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-faecalis/non-faecium enterococci; we aimed to assess the in vitro activity of ampicillin plus ceftriaxone (AMP + CTR) against these enterococci and to describe its clinical efficacy in IE cases. (2) Methods: Time-kill curves with standard (ISI) and high (IHI) inocula were performed to test VanC isolates [3 E. casseliflavus (ECAS) and 1 E. gallinarum (EGALL)] and non-VanC isolates [1 E. durans (EDUR), 1 E. hirae (EHIR) and 1 E. raffinosus (ERAF)]. The narrative literature review of IE cases treated with AMP + CTR was analyzed alongside three study cases. Clinical outcomes were relapse and death. (3) Results: Ampicillin plus gentamicin (AMP + GEN) showed synergistic and bactericidal activity against most isolates. AMP + CTR was synergistic at ISI for EGALL, EDUR, and EHIR and bactericidal against EHIR. At IHI, indifferent activity was observed for all isolates. In IE cases treated with AMP + CTR, it was only effective for EDUR and EHIR. Clinical information for EGALL IE is lacking. For IE caused by ECAS and ERAF, AMP + CTR seems suboptimal or ineffective, respectively. (4) AMP + CTR cannot be recommended for treating IE due to ECAS/ERAF. In contrast, this combination was effective in IE caused by EDUR/EHIR and could be recommended.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

  • Villacieros-Álvarez, Javier
  • Espejo, Carmen|||0000-0001-9949-5901
  • Arrambide, Georgina|||0000-0002-2657-5510
  • Dinoto, Alessandro|||0000-0002-3249-4792
  • Mulero, Patricia|||0000-0001-8716-8997
  • Rubio-Flores, Laura|||0000-0001-5570-8055
  • Nieto, Pablo
  • Alcalá, Carmen
  • Meca-Lallana, Jose Eustasio|||0000-0001-5050-9890
  • Millan-Pascual, Jorge|||0000-0003-2112-5964
  • Martínez-García, Pedro
  • Bernard-Valnet, Raphael|||0000-0001-7447-344X
  • González-Suárez, Inés|||0000-0002-9897-0771
  • Orviz, Aída
  • Téllez, Raquel
  • Navarro Canto, Laura
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Martínez Yélamos, Sergio|||0000-0001-9889-2040
  • Cuello, Juan Pablo
  • Alonso, Ana
  • Piñar Morales, Raquel|||0000-0003-3490-4932
  • Álvarez Bravo, Gary|||0000-0003-0342-0177
  • Benyahya, Lakhdar
  • Trouillet-Assant, Sophie|||0000-0001-6439-4705
  • Dyon-Tafan, Virginie
  • Froment Tilikete, Caroline|||0000-0002-1452-1398
  • Ruet, Aurélie|||0000-0002-0020-8739
  • Bourre, Bertrand|||0000-0002-2459-2480
  • Deschamps, Romain|||0000-0001-6291-8771
  • Papeix, Caroline|||0000-0003-4074-6125
  • Maillart, Elisabeth|||0000-0001-7699-0328
  • Kerschen, Philippe|||0000-0002-6450-0691
  • Ayrignac, Xavier|||0000-0003-3834-2981
  • Rovira, Alex|||0000-0002-2132-6750
  • Auger, Cristina|||0000-0001-9846-4767
  • Audoin, Bertrand|||0000-0002-9860-7657
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
  • Mariotto, Sara|||0000-0002-7806-3103
  • Cobo-Calvo, Álvaro|||0000-0002-2574-0721
  • Marignier, Romain|||0000-0002-5967-2800
To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. This retrospective multicentric cohort study included patients aged 16 years and older meeting MOGAD 2023 criteria, with serum samples collected at baseline (≤3 months from disease onset) and follow-up (≥6 months from the baseline), and age-matched and time to sampling-matched patients with multiple sclerosis (MS). Eleven cytokines were assessed using the ELLA system. Data comparisons and statistical analyses between cytokine levels and clinical outcomes were performed. Eighty-eight patients with MOGAD and 32 patients with MS were included. Patients with MOGAD showed higher IL6 (p = 0.036), IL8 (p = 0.012), and IL18 (p = 0.026) baseline levels compared with those with MS, in non-optic neuritis (ON) presentations. BAFF values increased over time, especially in patients with MOGAD treated with anti-CD20 (p = 0.002). Baseline BAFF, CXCL10, IL10, and IL8 levels correlated with disease severity at MOGAD onset (all p < 0.05). Finally, higher baseline BAFF levels predicted lower risk of relapses (hazard ratio 0.41 [0.19; 0.89], p = 0.024). This study suggests a proinflammatory Th17-dominant profile in non-ON MOGAD patients, with a novel finding of a potential protective role of BAFF on relapses. These results shed new light on the pathogenesis of MOGAD, potentially guiding therapeutic decisions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

  • Villacieros-Álvarez, Javier
  • Espejo, Carmen|||0000-0001-9949-5901
  • Arrambide, Georgina|||0000-0002-2657-5510
  • Castillo Juárez, Mireia|||0000-0001-8979-3219
  • Carbonell-Mirabent, Pere|||0000-0003-1349-9261
  • Rodriguez, Marta
  • Bollo, Luca|||0000-0002-3673-2030
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Galan, Ingrid|||0000-0001-5774-4260
  • Midaglia, Luciana|||0000-0001-7981-2228
  • Mongay-Ochoa, Neus|||0000-0002-0338-4797
  • Nos, Carlos|||0000-0002-3830-4910
  • Río, Jordi|||0000-0003-4546-7627
  • Rodríguez Acevedo, Breogán|||0000-0002-0314-753X
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Tur, Carmen|||0000-0003-1849-3184
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Vilaseca, Andreu|||0000-0001-8147-8505
  • Zabalza, Ana|||0000-0003-3860-5251
  • Auger, Cristina|||0000-0001-9846-4767
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
  • Cobo-Calvo, Álvaro|||0000-0002-2574-0721
Objective: Myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) distinguish multiple sclerosis (MS) from MOG-associated disease in most cases. However, studies analyzing MOG-Ab at the time of a first demyelinating event suggestive of MS in adults are lacking. We aimed to (1) evaluate the prevalence of MOG-Ab in a first demyelinating event suggestive of MS and (2) compare clinical and paraclinical features between seropositive (MOG-Ab+) and seronegative (MOG-Ab-) patients. Methods: Six hundred thirty adult patients with available serum samples obtained within 6 months from the first event were included. MOG-Ab were analyzed using a live cell-based assay. Statistical analyses included parametric and nonparametric tests, logistic regression, and survival models. Results: MOG-Ab were positive in 17 of 630 (2.7%). Fourteen out of 17 (82.4%) MOG-Ab+ patients presented with optic neuritis (ON) compared to 227of 613 (37.0%) MOG-Ab- patients (p = 0.009). Cerebrospinal fluid-restricted oligoclonal bands (CSF-OBs) were found in 2 of 16 (12.5%) MOG-Ab+ versus 371 of 601 (61.7%) MOG-Ab- subjects (p < 0.001). Baseline brain magnetic resonance imaging (MRI) was normal in 9 of 17 (52.9%) MOG-Ab+ versus 153 of 585 (26.2%) MOG-Ab- patients (p = 0.029). Absence of CSF-OBs and ON at onset were independently associated with MOG-Ab positivity (odds ratio [OR] = 9.03, 95% confidence interval [CI] = 2.04-53.6, p = 0.009; and OR = 4.17, 95% CI = 1.15-19.8, p = 0.042, respectively). Of MOG-Ab+ patients, 22.9% (95% CI = 0.0-42.7) compared to 67.6% (95% CI = 63.3-71.3) of MOG-Ab- patients fulfilled McDonald 2017 criteria at 5 years (log-rank p = 0.003). Interpretation: MOG-Ab are infrequent in adults with a first demyelinating event suggestive of MS. However, based on our results, we suggest to determine these antibodies in those patients with ON and absence of CSF-OBs, as long as the brain MRI is not suggestive of MS. ANN NEUROL 2024;95:116-128.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adherence to Supervised and Unsupervised Exercise Programmes in Ageing Population with Intermittent Claudication, A Randomized Controlled Trial

  • Herrero Alonso, Cecilia
  • López-Lifante, Víctor-Miguel|||0000-0002-0919-9998
  • Costa-Garrido, Anna|||0000-0001-5428-1408
  • Pera, Guillem|||0000-0003-3188-7268
  • Alzamora, M. Teresa|||0000-0002-0094-6547
  • Forés Raurell, Rosa|||0000-0001-7803-7442
  • Martínez-Ruíz, Esau José|||0000-0001-5442-3912
  • López-Palencia, Juan
  • Moizé-Arcone, Luciana|||0000-0001-6656-9089
  • Mateo-Aguilar, Ester|||0000-0003-2036-0444
  • Rodríguez-Sales, Vanesa|||0000-0001-7336-8058
  • Alventosa-Zaidin, Marina|||0000-0002-5539-089X
  • Heras, Antonio|||0000-0001-8132-6712
  • Valverde, Marta|||0000-0001-9922-2380
  • Violán, Concepció|||0000-0003-3309-5360
  • Torán-Monserrat, Pere|||0000-0002-9865-7427
Background : Intermittent Claudication symptomatic peripheral arterial disease (ICSPAD) is associated with reduced mobility, functional capacity, and quality of life. Physical exercise is an effective non-pharmacological intervention for the management of ICSPAD. Adherence to exercise programs is challenging, due to the nature of the disease and the complex comorbidities associated with it. This study aimed to determine adherence to three supervised physical exercise programs (a walking intervention, strength intervention, and concurrent intervention) and an unsupervised exercise program (standard advice) in individuals with ICSPAD. Methods : In this clinical trial, 122 patients were divided into four groups based on the type of exercise program they followed: standard advice, walking intervention, strength intervention, and concurrent intervention. Results : The results revealed that while the demographic characteristics were similar, the strength intervention group had a younger mean age, and the walking group had a higher prevalence of hypertension and increased usage of anti-hypertensive drugs. Adherence to physical exercise and pedometer wearing was highest in the standard advice group. Logistic regression analysis showed lower odds of adherence to exercise and pedometer wearing in the intervention groups compared to the standard advice group. Adherence did not significantly vary across ankle-brachial index categories. Furthermore, there was no significant difference in adherence between the severity levels of intermittent claudication, though mild cases tended to exhibit higher adherence. Conclusions : The results show that the standard advice from healthcare professionals positively influences treatment adherence.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Knowledge and practices regarding prostate cancer screening in Spanish men, The importance of personal and clinical characteristics (PROSHADE study)

  • Parker, Lucy A.
  • Caballero-Romeu, Juan-Pablo|||0000-0002-5737-6047
  • Chilet-Rosell, Elisa
  • Hernandez-Aguado, Ildefonso
  • Gómez-Pérez, Luis|||0000-0003-1396-0484
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Cebrián-Cuenca, Ana M.|||0000-0003-3710-6370
  • López-Garrigós, Maite
  • Moral Peláez, Irene|||0000-0002-3842-8796
  • Ronda, Elena
  • Gilabert, Mercedes
  • Canelo Aybar, Carlos Gilberto|||0000-0002-0844-4365
  • Párraga-Martínez, Ignacio
  • del Campo-Giménez, Maria
  • Lumbreras Lacarra, Blanca|||0000-0003-1665-0860
Patients' decisions on prostate cancer (PCa) opportunistic screening may vary. This study aimed to assess how demographic and health-related characteristics may influence knowledge and decisions regarding PCa screening. A cross-sectional survey was conducted among men aged over 40, randomly sampled from the Spanish population, 2022. The survey underwent development and content validation using a modified Delphi method and was administered via telephone. Binomial logistic regression was used to explore the relationship between respondents' characteristics and participants' knowledge and practices concerning PCa and the PSA test. Out of 1,334 men, 1,067 (80%) respondents were interviewed with a mean age of 58.6 years (sd 11.9). Most had secondary or university studies (787, 73.8%) and 61 (5.7%) selfreported their health status as bad or very bad. Most of the respondents (1,018, 95.4%) had knowledge regarding PCa with nearly 70% expressed significant concern about its potential development (720, 70.8%), particularly among those under 64 years (p = 0.001). Out of 847 respondents, 573 (67.7%) reported that they have knowledge regarding the PSA test: 374 (65.4%) reported receiving information from a clinicians, 324 (86.6%) information about the benefits of the test and 189 (49,5%) about its risks, with differences based on educational background. In a multivariable analysis (adjusted for age, educational level and previous prostate problems), respondents with higher levels of education were more likely to have higher knowledge regarding the PSA test (OR 1.75, 95%CI 1.24-2.50, p<0.001). Although most of the patients reported to have knowledge regarding PCa, half of the interviewed men reported knowledge about PSA test. Differences in knowledge prostate cancer screening and undesirable consequences highlight the need to develop and provide tailored information for patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Predictors of cocaine use disorder treatment outcomes, a systematic review

  • Palazón-Llecha, Alba|||0009-0002-9174-5317
  • Caparrós, Beatriz
  • Trujols, Joan|||0000-0003-0396-7105
  • Duran-Sindreu, Santiago|||0000-0002-8767-1821
  • Batlle, Francesca|||0000-0002-8684-9579
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Mallorquí-Bagué, Núria|||0000-0003-1434-3162
Psychosocial approaches are the first-line treatments for cocaine dependence, although they still present high dropout and relapse rates. Thus, there is a pressing need to understand which variables influence treatment outcomes to improve current treatments and prevent dropout and relapse rates. The aim of this study is to explore predictors of treatment retention and abstinence in CUD. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We searched three databases-PubMed, PsychINFO and Web of Science-for randomized clinical trials (RCTs) published in English and Spanish from database inception through April 1, 2023. We selected all studies that met the inclusion criteria (adults aged ≥ 18, outpatient treatment, CUD as main addiction, and no severe mental illness) to obtain data for the narrative synthesis addressing cocaine abstinence and treatment retention as main outcome variables. After data extraction was completed, risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials (RoB-2). A total of 566 studies were screened, and, of those, 32 RCTs were included in the synthesis. Younger age, more years of cocaine use, and craving levels were significant predictors of relapse and treatment dropout. Fewer withdrawal symptoms, greater baseline abstinence, greater treatment engagement, and more self-efficacy were all predictors of longer duration of abstinence. The role of impulsivity as a predictor of CUD is unclear due to conflicting data, although the evidence generally suggests that higher impulsivity scores can predict more severe addiction and withdrawal symptoms, and earlier discontinuation of treatment. Current evidence indicates which variables have a direct influence on treatment outcomes, including well-studied cocaine use-related variables. However, additional variables, such as genetic markers, appear to have a high impact on treatment outcomes and need further study. Systematic review registration: This systematic review is registered at PROSPERO (ID: CRD42021271847). This study was funded by the Spanish Ministry of Science, Innovation and Universities, Instituto Carlos III (ISCIII) (FIS PI20/00929) and FEDER funds and Fundació Privada Hospital de la Santa Creu i Sant Pau (Pla d'acció social 2020).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI

  • Aranha, Mateus|||0000-0001-9594-292X
  • Montal, Victor|||0000-0002-5714-9282
  • van den Brink, Hilde
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Benejam, Bessy|||0000-0002-6789-8615
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Fernández, Susana|||0000-0002-9777-1156
  • Ribas, Laia
  • Alcolea, Daniel|||0000-0002-3819-3245
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Bargalló, Núria|||0000-0001-6284-5402
  • Biessels, Geert Jan|||0000-0001-6862-2496
  • Blesa, Rafael|||0000-0003-4026-2884
  • Lleó, Alberto|||0000-0002-2568-5478
  • Coutinho, Artur Martins|||0000-0002-5555-4583
  • Leite, Cláudia Costa
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Fortea, Juan|||0000-0002-1340-638X
Cortical microinfarcts (CMI) were attributed to cerebrovascular disease and cerebral amyloid angiopathy (CAA). CAA is frequent in Down syndrome (DS) while hypertension is rare, yet no studies have assessed CMI in DS. We included 195 adults with DS, 63 with symptomatic sporadic Alzheimer's disease (AD), and 106 controls with 3T magnetic resonance imaging. We assessed CMI prevalence in each group and CMI association with age, AD clinical continuum, vascular risk factors, vascular neuroimaging findings, amyloid/tau/neurodegeneration biomarkers, and cognition in DS. CMI prevalence was 11.8% in DS, 4.7% in controls, and 17.5% in sporadic AD. In DS, CMI increased in prevalence with age and the AD clinical continuum, was clustered in the parietal lobes, and was associated with lacunes and cortico-subcortical infarcts, but not hemorrhagic lesions. In DS, CMI are posteriorly distributed and related to ischemic but not hemorrhagic findings suggesting they might be associated with a specific ischemic CAA phenotype. This is the first study to assess cortical microinfarcts (assessed with 3T magnetic resonance imaging) in adults with Down syndrome (DS). We studied the prevalence of cortical microinfarcts in DS and its relationship with age, the Alzheimer's disease (AD) clinical continuum, vascular risk factors, vascular neuroimaging findings, amyloid/tau/neurodegeneration biomarkers, and cognition. The prevalence of cortical microinfarcts was 11.8% in DS and increased with age and along the AD clinical continuum. Cortical microinfarcts were clustered in the parietal lobes, and were associated with lacunes and cortico-subcortical infarcts, but not hemorrhagic lesions. In DS, cortical microinfarcts are posteriorly distributed and related to ischemic but not hemorrhagic findings suggesting they might be associated with a specific ischemic phenotype of cerebral amyloid angiopathy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

RET Fusion Testing in Patients With NSCLC, The RETING Study

  • Conde, Esther
  • Hernandez, Susana
  • Rodriguez Carrillo, Jose Luis
  • Martinez, Rebeca
  • Alonso, Marta
  • Curto, Daniel
  • Jimenez, Beatriz
  • Caminoa, Alejandra
  • Benito, Amparo
  • Garrido, Pilar|||0000-0002-5899-6125
  • Clavé, Sergi|||0000-0002-9435-8454
  • Arriola, Edurne|||0000-0001-8960-7519
  • Esteban Rodríguez, Isabel|||0000-0003-1576-7215
  • Castro, Javier de|||0000-0002-3622-6306
  • Sansano, Irene|||0000-0003-0188-5210
  • Felip, Enriqueta|||0000-0002-7620-0098
  • Rojo, Federico|||0000-0001-9989-0290
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Abdulkader, Ihab
  • Garcia-Gonzalez, Jorge
  • Teixidó, Cristina|||0000-0002-7226-6567
  • Reguart, Noemi|||0000-0001-8190-499X
  • Compañ, Desamparados
  • Insa, Amelia|||0000-0002-3438-6170
  • Mancheño, Nuria
  • Palanca, Sarai
  • Juan, Óscar|||0000-0002-7772-9030
  • Baixeras, Nuria|||0000-0001-6127-0475
  • Nadal, Ernest|||0000-0002-9674-5554
  • Cebollero, Maria
  • Calles, Antonio
  • Martin, Paloma
  • Salas, Clara
  • Provencio Pulla, Mariano|||0000-0001-6315-7919
  • Aranda, Ignacio
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Majem Tarruella, Margarita|||0000-0002-9919-7485
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Lopez-Rios, Fernando
RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencing (NGS), or alternatively, fluorescence in situ hybridization (FISH) or reverse transcriptase-polymerase chain reaction (RT-PCR) when NGS is not possible or available. Taken together, the suboptimal performance of single-analyte assays to detect RET fusions, although consistent with the notion of encouraging universal NGS, is currently widening some of the clinical practice gaps in the implementation of predictive biomarkers in patients with advanced NSCLC. This situation prompted us to evaluate several RET assays in a large multicenter cohort of RET fusion-positive NSCLC (n = 38) to obtain real-world data. In addition to RNA-based NGS (the criterion standard method), all positive specimens underwent break-apart RET FISH with two different assays and were also tested by an RT-PCR assay. The most common RET partners were KIF5B (78.9%), followed by CCDC6 (15.8%). The two RET NGS-positive but FISH-negative samples contained a KIF5B(15)-RET(12) fusion. The three RET fusions not identified with RT-PCR were AKAP13(35)-RET(12), KIF5B(24)-RET(9) and KIF5B(24)-RET(11). All three false-negative RT-PCR cases were FISH-positive, exhibited a typical break-apart pattern, and contained a very high number of positive tumor cells with both FISH assays. Signet ring cells, psammoma bodies, and pleomorphic features were frequently observed (in 34.2%, 39.5%, and 39.5% of tumors, respectively). In-depth knowledge of the advantages and disadvantages of the different RET testing methodologies could help clinical and molecular tumor boards implement and maintain sensible algorithms for the rapid and effective detection of RET fusions in patients with NSCLC. The likelihood of RET false-negative results with both FISH and RT-PCR reinforces the need for upfront NGS in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Candida albicans infection model in Drosophila melanogaster suggests a strain-specific virulent factor boosting a stormy innate immune response

  • Cortacans, Mariona|||0009-0007-8397-8651
  • Arch Sisquella, Marta|||0000-0002-2120-1667
  • Fuentes, Esther|||0000-0002-6151-8204
  • Cardona, Pere-Joan|||0000-0001-5623-7873
Pathogens drive the evolution of host defence strategies, with both innate and adaptive immune systems playing key roles. Priming enhances the innate immune system's readiness by functionally reprogramming immune cells after initial exposure to stimuli, like β-glucans. In this sense, Drosophila melanogaster is a valuable model to evaluate the role of innate immunity to control infections. In this study we aimed to set light on the immune priming effect of oral treatment with heat-killed M. manresensis and two different heat-killed C. albicans isolates upon systemic infection by C. albicans in the D. melanogaster model. A clinical and a control ATCC 90028 Candida albicans strain were used. Flies were primed through oral administration of heat-killed C. albicans (hkCa), both clinical and control, and hk- Mycolicibacterium manresensis. After priming, flies were systemically infected with both C. albicans isolates. Host survival, pathogen load, and immune response in response to treatment and infection were evaluated. Both treatments showed a significant capacity to enhance the expression of antimicrobial peptides, in particular Diptericin, and Drosomycin in males. This response had a marked sexual dimorphism due to the difference in Upd3, Nox, and Duox expression. Surprisingly, even when priming was able to avoid the growth of both C. albicans strains, survival was not improved in the case of the clinical isolate, causing an unexpected mortality rate in hours, regardless of the host's sex. Gene expression analysis 24 hours post-infection showed an exacerbated increase in Diptericin, Drosomycin and Upd3 expression upon infection with the clinical strain. Data herein suggests the presence of a strain-specific component in C. albicans as the booster of a "stormy" innate immune response, which must be further investigated, and position D. melanogaster as a useful model for evaluating virulent factors related to the modulation of the innate immunity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of an automated artificial intelligence-based system for urogenital schistosomiasis diagnosis using digital image analysis techniques and a robotized microscope

  • Rubio Maturana, Carles|||0000-0002-5615-9278
  • Dantas de Oliveira, Allisson|||0000-0002-8267-9760
  • Serrat, Francesc Zarzuela|||0000-0001-7520-978X
  • Ruiz, Edurne
  • Sulleiro, Elena|||0000-0002-9783-6060
  • Mediavilla, Alejandro|||0009-0000-5273-9251
  • Martínez-Vallejo, Patricia
  • Nadal, Sergi|||0000-0002-8565-952X
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • López Codina, Daniel|||0000-0002-0408-4526
  • Abelló, Alberto|||0000-0002-3223-2186
  • Sayrol, Elisa|||0000-0002-0526-9733
  • Joseph-Munné, Joan
Background Urogenital schistosomiasis is considered a Neglected Tropical Disease (NTD) by the World Health Organization (WHO). It is estimated to affect 150 million people worldwide, with a high relevance in resource-poor settings of the African continent. The gold-standard diagnosis is still direct observation of Schistosoma haematobium eggs in urine samples by optical microscopy. Novel diagnostic techniques based on digital image analysis by Artificial Intelligence (AI) tools are a suitable alternative for schistosomiasis diagnosis. Methodology Digital images of 24 urine sediment samples were acquired in non-endemic settings. S. haematobium eggs were manually labeled in digital images by laboratory professionals and used for training YOLOv5 and YOLOv8 models, which would achieve automatic detection and localization of the eggs. Urine sediment images were also employed to perform binary classification of images to detect erythrocytes/leukocytes with the MobileNetv3Large, EfficientNetv2, and NasNetLarge models. A robotized microscope system was employed to automatically move the slide through the X-Y axis and to auto-focus the sample. Results A total number of 1189 labels were annotated in 1017 digital images from urine sediment samples. YOLOv5x training demonstrated a 99.3% precision, 99.4% recall, 99.3% F-score, and 99.4% mAP0.5 for S. haematobium detection. NasNetLarge has an 85.6% accuracy for erythrocyte/leukocyte detection with the test dataset. Convolutional neural network training and comparison demonstrated that YOLOv5x for the detection of eggs and NasNetLarge for the binary image classification to detect erythrocytes/leukocytes were the best options for our digital image database. Conclusions The development of low-cost novel diagnostic techniques based on the detection and identification of S. haematobium eggs in urine by AI tools would be a suitable alternative to conventional microscopy in non-endemic settings. This technical proof-of-principle study allows laying the basis for improving the system, and optimizing its implementation in the laboratories.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of valve-sparing aortic root replacement on aortic fluid dynamics and biomechanics in patients with syndromic heritable thoracic aortic disease

  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Ruiz Muñoz, Aroa|||0000-0002-1138-8528
  • Guala, Andrea|||0000-0002-5006-8164
  • Galian-Gay, Laura|||0000-0001-6828-5928
  • Fernandez-Galera, Rubén
  • Valente, Filipa|||0000-0002-5569-3292
  • Casas, Guillem|||0000-0001-7122-320X
  • Oliveró, Ruperto|||0000-0002-0888-8572
  • Ferrer-Cornet, Marta
  • Bragulat-Arévalo, Mireia
  • Carrasco-Poves, Alejandro
  • Garrido-Oliver, Juan|||0000-0002-5806-2031
  • Morales-Galán, Alberto
  • Johnson, Kevin M.
  • Wieben, Oliver
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Rodriguez-Palomares, José F
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
Patients with syndromic heritable thoracic aortic diseases (sHTAD) who underwent prophylactic aortic root replacement are at high risk of distal aortic events, but the underlying mechanisms remain unclear. This prospective, longitudinal study evaluates the impact of valve-sparing aortic root replacement (VSARR) on aortic fluid dynamics and biomechanics in these patients. Sixteen patients with Marfan or Loeys-Dietz syndrome underwent two time-resolved three-dimensional phase-contrast cardiovascular magnetic resonance (4D flow CMR) studies before (sHTAD-preSx) and after VSARR (sHTAD-postSx). Two matched cohorts of 40 healthy volunteers (HV) and 16 sHTAD patients without indication for aortic root replacement (sHTAD-NSx) with available 4D flow CMR were included for comparison. In-plane rotational flow (IRF), systolic flow reversal ratio (SFRR), wall shear stress (WSS), pulse wave velocity (PWV), and aortic strain were analyzed in the ascending (AscAo) and descending aorta (DescAo). All patients with sHTAD presented altered hemodynamics and increased stiffness (p < 0.05) compared to HV, both in the AscAo (median PWV 7.4 in sHTAD-NSx; 6.8 in sHTAD-preSx; 4.9 m/s in HV) and DescAo (median PWV 9.1 in sHTAD-NSx; 8.1 in sHTAD-preSx; 6.3 m/s in HV). Patients awaiting VSARR had markedly reduced in-plane (median IRF -2.2 vs 10.4 cm 2 /s in HV, p = 0.001), but increased through-plane flow rotation (median SFRR 7.8 vs 3.8% in HV, p = 0.002), and decreased WSS (0.36 vs 0.47 N/m 2 in HV, p = 0.004) in the proximal DescAo. After VSARR, proximal DescAo IRF (p = 0.010) and circumferential WSS increased (p = 0.011), no longer differing from HV, but SFRR, axial WSS and stiffness remained altered. Patients in which aortic tortuosity was reduced after surgery showed greater post-surgical increase in IRF compared to those in which tortuosity increased (median IRF increase 18.1 vs 3.3 cm 2 /s, p = 0.047). Most AscAo flow alterations were restored to physiological values after VSARR. In patients with sHTAD, VSARR partially restores downstream fluid dynamics to physiological levels. However, some flow disturbances and increased stiffness persist in the proximal DescAo. Further longitudinal studies are needed to evaluate whether persistent alterations contribute to post-surgical risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Llonga, Natalia|||0000-0003-4325-6201
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Carabí-Gassol, Pau
  • Arribas, Lorena|||0000-0002-9683-9999
  • Macias-Chimborazo, Valeria
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • del Castillo, Clara
  • Martínez, Laura
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Pagespetit, Èlia
  • Prat, Raquel|||0000-0001-8097-6617
  • Puigbó, Julia
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder

  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Vicent Gil, Muriel|||0000-0001-7534-5095
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Navarra-Ventura, Guillem|||0000-0001-9839-7357
  • Solé, Brisa|||0000-0003-1673-8248
  • Montejo, Laura|||0000-0003-4407-9454
  • Torrent, Carla|||0000-0003-0335-582X
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Palao, Diego|||0000-0002-3323-6568
  • Vieta, Eduard|||0000-0002-0548-0053
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Cano, Marta|||0000-0003-0675-9483
Bipolar disorder (BD) is characterized by episodic mood dysregulation, although a significant portion of patients suffer persistent cognitive impairment during euthymia. Previous magnetic resonance imaging (MRI) research suggests BD patients may have accelerated brain aging, observed as lower grey matter volumes. How these neurostructural alterations are related to the cognitive profile of BD is unclear. We aim to explore this relationship in euthymic BD patients with multimodal structural neuroimaging. A sample of 27 euthymic BD patients and 24 healthy controls (HC) underwent structural grey matter MRI and diffusion-weighted imaging (DWI). BD patient's cognition was also assessed. FreeSurfer algorithms were used to obtain estimations of regional grey matter volumes. White matter pathways were reconstructed using TRACULA, and four diffusion metrics were extracted. ANCOVA models were performed to compare BD patients and HC values of regional grey matter volume and diffusion metrics. Global brain measures were also compared. Bivariate Pearson correlations were explored between significant brain results and five cognitive domains. Euthymic BD patients showed higher ventricular volume (F(1, 46) = 6.04; p = 0.018) and regional grey matter volumes in the left fusiform (F(1, 46) = 15.03; pFDR = 0.015) and bilateral parahippocampal gyri compared to HC (L: F(1, 46) = 12.79, pFDR = 0.025/ R: F(1, 46) = 15.25, pFDR = 0.015). Higher grey matter volumes were correlated with greater executive function (r = 0.53, p = 0.008). We evaluated a modest sample size with concurrent pharmacological treatment. Higher medial temporal volumes in euthymic BD patients may be a potential signature of brain resilience and cognitive adaptation to a putative illness neuroprogression. This knowledge should be integrated into further efforts to implement imaging into BD clinical management.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Apolipoprotein J protects cardiomyocytes from lipid-mediated inflammation and cytotoxicity induced by the epicardial adipose tissue of diabetic patients

  • Puig Grifol, Núria|||0000-0002-4699-3162
  • Rives Jimenez, Jose|||0009-0001-5725-9270
  • Gil Millán, Pedro
  • Miñambres, Inka|||0000-0002-0899-3938
  • Ginel, Antonino|||0000-0002-8820-7545
  • Tauron, Manel|||0000-0002-5864-519X
  • Bonaterra-Pastra, Anna|||0000-0002-1480-622X
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Pérez, Antonio|||0000-0001-5528-1143
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Benitez, Sonia|||0000-0003-3565-0743
Diabetic patients present increased volume and functional alterations in epicardial adipose tissue (EAT). We aimed to analyze EAT from type 2 diabetic patients and the inflammatory and cytotoxic effects induced on cardiomyocytes. Furthermore, we analyzed the cardioprotective role of apolipoprotein J (apoJ). EAT explants were obtained from nondiabetic patients (ND), diabetic patients without coronary disease (DM), and DM patients with coronary disease (DM-C) after heart surgery. Morphological characteristics and gene expression were evaluated. Explants were cultured for 24 h and the content of nonesterified fatty acids (NEFA) and sphingolipid species in secretomes was evaluated by lipidomic analysis. Afterwards, secretomes were added to AC16 human cardiomyocytes for 24 h in the presence or absence of cardioprotective molecules (apoJ and HDL). Cytokine release and apoptosis/necrosis were assessed by ELISA and flow cytometry. The EAT from the diabetic samples showed altered expression of genes related to lipid accumulation, insulin resistance, and inflammation. The secretomes from the DM samples presented an increased ratio of pro/antiatherogenic ceramide (Cer) species, while those from DM-C contained the highest concentration of saturated NEFA. DM and DM-C secretomes promoted inflammation and cytotoxicity on AC16 cardiomyocytes. Exogenous Cer16:0, Cer24:1, and palmitic acid reproduced deleterious effects in AC16 cells. These effects were attenuated by exogenous apoJ. Diabetic secretomes promoted inflammation and cytotoxicity in cardiomyocytes. This effect was exacerbated in the secretomes of the DM-C samples. The increased content of specific NEFA and ceramide species seems to play a key role in inducing such deleterious effects, which are attenuated by apoJ.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alzheimer Dementia Among Individuals With Down Syndrome

  • Rubenstein, Eric
  • Tewolde, Salina
  • Michals, Amy
  • Weuve, Jennifer
  • Fortea, Juan|||0000-0002-1340-638X
  • Fox, Matthew P.
  • Pescador Jimenez, Marcia
  • Scott, Ashley
  • Tripodis, Yorghos
  • Skotko, Brian G.
What is the incidence and prevalence of Alzheimer dementia in patients with Down syndrome using data from the US Medicare and Medicaid? In this cohort study of 132 720 adults with Down syndrome enrolled in Medicaid or Medicare between 2011 to 2019, 23.3% of adults had Alzheimer dementia diagnoses, and the mean age of death was 59.2 years. These findings suggest that Alzheimer dementia is almost universal among people with Down syndrome, and administrative claims data may offer valuable insights into improving care for this diverse population. This cohort study examines the prevalence and incidence of Alzheimer disease among individuals with Down syndrome using US Medicare and Medicaid claims data. With the advancement in administrative data as a research tool and the reliance on public health insurance for individuals with Down syndrome, population-level trends in Alzheimer dementia in this population are beginning to be understood. To comprehensively describe the epidemiology of Alzheimer dementia in adults with Down syndrome in a full US Medicare and Medicaid sample. This cohort study included 132 720 adults aged 18 years or older with Medicaid and/or Medicare claims data with an International Statistical Classification of Diseases and Related Health Problems code for Down syndrome. Data were collected from January 1, 2011, to December 31, 2019, and analyzed from August 2023 to May 2024. The main outcome was prevalence of Alzheimer dementia in each calendar year and during the 9-year period. Alzheimer dementia incidence rates by calendar year and age and stratified for race or ethnicity as well as time to death after Alzheimer dementia diagnosis were also assessed. There were 132 720 unique adults with Down syndrome from 2011 to 2019: 79 578 (53.2%) were male, 17 090 (11.7%) were non-Hispanic Black, 20 777 (15.7%) were Hispanic, 101 120 (68.8%) were non-Hispanic White, and 47 692 (23.3%) had ever had an Alzheimer dementia diagnosis. Incidence was 22.4 cases per 1000 person-years. The probability of an incident Alzheimer dementia diagnosis over 8 years was 0.63 (95% CI, 0.62-0.64) for those entering the study between ages 55 to 64 years. Mean (SD) age at incident diagnosis was 54.5 (7.4) years and median (IQR) age was 54.6 (9.3) years. Mean (SD) age at death among those with Alzheimer dementia was 59.2 (6.9) years (median [IQR], 59.0 [8.0] years). The mean (SD) age at onset for the Hispanic group was 54.2 (9.2) years, 52.4 (7.8) years for the American Indian or Alaska Native group, and 52.8 (8.2) years for the mixed race groups compared with 55.0 (7.8) years for the White non-Hispanic group. For age at death, there were no differences by sex. The mean (SD) age at death was later for the White non-Hispanic group (59.3 [6.8] years) compared with the Hispanic group (58.5 [7.8] years), Native American group (57.8 [7.1] years), and mixed race group (58.2 [7.0] years). In this cohort study of adults with Down syndrome who were enrolled in Medicaid and Medicare, Alzheimer dementia occurred at high rates. Consistency with clinical studies of dementia in Down syndrome supports the use of administrative data in Down syndrome-Alzheimer dementia research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown. We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ/Aβ ratio. Plasma pTau, pTau, Aβ and Aβ were measured in the fully-automated LUMIPULSE platform. We used linear regression to compare plasma biomarkers concentrations between A + and A- groups, evaluated Spearman's correlation between plasma and CSF and performed ROC analyses to assess their diagnostic accuracy to detect brain amyloidosis as determined by CSF Aβ/Aβ ratio. We analyzed the potential of pTau to predict amyloidosis in CSF. Plasma pTau and pTau concentration were higher in A + than A- while the plasma Aβ/Aβ ratio was lower in A + compared to A-. pTau and the Aβ/Aβ ratio showed moderate correlation between plasma and CSF (Rho = 0.66 and 0.69, respectively). The areas under the ROC curve to discriminate A + from A- participants were 0.94 (95% CI 0.92-0.97) for pTau, and 0.88 (95% CI 0.84-0.92) for both pTau and Aβ/Aβ. Chronic kidney disease (CKD) was related to increased plasma biomarker concentrations, but ratios were less affected. Plasma pTau had the highest fold change (x4.2) and showed high predictive capability in discriminating A + from A-, having 4-7% misclassification rate. The global accuracy of plasma pTau using a two-threshold approach was robust in symptomatic groups, exceeding 90%. The evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau showed excellent diagnostic accuracy to identify participants with AD in a consecutive sample representing the routine clinical practice in a specialized memory unit.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's disease

  • Kac, Przemysław R.|||0000-0001-5083-0924
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Montoliu Gaya, Laia|||0000-0001-7684-6318
  • Fernández, Susana|||0000-0002-9777-1156
  • Lantero Rodríguez, Juan|||0000-0002-7426-678X
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • González-Ortiz, Fernando
  • Benejam, Bessy|||0000-0002-6789-8615
  • Turton, Michael
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Harrison, Peter
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Lleó, Alberto|||0000-0002-2568-5478
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Karikari, Thomas K.|||0000-0003-1422-4358
  • Fortea, Juan|||0000-0002-1340-638X
  • Blennow, Kaj|||0000-0002-1890-4193
All individuals with Down Syndrome (DS) will develop full-blown Alzheimeŕs disease (AD) pathology by age 40, decades before the occurrence of sporadic late-onset AD. Understanding this strong biological relation between age and AD pathology risk in DS is important to accelerate diagnostics, disease monitoring, and treatment. Several genes encoded in chromosome 21 including dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) have been proven to contribute to the pathology. A recently validated plasma immunoassay to measure tau phosphorylation at threonine-212 (p-tau212) has very high diagnostic accuracy in detecting AD. P-tau212 is also very sensitive to DYRK1A phosphorylation and is increased in DSAD brain lysates. Here, we assessed the potential of this biomarker in DSAD and sporadic AD. Using Simoa technology, we tested p-tau212 and p-tau181 (n=245 for plasma, n=114 matching cerebrospinal fluid (CSF) samples). We used AUC-ROC to examine diagnostic performance and the DeLong test to compare the AUC-ROC differences between methods. Spearman correlation is used to examine correlations. Fold changes relative to median levels were calculated for their respective asymptomatic groups. ANCOVA followed by Tukey posthoc test was used to calculate differences across groups. LOESS was used to determine the temporality of plasma biomarker changes. We have confirmed that p-tau212 has extremely high accuracy in detecting AD-related changes in euploid controls. For the DS population, we observed a strong correlation between plasma and CSF p-tau212 (r=0.867; p<0.001). In prodromal DS (pDS) and dementia DS (dDS), we observed significantly elevated levels of p-tau212 in reference to asymptomatic DS (aDS). The diagnostic accuracy to differentiate between aDS and dDS was AUC=0.91 and AUC = 0.86 in discriminating between DS amyloid positive and amyloid negative participants. Plasma p-tau212 started increasing approximately when people became amyloid PET-positive. We have confirmed that the levels of plasma p-tau212 are increased in the DS population and sporadic AD cases including prodromal and MCI states. Plasma p-tau212 might have utility for theragnostic, monitoring therapy efficacy, and as a target engagement biomarker in clinical trials both in sporadic and DSAD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multiple sclerosis, emerging epidemiological trends and redefining the clinical course

  • Portaccio, Emilio
  • Magyari, Melinda|||0000-0002-0972-5222
  • Kubala Havrdova, Eva|||0000-0002-9543-4359
  • Ruet, Aurelie
  • Brochet, Bruno
  • Scalfari, Antonio
  • Di Filippo, Massimiliano
  • Tur, Carmen|||0000-0003-1849-3184
  • Montalban, Xavier|||0000-0002-0098-9918
  • Amato, Maria Pia|||0000-0003-3325-3760
Multiple sclerosis is a chronic, inflammatory, and neurodegenerative disease of the central nervous system and a major cause of neurological disability in young adults. Its prevalence and incidence are increasing, and it has been estimated at over 2.8 million cases worldwide, in addition to recent trends towards a shift in MS prevalence to older ages, with peak prevalence estimates in the sixth decade of life. Although historically the relapsing and progressive phases of the disease have been considered separate clinical entities, recent evidence of progression independent of relapse activity (PIRA) has led to a reconsideration of multiple sclerosis as a continuum, in which relapsing and progressive features variably coexist from the earliest stages of the disease, challenging the traditional view of the disease course. In this Series article, we provide an overview of how the traditional description of the clinical course of MS and epidemiological trends in Europe have evolved. For this purpose, we focus on the concept of PIRA, discussing its potential as the main mechanism by which patients acquire disability, how its definition varies between studies, and ongoing research in this field. We emphasise the importance of incorporating the assessment of hidden clinical manifestations into patient management to help uncover and quantify the PIRA phenomenon and the possible implications for future changes in the clinical classification of the disease. At the same time, we provide insights into overcoming the challenges of identifying and defining PIRA and adopting a new understanding of the clinical course of MS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Analysis of Inflammatory Features in Suspicious Lesions for Significant Prostate Cancer on Magnetic Resonance Imaging-Are They Mimickers of Prostate Cancer?

  • Morote Robles, Juan|||0000-0002-2168-323X
  • Celma, Ana|||0000-0002-3128-3811
  • Semidey, M. Eugenia
  • Antolín, Andreu|||0000-0001-6973-4246
  • Miró, Berta|||0000-0001-6049-8697
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Trilla Herrera, Enrique|||0000-0001-9401-0872
Background. Inflammatory features can mimic PCa in suspicious MRI-lesions. Objectives: To assess the incidence of inflammatory features in targeted biopsies to suspicious lesions. Methods. A prospective analysis was conducted of 531 MRI-suspicious lesions with Prostate Imaging-Reporting and Data System (PI-RADS) scores of 3 to 5 in 364 men suspected of having PCa. Results. The incidence of inflammatory features in the MRI-suspicious lesions without PCa was 69.6%, compared to 48.1% in those with PCa (p < 0.001). Among the suspicious lesions without PCa, the incidence of inflammatory features ranged from 68.6% to 71.2% across the PI-RADS categories (p = 0.870). Mild chronic prostatitis increased with higher PI-RADS scores, while acute prostatitis decreased, and granulomatous prostatitis was exclusively observed in patients with PI-RADS scores of 4 and 5. The incidence of inflammatory features in the lesions with insignificant PCa (grade group 1) was 66.7%, compared to 42.7% in those with significant PCa (grade group 2 to 5; p = 0.027). The detection of inflammatory features in MRI-suspicious lesions was identified as an independent predictor of a lower likelihood of significant PCa detection, with an odds ratio (OR) of 0.326 (95% CI 0.196-0.541). Mild chronic prostatitis was the only type of prostatitis which was an independent predictor of a lower likelihood of significant PCa, with an OR of 0.398 (95% CI 0.268-0.590). Conclusions. These data suggest that inflammatory features may be considered mimickers of significant PCa on MRI.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GSR-DB, a manually curated and optimized taxonomical database for 16S rRNA amplicon analysis

  • Molano, L.A.G.|||0000-0003-0069-6098
  • Vega-Abellaneda, Sara
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
Taxonomic assignments of microorganisms have long been hindered by inconsistent nomenclature and annotation issues in existing databases like SILVA, Greengenes, Greengenes2, Genome Taxonomy Database, or Ribosomal Database Project. To overcome these issues, we created Greengenes-SILVA-RDP database (GSR-DB), accurate and comprehensive taxonomic annotations of 16S amplicon data. Unlike previous approaches, our innovative pipeline includes a unique taxonomy unification step, ensuring consistent and reliable annotations. Our evaluation analyses showed that GSR-DB outperforms existing databases in providing species-level resolution, especially based on mock-community analysis, making it a game-changer for microbiome studies. Moreover, GSR-DB is designed to be accessible to researchers with limited computational resources, making it a powerful tool for scientists across the board. Available for full-length 16S sequences and commonly used hypervariable regions, including V4, V1-V3, V3-V4, and V3-V5, GSR-DB is a go-to database for robust and accurate microbial taxonomy analysis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

  • Verberk, I.M.W.
  • Jutte, J.
  • Kingma, M.Y.
  • Vigneswaran, S.
  • Gouda, M.M.T.E.E.
  • van Engelen, M.P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Chevalier, C.
  • Marizzoni, M.
  • van de Giessen, E.M.
  • Lemstra, A.W.
  • Pijnenburg, Y.A.L.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • den Braber, A.
  • Wilson, D.
  • Schut, M.C.
  • van Harten, A.C.
  • Teunissen, C.E.
INTRODUCTION: We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS: We measured the plasma biomarkers with Simoa (n = 1199), applied LASSO regression for biomarker selection and receiver operating characteristics (ROC) analyses to determine diagnostic accuracy. We validated our findings in two independent cohorts and constructed a visualization approach. RESULTS: P-tau181, GFAP, and NfL were selected. This combination had area under the curve (AUC) = 83% to identify amyloid positivity in pre-dementia stages, AUC = 87%-89% to differentiate Alzheimer's or controls from frontotemporal dementia, AUC = 74%-76% to differentiate Alzheimer's or controls from dementia with Lewy bodies. Highly reproducible AUCs were obtained in independent cohorts. The resulting visualization tool includes UpSet plots to visualize the stand-alone biomarker results and density plots to visualize the biomarker results combined. DISCUSSION: Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings. Highlights: We developed a multimarker blood test interpretation tool for clinical dementia practice. Our interpretation tool includes plasma biomarkers P-tau, GFAP, and NfL. Our tool is particularly useful for Alzheimer's and frontotemporal dementia diagnosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis, A two-year follow-up study

  • Clougher, Derek|||0000-0001-7631-3845
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Penadés, Rafael|||0000-0002-1564-3717
  • Lobo, Antonio|||0000-0002-9098-655X
  • Pinto, A.G.
  • Panadero, Rocío
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Trabsa, Amira|||0000-0002-8669-0676
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Torrent, Carla|||0000-0003-0335-582X
  • Tortorella, A.
  • Menculini, G.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cuesta, M.J.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Salmerón, Sergi|||0000-0002-0212-4491
  • Arbelo, Néstor|||0000-0002-2630-3259
  • Ferrer-Quintero, Marta|||0000-0002-7935-9424
  • Echevarría, A.
  • Selma, Judit
  • Grasa, Eva|||0000-0003-1100-7489
  • Marin, Julen
  • Mar, Lorea
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruíz-Lázaro, P.M.
  • Nacher, Juan|||0000-0001-7599-3957
  • Cañete Nicolas, Carlos
  • Mané, Anna|||0000-0003-2127-349X
  • Toll, Alba|||0000-0003-2399-5250
  • Solé, Brisa|||0000-0003-1673-8248
  • Mallorquí, Aida|||0000-0003-4038-3045
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Contreras, Fernando|||0000-0003-2929-2804
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Segarra, R.
  • Zabala Torres, Alaitz|||0000-0002-3931-4221
  • Scala, Marcello|||0000-0003-2194-7239
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Pomarol-Clotet, E.
  • García-León, M.Á.
  • Ibañez, A.
  • Moreno-Izco, L.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Characterization of white matter hyperintensities in Down syndrome

  • Morcillo Nieto, Alejandra O.|||0000-0003-2202-3521
  • Zsadanyi, Sara E.|||0000-0002-2033-5989
  • Arriola Infante, José Enrique|||0000-0002-3298-4601
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Montal, Victor|||0000-0002-5714-9282
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Aranha, Mateus|||0000-0001-9594-292X
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Padilla, Concepción|||0000-0003-4102-6787
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Fernandez, S.
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Giménez, Sandra|||0000-0001-8031-2319
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Bargalló, Núria|||0000-0001-6284-5402
  • Ribas, Laia
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Torres Alcalá, Soraya|||0000-0002-7054-2046
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Belbin, Olivia|||0000-0002-6109-6371
  • Camacho, Valle|||0000-0003-0748-0847
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Bejanin, Alexandre|||0000-0002-9958-0951
INTRODUCTION: In Down syndrome (DS), white matter hyperintensities (WMHs) are highly prevalent, yet their topography and association with sociodemographic data and Alzheimer's disease (AD) biomarkers remain largely unexplored. METHODS: In 261 DS adults and 131 euploid controls, fluid-attenuated inversion recovery magnetic resonance imaging scans were segmented and WMHs were extracted in concentric white matter layers and lobar regions. We tested associations with AD clinical stages, sociodemographic data, cerebrospinal fluid (CSF) AD biomarkers, and gray matter (GM) volume. RESULTS: In DS, total WMHs arose at age 43 and showed stronger associations with age than in controls. WMH volume increased along the AD continuum, particularly in periventricular regions, and frontal, parietal, and occipital lobes. Associations were found with CSF biomarkers and temporo-parietal GM volumes. DISCUSSION: WMHs increase 10 years before AD symptom onset in DS and are closely linked with AD biomarkers and neurodegeneration. This suggests a direct connection to AD pathophysiology, independent of vascular risks. Highlights: White matter hyperintensities (WMHs) increased 10 years before Alzheimer's disease symptom onset in Down syndrome (DS). WMHs were strongly associated in DS with the neurofilament light chain biomarker. WMHs were more associated in DS with gray matter volume in parieto-temporal areas.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Surpassing protein specificity in biomimetics of bacterial amyloids

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
In nature, nontoxic protein amyloids serve as dynamic, protein-specific depots, exemplified by both bacterial inclusion bodies and secretory granules from the endocrine system. Inspired by these systems, chemically defined and regulatory-compliant artificial protein microgranules have been developed for clinical applications as endocrine-like protein repositories. This has been achieved by exploiting the reversible coordination between histidine residues and divalent cations such as Zn, that promotes protein-protein interactions. While stereospecificity is a main architectonic feature of natural amyloids, the potential for synthetic approaches to create hybrid protein materials remains unexplored. Such materials could enable the occurrence and synchronized local application of diverse proteins in predefined molar ratios, for coupled enzymatic reactions or delivery of synergistically acting polypeptides. Here, we report on the fabrication of artificial protein granules with amyloidal architecture formed by combining two structurally distinct polypeptides. Specifically, we tested co-aggregation of the pairs GFP/IRFP and GFP/β-galactosidase. The formation of hybrid microparticles was confirmed through FRET and complementary methodologies, demonstrating that the His-Zn clustering technology does not require sequential or structural homologies between aggregating polypeptides. This approach opens new avenues for the development of functional depots that capitalize on synergistic protein functionalities, paving the way for next-generation functional materials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the Barcelona Magnetic Resonance Imaging Predictive Model for Significant Prostate Cancer Detection in Men Undergoing Mapping per 0.5 Mm-Core Targeted Biopsies of Suspicious Lesions and Perilesional Areas

  • Paesano, Nahuel|||0000-0001-9278-5543
  • Català, Violeta
  • Tcholakian, Larisa
  • Alomar Serrallach, Xavier
  • Barranco, Miguel Ángel
  • Hernández Mancera, Jonathan|||0000-0002-2267-7536
  • Miró, Berta|||0000-0001-6049-8697
  • Trilla Herrera, Enrique|||0000-0001-9401-0872
  • Morote Robles, Juan|||0000-0002-2168-323X
The validation of predictive models is essential for informing clinical decisions, particularly in new individual populations or as diagnostic methods advance. This study evaluates the performance of the Barcelona-MRI predictive model (BCN-MRI PM) for identifying significant prostate cancer (sPCa) within the context of an advanced prostate biopsy protocol. In a cohort of 457 men suspected of having PCa, the model demonstrated high accuracy and clinical applicability, reducing unnece-ssary biopsies by 24.9% while maintaining a 95% detection rate for sPCa. These results validate the efficacy of the BCN-MRI PM and support its readiness for clinical implementation in this diagnostic framework. Background/Objectives: Validation of predictive models (PMs) is crucial to be implemented in new populations or when advances in diagnostic approaches occurred. The aim of this study is to validate the BCN-MRI PM for sPCa when a highly effective prostate biopsy protocol is used. Methods: A prospective cohort of 457 men suspected of having PCa, for whom MRI results were reported with the Prostate Imaging-Reporting and Data System (PI-RADS) v 2.1, underwent a per 0.5 mm-core mapping targeted biopsy of suspicious lesions and perilesional areas, followed by a 12-core-systematic biopsy. These procedures took place between 1 February 2022, and 29 February 2024, at a reference center for prostate biopsy. The individual likelihood of sPCa was assessed through the BCN-MRI risk calculator. Results: The overall sPCa detection rate was 58.3%. The calibration curve of the BCN-MRI PM showed an appropriate accuracy between expected and observed probabilities with a discrimination ability for sPCa yielding an area under the curve (AUC) of 0.862 (95% CI 0.828-0.896) comparable to the AUC of 0.858 (95% CI 0.833-0.883) observed in the development cohort. The application of the BCN-MRI PM provided a net benefit over performing biopsies on all men, avoiding 24.9% of prostate biopsies at 95% sensitivity for sPCa, compared to the 23.7% reduction observed in the development cohort. Conclusions: We conclude that the BCN-MRI PM is ready to be implemented when this biopsy protocol is employed.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome

  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • O'Connor, A.
  • Llibre-Guerra, J.
  • Lao, P.|||0000-0003-2243-3547
  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
Autosomal dominant Alzheimer's disease (ADAD) and Down syndrome (DS) constitute genetic forms of Alzheimer's disease (AD). The study of these forms has been crucial in understanding the biomarker changes and disease progression, notably in advancing our knowledge of the natural history of AD. However, some specific characteristics of biomarkers in genetically determined forms and, most importantly, the near full penetrance and predictability of disease onset lead to a very different context of use for biomarkers in these populations. This article delves into the similarities and differences in biomarker profiles between genetically determined AD and sporadic cases, discussing the implications for research and clinical practice. It also emphasizes the need to account for factors that may affect biomarker reliability differently in genetically determined AD. Enhancing our understanding of the disease will pave the way for more personalized therapeutic approaches for affected individuals.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sequencing the Barcelona-MRI predictive model and Proclarix for improving the uncertain PI-RADS 3

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Atherogenic circulating lipoproteins in ischemic stroke

  • Benitez, Sonia|||0000-0003-3565-0743
  • Puig Grifol, Núria|||0000-0002-4699-3162
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
The fundamental role of qualitative alterations of lipoproteins in the early development of atherosclerosis has been widely demonstrated. Modified low-density lipoproteins (LDL), such as oxidized LDL (oxLDL), small dense LDL (sdLDL), and electronegative LDL [LDL(-)], are capable of triggering the atherogenic process, favoring the subendothelial accumulation of cholesterol and promoting inflammatory, proliferative, and apoptotic processes characteristic of atherosclerotic lesions. In contrast, high-density lipoprotein (HDL) prevents and/or reverses these atherogenic effects. However, LDL's atherogenic and HDL's anti-atherogenic actions may result altered in certain pathological conditions. The molecular mechanisms underlying the impaired effects of altered lipoproteins have been studied in numerous in vitro and in vivo studies, and have been extensively analyzed in coronary atherosclerosis, especially in the context of pathologies such as dyslipidemia, diabetes, obesity, and metabolic syndrome. However, the corresponding studies are scarcer in the field of ischemic stroke, despite carotid arteriosclerosis progression underlies at least 20% of ischemic strokes. The present review relates qualitative alterations of LDL and HDL with the development of carotid arteriosclerosis and the occurrence of ischemic stroke.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Citrate-Assisted Regulation of Protein Stability and Secretability from Synthetic Amyloids

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Chellou-Bakkali, Sara|||0009-0007-1643-4558
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
The mammalian endocrine system uses functional amyloids as dynamic depots to store and release protein hormones into the bloodstream. Such depots, acting as secretory granules within the microscale, are formed in specialized cells by the coordination between the ionic, divalent form of zinc (Zn2+) and the imidazole ring from accessible His residues. The reversibility of such cross-linking events allows for the release of monomeric or oligomeric forms of the functional protein for biological activity. In vitro, and mimicking such a natural coordination process, synthetic amyloidal granules with secretory properties can be fabricated using selected therapeutic proteins as building blocks. Then, these microparticles act as delivery systems for endocrine-like, sustained protein release, with proven applicability in vaccinology, cancer therapy, regenerative medicine, and as antimicrobial agents. While the temporal profile in which the protein is leaked from the material might be highly relevant to clinically oriented applications, the fine control of such parameters remains unclear. We have explored here how the kinetics of protein release can be regulated by intervening in the storage formulation of the granules, through the concentration of citrate not only as a buffer component and protein stabilizer but also as a chelating agent. The citrate-assisted, time-prolonged regulatable release of proteins, in their functional form, opens a spectrum of possibilities to adjust the preparation of synthetic secretory granules to specific clinical needs.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Screening Strategies to Improve Early Diagnosis in Endometrial Cancer

  • Cabrera, S.
  • de la Calle, Irene|||0000-0002-2227-1640
  • Baulies Caballero, Sonia|||0000-0001-7670-5603
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Colás Ortega, Eva|||0000-0003-0302-4828
Endometrial cancer is the most common gynecological malignancy in high-income countries and the sixth most common cancer in women. Overall incidence has risen in the last few decades as a consequence of the increase in the prevalence of its risk factors, mainly obesity and the aging of the population, and although diagnoses have increased across all age groups, the incidence rates have doubled in women under the age of 40 years. The survival rates of endometrial cancer are highly dependent on its stage at diagnosis, bringing to the fore the importance of early diagnosis. The aim of a screening strategy in this type of tumor should be to detect the disease in the pre-invasive or early stage (before developing myometrial invasion), which would improve cure rates, reduce the morbidity associated with aggressive treatment and offer uterus-sparing management options for younger women. The ideal screening tool in this scenario would be a minimally invasive, inexpensive and easy-to-perform test or auto-test, which could be implemented in a routine gynecologic checkup of patients at-risk or in the general adult population. In this comprehensive review, we aim to define the populations at higher risk of developing endometrial cancer, to assess the performance of current diagnostic tools when used in a screening setting and to discuss the accuracy of new molecular screening strategies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

  • Cano, Amanda|||0000-0001-9567-4283
  • Capdevila, María
  • Puerta, Raquel|||0000-0002-1191-5893
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • García-González, Pablo|||0000-0003-0125-5403
  • Olivé Roig, Clàudia|||0000-0002-9438-5639
  • García-Gutiérrez, Fernando
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Aguilera, Nuria
  • Ramis, Maribel
  • Rosende-Roca, Maite
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Tartari, Juan Pablo
  • Lafuente, Asunción
  • Vargas, Liliana|||0000-0001-5685-5903
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Muñoz, Nathalia
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Morató, Xavier|||0000-0002-3012-2864
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Fernández, Victoria
  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
The identification of patients with an elevated risk of developing Alzheimer's disease (AD) dementia and eligible for the disease-modifying treatments (DMTs) in the earliest stages is one of the greatest challenges in the clinical practice. Plasma biomarkers has the potential to predict these issues, but further research is still needed to translate them to clinical practice. Here we evaluated the clinical applicability of plasma pTau181 as a predictive marker of AD pathology in a large real-world cohort of a memory clinic. Methods: Three independent cohorts (modelling [n = 991, 59.7% female], testing [n = 642, 56.2% female] and validation [n = 441, 55.1% female]) of real-world patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI), AD dementia, and other dementias were included. Paired cerebrospinal fluid (CSF) and plasma samples were used to measure AT(N) CSF biomarkers and plasma pTau181. CSF and plasma pTau181 showed correlation in all phenotypes except in SCD and other dementias. Age significantly influenced the biomarker's performance. The general Aβ(+) vs Aβ(-) ROC curve showed an AUC = 0.77 [0.74-0.80], whereas the specific ROC curve of MCI due to AD vs non-AD MCI showed an AUC = 0.89 [0.85-0.93]. A cut-off value of 1.30 pg/ml of plasma pTau181 exhibited a sensitivity of 93.57% [88.72-96.52], specificity of 72.38% [62.51-79.01], VPP of 77.85% [70.61-83.54], and 8.30% false negatives in the subjects with MCI of the testing cohort. The HR of cox regression showed that patients with MCI up to this cut-off value exhibited a HR = 1.84 [1.05-3.22] higher risk to convert to AD dementia than patients with MCI below the cut-off value. Plasma pTau181 has the potential to be used in the memory clinics as a screening biomarker of AD pathology in subjects with MCI, presenting a valuable prognostic utility in predicting the MCI conversion to AD dementia. In the context of a real-world population, a confirmatory test employing gold-standard procedures is still advisable. This study has been mainly funded by Ace Alzheimer Center Barcelona, Instituto de Salud Carlos III (ISCIII), Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Spanish Ministry of Science and Innovation, Fundación ADEY, Fundación Echevarne and Grífols S.A.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Insights into the use of biomarkers in clinical trials in Alzheimer's disease

  • Pascoal, Tharick|||0000-0001-9057-8014
  • Aguzzoli, C.S.
  • Lussier, F.Z.
  • Crivelli, L.
  • Suemoto, C.K.|||0000-0002-5942-4778
  • Fortea, Juan|||0000-0002-1340-638X
  • Rosa-Neto, P.
  • Zimmer, E.R.
  • Ferreira, P.C.L.
  • Bellaver, B.|||0000-0002-2212-3373
Biomarkers have been instrumental in population selection and disease monitoring in clinical trials of recently FDA-approved drugs targeting amyloid-β to slow the progression of Alzheimer's disease (AD). As new therapeutic strategies and biomarker techniques emerge, the importance of biomarkers in drug development is growing exponentially. In this emerging landscape, biomarkers are expected to serve a wide range of contexts of use in clinical trials focusing on AD and related dementias. The joint FDA-NIH BEST (Biomarkers, EndpointS, and other Tools) framework provides standardised terminology to facilitate communication among stakeholders in this increasingly complex field. This review explores various applications of biomarkers relevant to AD clinical trials, using the BEST resource as a reference. For simplicity, we predominantly provide contextual characterizations of biomarkers use from the perspective of drugs targeting amyloid-β and tau proteins. However, general definitions and concepts can be extrapolated to other targets.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Persistent varices in cured patients, Understanding the role of hepatic venous pressure gradient

  • Olivas, Pol|||0000-0002-1919-0284
  • Soler-Perromat, Alexandre|||0000-0003-2531-2484
  • Tellez, L.
  • Carrión Rodríguez, José Antonio|||0000-0001-7191-6081
  • Alvarado-Tapias, Edilmar|||0000-0003-2036-6133
  • Ferrusquía-Acosta, José|||0000-0001-8034-1291
  • Lens, Sabela|||0000-0003-4900-411X
  • Guerrero, A.
  • Falgà Tirado, Angeles
  • Vizcarra, Pamela
  • Orts, Lara|||0000-0002-3070-0310
  • Pérez Campuzano, Valeria|||0000-0002-5997-9511
  • Shalaby, Sarah|||0000-0002-8700-6282
  • Torres, Sonia
  • Baiges, Anna|||0000-0002-6963-9203
  • Turon, Fanny|||0000-0001-5940-2838
  • García-Pagán, JC.|||0000-0001-9032-4954
  • García Criado, Ángeles|||0000-0003-3536-4288
  • Hernández-Gea, Virginia|||0000-0001-7937-984X
Etiologic factor removal (ER) drives recompensation and improves portal hypertension in cirrhosis. Esophageal varices (EV) and portosystemic shunts (PSS) have been found in patients despite hepatic venous pressure gradient (HVPG) dropping below 10 mmHg after ER, questioning HVPG accuracy in reflecting true portal pressure in the setting of ER. We aim to evaluate the correlation of HVPG with direct portal pressure (DPP) in patients with persistence of EV after ER despite HVPG <10 mmHg. Methods: This is a bicentric 'proof of concept' study evaluating HVPG and ultrasound-guided percutaneous DPP in patients with HCV or alcohol-related cirrhosis with persistent varices and HVPG <10 mmHg after at least 5 years of ER. Seven patients with HCV and three with alcohol-related cirrhosis with persistent varices and HVPG <10 mmHg after at least 5 years of ER were included. At evaluation, all patients had a patent portal vein and were compensated. The median platelet count was 129.5 (IQR 95-145) × 10/ml, and the median liver stiffness measurement was 16.15 (IQR 14.4-22.3) kPa. In five patients, EV remained the same size (two large and three small), and five downsized to small after ER. Wedge hepatic vein pressure (median 19 [IQR 16.5-20] mmHg) and portal pressure (median 18 [IQR 15-19.5] mmHg) had an excellent correlation (R = 0.93, p <0.0001). Portal pressure gradient (PPG) confirmed the absence of clinically significant portal hypertension as identified by HVPG across all the patients. HVPG accurately reflects PPG in the context of HCV and alcohol-related cirrhosis regression. After ER, EV may persist despite HVPG <10 mmHg. The benefit of prophylaxis in patients with EV and HVPG <10 mmHg is unknown. Future studies with clinical endpoints are needed to validate our findings. Despite a favorable evolution after the removal of the etiologic factor, varices persist in some patients, and there is a lack of concise guidelines for the evaluation and management of portal hypertension in this population. Our research underscores the persistence of varices in the absence of clinically significant portal hypertension and significantly demonstrates the accuracy of hepatic venous pressure gradient (HVPG) in reflecting portal vein pressure in this specific patient group. These findings emphasize the crucial role of HVPG in the assessment of portal hypertension after etiologic factor removal and lay the groundwork for further investigation into clinical outcomes and the necessity of non-selective beta-blockers in individuals with persistent varices after the removal of etiologic factor.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Kleptomania on the impulsive-compulsive spectrum, linical and therapeutic considerations for women

  • Munguía Godínez, Jazmín Lucero|||0000-0002-9751-810X
  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Granero, Roser|||0000-0001-6308-3198
  • Fábregas Balcells, Mar
  • Gaspar Pérez, Anahí|||0000-0002-1427-3697
  • Rosinska, Magda Julia|||0009-0009-9918-7592
  • Potenza, Marc N.|||0000-0002-6323-1354
  • Cuquerella Fuentes, Àngel|||0000-0001-8028-1700
  • Tapia-Martínez, Javier
  • Cabús Grange, Rosa María
  • Taranilla Castro, Ana María
  • Macharé Alberni, Marta Elisabet
  • Talón-Navarro, María Teresa
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
The current literature regarding kleptomania (KM) is scarce, especially regarding treatment approaches and outcomes. The aims of the present study involved: (1) exploring characteristics of people with KM (with and without co-occurring eating disorders (EDs)); (2) considering KM along an impulsive-compulsive spectrum; and, (3) investigating treatment outcomes in a clinical sample of female patients with KM. The study sample included 150 female participants with either a diagnosis of KM only (n = 13), co-occurring KM and EDs (n = 71), or healthy control individuals (HCs) (n = 66). The KM-only group was diagnosed using DSM-5 criteria and by a face-to-face clinical interviewed. EDs were diagnosed through a face-to-face semi-structured clinical interview based on DSM-5 criteria, and co-occurring KM was self-reported by patients. Psychopathology, impulsivity and personality features were assessed. Clinical groups received cognitive behavioral treatment. Compared to HCs, both KM groups reported more psychopathology, higher impulsivity, and more dysfunctional personality features. Relative to the clinical groups, that with KM + ED was more impulsive; in contrast, harm avoidance scores were higher in the KM-only group. Both clinical groups present poor treatment outcomes. KM can present impulsive and compulsive features, and these may impact treatment outcomes. Co-occurring KM and EDs may worsen clinical profiles and warrant specific interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers

  • Pablo-Fontecha, Verónica|||0000-0001-9084-4597
  • Hernández-Illán, Eva
  • Reparaz, Andrea
  • Asensio, Elena
  • Morata, Jordi|||0000-0002-6146-4322
  • Tonda, Raúl
  • Lahoz, Sara|||0000-0002-4491-9911
  • Parra, Carolina
  • Lozano, Juan José
  • García-Heredia, Anabel
  • Martínez-Roca, Alejandro
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Jover, Rodrigo
  • Castells, Antoni|||0000-0001-8431-2033
  • Trullàs, Ramon
  • Podlesniy, Petar
  • Camps, Jordi|||0000-0003-2929-4228
Somatic single-nucleotide variants (SNVs) occur every time a cell divides, appearing even in healthy tissues at low frequencies. These mutations may accumulate as neutral variants during aging, or eventually, promote the development of neoplasia. Here, we present the SP-ddPCR, a droplet digital PCR (ddPCR) based approach that utilizes customized SuperSelective primers aiming at quantifying the proportion of rare SNVs. For that purpose, we selected five potentially pathogenic variants identified by whole-exome sequencing (WES) occurring at low variant allele frequency (VAF) in at-risk colon healthy mucosa of patients diagnosed with colorectal cancer or advanced adenoma. Additionally, two APC SNVs detected in two cancer lesions were added to the study for WES-VAF validation. SuperSelective primers were designed to quantify SNVs at low VAFs both in silico and in clinical samples. In addition to the two APC SNVs in colonic lesions, SP-ddPCR confirmed the presence of three out of five selected SNVs in the normal colonic mucosa with allelic frequencies ≤ 5%. Moreover, SP-ddPCR showed the presence of two potentially pathogenic variants in the distal normal mucosa of patients with colorectal carcinoma. In summary, SP-ddPCR offers a rapid and feasible methodology to validate next-generation sequencing data and accurately quantify rare SNVs, thus providing a potential tool for diagnosis and stratification of at-risk patients based on their mutational profiling.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Trans-Mediated, Cis-Inhibited Paradoxal Activity of Clostridium perfringens Enterotoxin (c-CPE) in Modulating Epithelial Permeability

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Parladé, Eloi|||0000-0001-5750-550X
  • Di Somma, Angela|||0000-0003-4916-7875
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Villaverde, Antonio|||0000-0002-2615-4521
In the context of transdermal delivery, favoring the drug permeability of epithelia through convenient formulations would open new opportunities for local versus systemic drug delivery, envisaging higher patient comfort and an enhanced therapeutic effect. Ligands of tight junctions are interesting agents that enhance epithelial permeability by relaxing the protein complexes that form them. The C-terminal domain of Clostridium perfringens enterotoxin (c-CPE), which binds claudins, one of the tight junction (TJ) components, has been explored here as a functional domain in modular recombinant proteins, to evaluate its ability to self-promote its paracellular epithelial passage in a Caco-2 cell monolayer model. c-CPE-containing fusion proteins bind cells in the absence of internalization and cytotoxicity and support the passage, in trans, of other fusion proteins devoid of c-CPE. However, c-CPE-carrying proteins fail to cross the epithelia by themselves, probably because their affinity for TJs immobilizes them in the intercellular space. Therefore, while recombinant c-CPE versions have been here confirmed as convenient epithelial-permeabilizing agents, a paradoxical behavior has been observed where this effect is only successful when applied in trans, specifically on entities that lack c-CPE. Then, c-CPE itself inhibits the paracellular mobility of carrier molecules, not being suited as a self-driver (in c-CPE-drug complexes) for drug delivery through epithelia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection, a randomized, placebo-controlled phase 1 trial

  • Bailón, Lucía|||0000-0001-7277-9314
  • Llano Montero, Anuska|||0000-0002-0133-9888
  • Cedeño, Samandhy|||0000-0001-8312-0208
  • Escribà, Tuixent|||0000-0001-9467-7802
  • Rosás-Umbert, Miriam|||0000-0002-2850-6586
  • Parera, Mariona|||0000-0002-0756-8307
  • Casadellà, Maria|||0000-0002-4115-2305
  • Lopez, Miriam
  • Pérez, Francisco
  • Oriol-Tordera, Bruna|||0000-0002-2714-9097
  • Ruiz Riol, Marta|||0000-0003-1899-8879
  • Coll, Josep
  • Pérez, Félix|||0000-0002-6799-9272
  • Rivero, Ángel|||0000-0003-2136-0702
  • Leselbaum, Anne R.
  • McGowan, Ian
  • Sengupta, Devi
  • Wee, Edmund G.
  • Hanke, Tomáš|||0000-0002-6076-9546
  • Paredes, Roger|||0000-0002-6553-691X
  • Alarcón-Soto, Yovaninna|||0000-0002-9977-8634
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Brander, Christian|||0000-0002-0548-5778
  • Moltó, José|||0000-0003-4564-1963
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Barriocanal, Ana María|||0000-0002-4159-519X
  • Benet, Susana|||0000-0002-2219-8826
  • Cobarsi, Patricia|||0000-0003-3977-230X
  • Geleziunas, Romas
  • Loste, Cora
  • Meulbroek, Michael
  • Miranda, Cristina
  • Muñoz-Moreno, José Antonio|||0000-0002-7239-5422
  • Naval, Jordi
  • Nieto Gil-Ortega, Aroa|||0000-0001-8477-5062
  • Pujol Vila, Ferran|||0000-0002-6811-2426
  • Puig, Jordi|||0000-0002-4075-0346
HIVACAT T-cell immunogen (HTI) is a novel human immunodeficiency virus (HIV) vaccine immunogen designed to elicit cellular immune responses to HIV targets associated with viral control in humans. The AELIX-002 trial was a randomized, placebo-controlled trial to evaluate as a primary objective the safety of a combination of DNA.HTI (D), MVA.HTI (M) and ChAdOx1.HTI (C) vaccines in 45 early-antiretroviral (ART)-treated individuals (44 men, 1 woman; NCT03204617). Secondary objectives included T-cell immunogenicity, the effect on viral rebound and the safety of an antiretroviral treatment interruption (ATI). Adverse events were mostly mild and transient. No related serious adverse events were observed. We show here that HTI vaccines were able to induce strong, polyfunctional and broad CD4 and CD8 T-cell responses. All participants experienced detectable viral rebound during ATI, and resumed ART when plasma HIV-1 viral load reached either.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases, Observations from a VALDIG multicenter study

  • Pérez Campuzano, Valeria|||0000-0002-5997-9511
  • Rautou, Pierre-Emmanuel|||0000-0001-9567-1859
  • Marjot, Thomas
  • Praktiknjo, Michael|||0000-0001-7033-9956
  • Alvarado-Tapias, Edilmar|||0000-0003-2036-6133
  • Turco, Laura|||0000-0001-8148-3769
  • Ibáñez Samaniego, Luis|||0000-0002-0309-2727
  • González-Alayón, C.|||0000-0003-0215-4874
  • Puente, Ángela
  • Llop, Elba
  • Simón Talero, Macarena|||0000-0002-1409-3936
  • Álvarez-Navascués, Carmen
  • Reiberger, Thomas|||0000-0002-4590-3583
  • Verhelst, Xavier|||0000-0002-2798-5415
  • Tellez, Luis
  • Bergmann, JJohanna Birte
  • Orts, Lara|||0000-0002-3070-0310
  • Grassi, Giuseppe
  • Baiges, Anna|||0000-0002-6963-9203
  • Audrey, Payance|||0000-0003-1174-8375
  • Trebicka, Jonel|||0000-0002-7028-3881
  • Villanueva, Càndid|||0000-0002-3674-914X
  • Morelli, Maria Cristina|||0000-0002-9742-1981
  • Murray, Sam
  • Meacham, Georgina|||0000-0003-1929-4152
  • Luetgehetmann, Marc
  • Schulze zur Wiesch, Julian|||0000-0002-5033-1938
  • García-Pagán, JC.|||0000-0001-9032-4954
  • Barnes, Eleanor
  • Plessier, Aurélie|||0000-0001-5656-1622
  • Hernández-Gea, Virginia|||0000-0001-7937-984X
Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our study. Methods: International, multicenter, prospective observational study in patients with VLD analyzing the incidence of COVID-19 infection after vaccination, severity of side effects, occurrence of thromboembolic events and hepatic decompensation. In a subgroup of patients, the humoral and cellular responses to vaccination were also analyzed. Results: A total of 898 patients from 14 European centers - part of the VALDIG network - were included, 872 (97.1%) patients received two vaccine doses (fully vaccinated), and 674 (75.1%) three doses. Of the total cohort, 151/898 had a COVID-19 infection prior to vaccination, of whom 9/151 (5.9%) were re-infected. Of the 747/898 patients who were not previously infected, 11.2% (84/747) were diagnosed with a COVID-19 infection during the study period. Two infected patients required intensive care unit admission and infection was fatal in two fully vaccinated patients. Adverse effects were reported in around 40% of patients, with local side effects being the most frequent. During the study period, 31 (3.5%) patients had thromboembolic events and 21 (2.3%) hepatic decompensations. No cases of vaccine-induced thrombocytopenia were reported. Vaccine immunogenicity was assessed in 36 patients; seroconversion reached 100% and IFNy T-cell responses significantly increased post two mRNA-1273 vaccine doses. Conclusion: Patients with VLD seem to have a preserved immune response to SARS-CoV-2 vaccination, which appears to be safe and effective in preventing severe COVID-19 infection. Our study cannot definitively establish a direct link between vaccination and thrombotic events, though the contribution of vaccination as a cofactor in VLD remains to be elucidated. Impact and implications: Patients with vascular liver disease (VLD) are at increased risk of both SARS-CoV-2 infection and severe COVID-19 disease. The potential risks associated with vaccination against this infection need thorough investigation. Our research enhances the understanding of the effects of COVID-19 vaccination in patients with VLD, highlighting its good tolerability. Moreover, patients with VLD appear to have a preserved immune response to SARS-CoV-2 vaccination, providing protection against severe COVID-19 infection. Our study cannot definitively establish a direct link between vaccination and thrombotic events, and no cases of vaccine-induced thrombocytopenia were reported.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans

  • Caicedo di Filippo, Dolly Andrea|||0009-0009-6523-0265
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Papaseit, Esther|||0000-0003-2620-4274
Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and with new approvals and therapeutic indications, there are challenges in minimizing the risks and interactions between cannabis-based products, cannabis prescription drugs, other approved prescription drugs, and other substances of abuse. Thus, identifying the enzymes metabolizing cannabinoid drugs and their relationship with other prescription drugs is crucial for understanding the potential interactions and effects of their simultaneous use. This article offers a comprehensive review of cannabis and the pharmacokinetic interactions between cannabis products, cannabis prescription drugs, and other approved prescription drugs, as well as other substances of abuse. It also compiles existing evidence of these interactions and describes the clinical outcomes associated with the inhibition or induction of various enzymes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The reproductive status determines tolerance and resistance to Mycobacterium marinum in Drosophila melanogaster

  • Arch Sisquella, Marta|||0000-0002-2120-1667
  • Vidal Ramos, Maria|||0000-0003-2705-9873
  • Fuentes, Esther|||0000-0002-6151-8204
  • Abat, Anmaw Shite
  • Cardona, Pere-Joan|||0000-0001-5623-7873
Sex and reproductive status of the host have a major impact on the immune response against infection. Our aim was to understand their impact on host tolerance or resistance in the systemic Mycobacterium marinum infection of Drosophila melanogaster. We measured host survival and bacillary load at time of death, as well as expression by quantitative real-time polymerase chain reaction of immune genes (diptericin and drosomycin). We also assessed the impact of metabolic and hormonal regulation in the protection against infection by measuring expression of upd3, impl2 and ecR. Our data showed increased resistance in actively mating flies and in mated females, while reducing their tolerance to infection. Data suggests that Toll and immune deficiency (Imd) pathways determine tolerance and resistance, respectively, while higher basal levels of ecR favours the stimulation of the Imd pathway. A dual role has been found for upd3 expression, linked to increased/decreased mycobacterial load at the beginning and later in infection, respectively. Finally, impl2 expression has been related to increased resistance in non-actively mating males. These results allow further assessment on the differences between sexes and highlights the role of the reproductive status in D. melanogaster to face infections, demonstrating their importance to determine resistance and tolerance against M. marinum infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis

  • Fondelli, Federico|||0000-0002-6875-4744
  • Willemyns, Jana|||0000-0001-6325-9309
  • Domenech-Garcia, Roger|||0009-0002-5742-566X
  • Mansilla, Maria José
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Ferreté-Bonastre, Anna G.|||0000-0003-3327-6129
  • Agúndez-Moreno, Alex|||0009-0000-9524-235X
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
Multiple sclerosis (MS) is a chronic disease characterized by dysregulated self-reactive immune responses that damage the neurons' myelin sheath, leading to progressive disability. The primary therapeutic option, immunosuppressants, inhibits pathogenic anti-myelin responses but depresses the immune system. Antigen-specific monocyte-derived autologous tolerogenic dendritic cells (tolDCs) offer alternative therapeutic approaches to restore tolerance to autoantigens without causing generalized immunosuppression. However, immune dysregulation in MS could impact the properties of the monocytes used as starting material for this cell therapy. Here, we characterized CD14+ monocytes, mature dendritic cells, and vitamin D3-tolDCs (VitD3-tolDCs) from active, treatment-naive MS patients and healthy donors (HDs). Using multiomics, we identified a switch in these cell types toward proinflammatory features characterized by alterations in the aryl hydrocarbon receptor (AhR) and NF-κB pathways. MS patient-derived VitD3-tolDCs showed reduced tolerogenic properties compared with those from HDs, which were fully restored through direct AhR agonism and by use of in vivo or in vitro dimethyl fumarate (DMF) supplementation. Additionally, in the experimental autoimmune encephalomyelitis mouse model, combined therapy of DMF and VitD3-tolDCs was more efficient than monotherapies in reducing the clinical score of mice. We propose that a combined therapy with DMF and VitD3-tolDCs offers enhanced therapeutic potential in treating MS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

  • Herencia-Ropero, Andrea|||0009-0002-9448-1484
  • Llop Guevara, Alba|||0000-0002-7913-9472
  • Staniszewska, Anna D.
  • Domènech-Vivó, Joanna|||0000-0002-8049-7488
  • García-Galea, Eduardo|||0000-0003-4699-0786
  • Moles-Fernández, Alejandro|||0000-0003-0252-6084
  • Pedretti, Flaminia
  • Domènech, Heura
  • Rodríguez, Olga|||0000-0002-0123-9975
  • Guzmán, Marta|||0000-0002-0924-9887
  • Arenas, Enrique
  • Verdaguer, Helena|||0000-0001-6163-382X
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Talbot, Sara
  • Tobalina, Luis
  • Leo, Elisabetta
  • Lau, Alan|||0000-0003-1055-9812
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Dienstmann, Rodrigo|||0000-0001-5997-318X
  • Macarulla Mercadé, Teresa|||0000-0002-5856-4082
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Diez, Orland|||0000-0001-7339-0570
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Forment, Josep V.|||0000-0002-7797-2583
  • O'Connor, Mark J.|||0000-0003-1823-625X
  • Albertella, Mark Robert
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Serra, Violeta|||0000-0001-6620-1065
Background: Poly (ADP-ribose) polymerase 1 and 2 (PARP1/2) inhibitors (PARPi) are targeted therapies approved for homologous recombination repair (HRR)-deficient breast, ovarian, pancreatic, and prostate cancers. Since inhibition of PARP1 is sufficient to cause synthetic lethality in tumors with homologous recombination deficiency (HRD), PARP1 selective inhibitors such as saruparib (AZD5305) are being developed. It is expected that selective PARP1 inhibition leads to a safer profile that facilitates its combination with other DNA damage repair inhibitors. Here, we aimed to characterize the antitumor activity of AZD5305 in patient-derived preclinical models compared to the first-generation PARP1/2 inhibitor olaparib and to identify mechanisms of resistance. Methods: Thirteen previously characterized patient-derived tumor xenograft (PDX) models from breast, ovarian, and pancreatic cancer patients harboring germline pathogenic alterations in BRCA1, BRCA2, or PALB2 were used to evaluate the efficacy of AZD5305 alone or in combination with carboplatin or an ataxia telangiectasia and Rad3 related (ATR) inhibitor (ceralasertib) and compared it to the first-generation PARPi olaparib. We performed DNA and RNA sequencing as well as protein-based assays to identify mechanisms of acquired resistance to either PARPi. Results: AZD5305 showed superior antitumor activity than the first-generation PARPi in terms of preclinical complete response rate (75% vs. 37%). The median preclinical progression-free survival was significantly longer in the AZD5305-treated group compared to the olaparib-treated group (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables, Is Machine Learning Superior to Logistic Regression?

  • Morote Robles, Juan|||0000-0002-2168-323X
  • Miró, Berta|||0000-0001-6049-8697
  • Hernando-Sánchez, Patricia
  • Paesano, Nahuel|||0000-0001-9278-5543
  • Picola, Natàlia|||0000-0002-8944-4294
  • Muñoz Rodríguez, Jesús|||0000-0001-5406-4729
  • Ruiz-Plazas, Xavier|||0000-0003-2135-3860
  • Muñoz Rivero, Marta Viridiana|||0000-0002-6899-3956
  • Celma, Ana|||0000-0002-3128-3811
  • García-de Manuel, Gemma
  • Servian, Pol|||0000-0002-3727-8159
  • Abascal, Jose Maria|||0000-0001-8374-6593
  • Trilla Herrera, Enrique|||0000-0001-9401-0872
  • Méndez Fernández, Olga|||0000-0003-4237-330X
Objective: This study compares machine learning (ML) and logistic regression (LR) algorithms in developing a predictive model for sPCa using the seven predictive variables from the Barcelona (BCN-MRI) predictive model. Method: A cohort of 5005 men suspected of having PCa who underwent MRI and targeted and/or systematic biopsies was used for training, testing, and validation. A feedforward neural network (FNN)-based SimpleNet model (GMV) and a logistic regression-based model (BCN) were developed. The models were evaluated for discrimination ability, precision-recall, net benefit, and clinical utility. Both models demonstrated strong predictive performance. Results: The GMV model achieved an area under the curve of 0.88 in training and 0.85 in test cohorts (95% CI: 0.83-0.90), while the BCN model reached 0.85 and 0.84 (95% CI: 0.82-0.87), respectively (p.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d, An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration

  • Buxeda, Anna|||0000-0001-7305-3259
  • Llinàs Mallol, Laura|||0000-0003-4696-3331
  • Gimeno Beltran, Javier|||0000-0001-6085-5228
  • Redondo-Pachón, Dolores|||0000-0002-0458-0052
  • Arias Cabrales, Carlos E.|||0000-0002-1729-8152
  • Burballa, Carla|||0000-0002-0091-1459
  • Puche, Adrian
  • López-Botet, Miguel|||0000-0003-4882-065X
  • Yélamos, José|||0000-0003-1195-1496
  • Vilches, Carlos|||0000-0002-0300-9225
  • Naesens, Maarten|||0000-0002-5625-0792
  • Pérez-Sáez, María José|||0000-0002-8601-2699
  • Pascual, Julio|||0000-0002-4735-7838
  • Crespo, Marta|||0000-0001-6992-6379
Isolated microvascular inflammation (iMVI) without HLA donor-specific antibodies or C4d deposition in peritubular capillaries remains an enigmatic phenotype that cannot be categorized as antibody-mediated rejection (ABMR) in recent Banff classifications. We included 221 kidney transplant recipients with biopsies with ABMR (n = 73), iMVI (n = 32), and normal (n = 116) diagnoses. We compared peripheral blood leukocyte distribution by flow cytometry and inflammatory infiltrates in kidney transplant biopsies among groups. Flow cytometry showed fewer lymphocytes and total, CD4, and CD8 peripheral T cells in iMVI compared with ABMR and normal cases. ABMR and iMVI had fewer total natural Killer (NK) cells but more NKG2A NK cells. Immunohistochemistry indicated that ABMR and iMVI had greater CD3 and CD68 glomerular infiltration than normal biopsies, whereas CD8 and TIA1 cells showed only increased iMVI, suggesting they are cytotoxic T cells. Peritubular capillaries displayed more CD3, CD56, TIA1, and CD68 cells in both ABMR and iMVI. In contrast, iMVI had less plasma cell infiltration in peritubular capillaries and interstitial aggregates than ABMR. iMVI displayed decreased circulating T and NK cells mirrored by T cell and NK cell infiltration in the renal allograft, similar to ABMR. However, the lesser plasma cell infiltration in iMVI may suggest an antibody-independent underlying stimulus.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Amyloid deposition in adults with drug-resistant temporal lobe epilepsy

  • Fonseca, Elena|||0000-0002-3895-1237
  • Lallana, Sofía|||0000-0002-5999-9889
  • Ortega, Gemma
  • Cano, Amanda|||0000-0001-9567-4283
  • Sarria Estrada, Silvana|||0000-0003-0083-362X
  • Pareto, Deborah|||0000-0001-7356-3769
  • Quintana, Manuel|||0000-0003-0288-9088
  • Lorenzo Bosquet, Carles|||0000-0002-8824-4602
  • López Maza, Samuel|||0000-0003-3660-2604
  • Gifreu, Ariadna
  • Campos Fernández, Daniel|||0000-0003-4795-5309
  • Abraira del Fresno, Laura|||0000-0002-5119-7929
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Puerta, Raquel|||0000-0002-1191-5893
  • Aguilera, Núria
  • Ramis, Maribel
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Rovira, Alex|||0000-0002-2132-6750
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Toledo, Manuel|||0000-0003-1550-3316
Objective: Pathological amyloid-β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1-42 and p181-tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug-resistant temporal lobe epilepsy (TLE). Methods: In this cross-sectional study, we enrolled individuals with drug-resistant TLE who were 25-55 years old. Each participant underwent F-flutemetamol PET, determination of CSF Aβ1-42, p181-tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET. Results: Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4-24) years. Twenty-six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z-score =.90, 95% confidence interval [CI] =.60-1.20; contralateral: SUVR z-score =.92, 95% CI =.57-1.27; p <.001), which was higher when compared to SUVR z-scores in all the remaining regions (p <.001) and in the ipsilateral anterior cingulate (SUVR z-score =.27, 95% CI =.04-.49, p =.020). No significant deposition was observed in other regions. Seven patients (23%) had low Aβ1-42 levels, and two (7%) had elevated p181-tau levels in CSF. Higher p181-tau levels correlated with poorer verbal fluency (R = -.427, p =.044). Significance: Our findings reveal a considerable Aβ deposition in mesial temporal regions and ipsilateral anterior cingulate among adults with drug-resistant TLE. Additionally, abnormal CSF Aβ1-42 levels were observed in a significant proportion of patients, and p181-tau levels were associated with verbal fluency. These results suggest that markers of neuronal damage can be observed in adults with TLE, warranting further investigation.